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Preparation of Enantioenriched Alkyltin Species and Their Application in Stereospecific 
Transformations: A Case Study  
 
by 
Glenn O. Ralph 
 
Advisor: Doctor Mark Biscoe 
Organometallic reagents containing the tin-carbon bond are used extensively in modern synthetic 
chemistry for the formation of new bonds to carbon. Over recent decades, transition metal 
catalyzed cross coupling reactions between two C(sp2) centers have been widely developed. 
However, the introduction of a C(sp3) center complicates the catalytic cycle, and opens 
unproductive chemical pathways which lead to isomerization, elimination, and racemization 
(Figure 1). Our lab has developed a modified-Stille reaction to combat the deleterious effects of 
β-hydride elimination. Our protocol enables unactivated 2° alkyl organotin nucleophiles to 
undergo efficient cross coupling reactions with C(sp2) electrophiles, avoiding the drawbacks 
commonly associated with such a synthetic approach. Analysis of the final products has shown 
our system to be highly stereospecific, which allows for translation of chiral information from 
our organometallic nucleophiles to the resulting arylation and acylation products (Figure 2-a,b). 
This specificity was also found to exist in an electrophilic halogenation reaction unrelated to the 
cross coupling mechanism (Figure 2-c). 
This report will focus on our attempt to solve the major bottleneck for broader utility of our 
system, the preparation of enantioenriched tin precursors. Until recently, 2° alkyl tin compounds 
 v 
were not a synthetically useful species, as the rate of 2° alkyl transfer was simply too slow. With 
our nucleophiles exempt from that limitation, we began searching for a proper, general synthetic 
method for their preparation. We found that by utilizing a lithium-naphthalide catalyst, a 
tricarbastannatrane anion could be prepared from the corresponding chloride. By using this 
reagent, we observed the clean inversion of alkyl sulfonates from commercially available 
enantioenriched alcohols (Figure 3). No longer tethered to directed lithiation or chiral prep-
HPLC separations, we were able to expand our library of tin nucleophiles with defined 
stereochemistry. This report will cover the development of the tricarbastannatrane anion and a 
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 By design, the fundamental goal of modern synthetic chemistry will always be just out of 
reach. Synthetic chemists worldwide are forever in search of better control of atoms, molecules, 
and their behavior. Agriculture, energy, and medicine, the pillar stones of civilization, rely 
heavily on our ability to rationally manipulate the chemical space. To achieve forward progress 
in these areas, it is essential that our chemistry is always more robust, more selective, more 
efficient, and more straightforward.   
 Organic chemists implement a diverse set of synthetic methods to craft the molecules our 
civilization relies upon.  The shape of the carbon framework and selected presence of 
heteroatoms dictate the behavior of these compounds.  Typically, a given framework will consist 
of several hybridization states of carbon, which help define its chemical, physical, and biological 
properties. When carbon has bonds to four atoms, the bonds are C(sp3) hybridized, are lowest in 
energy, and tend to be most stable. It is well established that as unsaturation increases, to C(sp2), 
then C(sp), the bonds get shorter, more reactive, and higher in energy.  Hybridization effects 
structural orientation as well. C(sp3) hybridized carbon bonds are tetrahedral, meaning they 
occupy functional space in all three dimensions.  C(sp2) hybridization has been described as 
“flat”, occupying space in two dimensions, with C(sp) hybridization occupying only one.1 
  In the case of a saturated carbon with four unique bonds, some properties are affected by 
the “handedness”, or chirality of the molecule.  Louis Pasteur first discovered molecular chirality 
in the mid-19th century.  He noticed portions of conglomerate crystals of tartaric acid salts 
appeared to be non-superimposable-mirror-images, and completed the first identification and 
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intentional separation of a racemic mixture.2 In his later career exploring fermentation, he 
reported that 
“...the two tartaric acids, right and left, is subjected to the same method of fermentation, 
it is resolved into the right acid which is fermented and left acid which remains intact, in such a 
way that the best means of obtaining left tartaric acid I know of today is to resolve paratartaric 
acid by fermentation.”2 
This is the first published observation of racemate selectivity in a biological process; 
meaning one part of the racemate, or an enantiomer, had observable properties in contrast to the 
opposite enantiomer. 
 From the discovery of the Grignard reagent in the 1900’s, to the more sophisticated 
transformations of the present, expertise regarding the behavior of carbon during a chemical 
reaction is essential to address our synthetic goals.  The diversity of carbon bond manipulations 
known to modern chemists is, for obvious reasons, too vast to summarize.  However, it is 
possible to emphasize the importance of direct, rational control of general synthetic methods in 
order to attain the molecule of interest.  Regardless of specific field, organic synthesis targets 
contain a variety of complex carbon states, and the ability to control carbon bond-forming 
reactions within a diversity framework is essential.  The following is a statement regarding the 
impact of modern synthetic methodology on structural diversity. 
 
1.1 Criticisms of a modern approach to synthesis:  
In the last decade, there have been several well-written criticisms of the current 
implementation of synthetic chemistry for medicinal drug discovery.  In 2009, Frank Lovering 
published his opinion in the Journal of Medicinal Chemistry, suggesting an “Escape from 
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flatland” is needed,1 while Dean J. Brown, in 2015 asks; “Where have all the new reactions 
gone?”3 It could be argued that these critiques are relevant in some degree to all forms of 
synthesis research. The two reports are related as they both criticize modern developments in 
synthetic chemistry for biasing towards less complex, less structurally interesting molecular 
scaffolds.  Additionally, these reports are evidence that modern complexity-building methods are 
not robust or straightforward enough for a broader general utility within the synthetic 
community. 
 Lovering began his argument with the hypothesis that developments in reliability, 
versatility, and high throughput capability of C(sp2)-C(sp2) cross coupling reactions are biasing 
drug discovery efforts toward targets with less natural product-like character.  To test the 
hypothesis, he looked for a correlation between the complexity of a molecule and its ability to 
progress through the phases of clinical testing.1 For his study, he approximated the complexity of 
a molecule by comparing saturation and chirality.  He defined saturation as Fsp3, or the fraction 
of Csp3 hybridized carbons over the total number of carbons present in the molecule.  For 
chirality, he simply observed whether or not the molecule in question contained one or more 
chiral centers.  Screening these conditions against the clinical testing database of GVK BIO from 
1980 onwards, he found a direct correlation between his definition of complexity and progress 
through the trial phases.  He concluded his work by referencing the diversity-oriented synthesis 
movement in synthetic chemistry.  The goal of which is to combat flatland with the discovery of 
more accessible and reliable methods to increase complexity in molecules.1  
 Dean J. Brown, who several years later cites Lovering’s work in his own criticism, is also 
a proponent of diversity-oriented synthesis.  His article is a simple yet thorough analysis of the 
historical (1984) and modern (2014) synthetic approaches to medicinal and natural product 
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targets.  He extracted relevant publications from the Journal of Medicinal Chemistry, the Journal 
of the American Chemical Society, and Angewandte Chemie International Edition from each of 
the two years, and reviewed the most frequently used chemical reactions (Figure 1.1).3 He found 
the most commonly used reactions of 1984 were still the most popular 30 years later, with the 
exception of C(sp2)-C(sp2) cross coupling and amide bond formation. He also argues the need to 
move away from C(sp2) bond based structures in order to access a new era of  chemical 
scaffolds.  Among other things, he proposes expedited integration of modern chemical 
methodologies, expansion into less occupied chemical space (i.e., three dimensions), and the 
selection of the most appropriate chemical route, not simply the most expeditious.  
 
Figure 1.1: 30 years of impact.  Brown reports the most used chemical reactions from the years 
1984 and 2014.3 The arrowed dates refer to the date of discovery, which emphasizes the 
popularity and age of the reaction. 
 
30 years of impact
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1.2 Necessity for enantiomerically pure chemical targets:  
For the total synthesis of functionalized three-dimensional molecules containing chiral 
centers, control of final product stereochemistry is essential.  A chiral drug administered as a 
racemic mixture can essentially behave as two separate drugs in biological systems. For 
example, racemic albuterol is a chiral small molecule drug commonly used for inhalation therapy 
of acute airway obstruction.  The Merck Manual, Veterinary Manual, describes the difference in 
biological activity as follows. 
 “The R-enantiomer has bronchodilatory and anti-inflammatory effects, and the S-
enantiomer paradoxically is associated with increased airway hyperreactivity and pro-
inflammatory effects.” 4  
For this racemic mixture, the beneficial enantiomer can be used to help treat breathing 
problems, while the opposite configuration was shown to exacerbate breathing problems (Figure 
1.2-a). This biological selectivity is not the only, or most severe example known.  Thalidomide is 
an infamous biologically active small molecule drug. Initially developed in Germany, 
Thalidomide was released globally in the 1950’s. It was, and to some degree still is, used as a 
therapy for a variety of ailments including morning sickness, leprosy, certain cancers, Crohn’s 
disease, and HIV.5 Its use to combat morning sickness in the 1950’s led to reports of birth 
defects and other pathologies.  It took 10 years and 10,000 cases of major birth defects before the 
therapy was discontinued.  It was then discovered that the (R)-enantiomer was responsible for 
the therapeutic effects, while the (S)-enantiomer was responsible for birth defects.  Thalidomide 
has been considered the largest man-made medical disaster in history (Figure 1.2-b).5  
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Figure 1.2: Racemate selectivity in biological processes. The inversion of single point chirality 





From a practical standpoint, the three common ways to obtain a single product 
enantiomer are racemate separation, asymmetric induction, or stereospecific translation.  All 
three methodologies have merit.  Separation of racemates is effective, but suffers from complex, 
sometimes difficult or impossible separation techniques, along with the obvious waste associated 
with formation of the opposite enantiomer.  Referring back to Louis Pasteur, his painstaking 







































conglomerate.  This process was indeed tedious, and required multiple 
solvation/recrystallization/separation cycles.  In an achiral environment, enantiomers have 
identical chemical and physical properties.  The conglomerate crystal mixture Pasteur observed 
occurred due to the affinity of an enantiomer to crystalize with itself.  Although archaic sounding 
by todays standards, the fundamental principal behind the first separation remains the foundation 
of modern chiral separation techniques; i.e. enantiomers are non-identical compounds, and can 
behave selectively in strictly optimized chemical environments.6   
Sohrab Rohani, in 2010 from the University of Western Ontario, reviewed resolution by 
crystallization of modern active pharmaceutical ingredients (API).7 The work explains how 
enantiomer self-affinity crystallization is unreliable.  Conglomerate crystals from racemic 
mixtures of single point chirality APIs are, in large part, inseparable.  This is because in non-
ideal circumstances, crystal lattices can alternate between (R)- and (S)- either orderly, or in a 
random distribution. Therefore, common industrial crystallizations rely on pre-derivatization 
with a resolving agent to form diastereomers, or non-mirror-image stereoisomers.  Often times, 
the difference in solubility of diastereomers is conducive to a separation by crystallization.  Loss 
of yield due to non-essential chemical manipulation and handling, and incompatibility with non-
crystalline materials are limitations of this method. 
Another modern method for racemate separation is chiral chromatography.  This process 
utilizes chiral stationary phase interactions to introduce racemate differentiation, even on an 
industrial scale.  In 2014, The Daicel group by Chiral Technologies Inc. presented their solutions 
to some of the problems associated with enantiomer crystallization.8 They argue that practical 
chromatography is not the temporary, inelegant solution that conventional wisdom believes it to 
be. Their development solution involves the determination of optimum analytical conditions 
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based on a thorough method screening. In combination with a loading and stability study, the 
process can result in the isolation of megatons of a single enantiomer in flow, or in batch.   
Although useful for the large-scale synthesis of complex API molecules, there are serious 
limitations for crystallization or chiral chromatography as a technique to obtain enantiopure 
products. There is a significant waste associated with the exclusion of the non-target enantiomer. 
If late-stage chirality is introduced, the yield of potentially valuable intermediates is then reduced 
to a maximum of 50%.  Second, if derivatization to diastereomers is required, then non-essential 
losses of yield based on further chemical manipulation and handling is incurred. Racemate 
separation via crystallization is not appropriate for compounds that do not form lattice structures, 




Asymmetric induction, or the selective generation of a stereocenter via catalyst, substrate, 
enzyme, or additive control, is an incredibly powerful synthetic methodology that is continually 
being developed. Induction via chiral catalyst, of which there are many examples in the 
literature, capitalizes on the difference in energy between the transition states of opposing 
enantiomer formation.  If the energy difference is sufficient, the pro-chiral substrate is oriented 
or activated so the desired bond forms one product enantiomer selectively. Many bond-forming 
iterations of this technique are used regularly. It must be emphasized that absolute configuration 
of the final product is being generated by the reaction of non-chiral or racemic starting materials.  
Another method of asymmetric induction, dubbed “deracemization”, must be mentioned 
in this context.  Deracemization can be thought of as a dynamic equilibrium in the presence of a 
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chiral agent. Yue Ji published a great example of this reaction in 2015.  In this work, it was 
shown that a one-pot redox reaction was capable of producing a single enantiomer from racemic 
compounds containing a tetrahydroisoquinoline core.9 By choosing an orthogonal oxidative and 
reductive agent pair, and the addition of a chiral ligand, Ji was able to deracemize the title 
amines with excellent yields and enantioenrichment (Figure 1.3).  A deuterium labeling study 
suggested an imine intermediate, and it was proposed that the reduction reaction is selective via 
chiral ligated iridium-based hydrogenation.  As the equilibrium proceeds, enantiodifferentiation 
occurs between the chiral catalyst and proposed imine during hydrogenation, which favors the 
formation of a single enantiomer.  
 
 
Figure 1.3: Deracemization of tetrahydroisoquinoline core: Optically active final products 
are observed for the redox deracemization of tetrahydroisoquinoline cores using NBS and 
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Deracemization of tetrahydroisoquinoline core
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There have been many examples in the recent literature that validate asymmetric 
induction as a methodology for obtaining enantioenriched final products. However, it has been 
shown that small steric or electronic perturbations of the substrate can decrease or erase this 
selectivity entirely.  It is difficult to predict how strongly these catalyst/substrate interactions will 
be, or which orientation will form the desired bond, so this methodology often requires intense 
optimization from substrate to substrate. This becomes problematic for SAR studies, for 
instance, where targeted diversity among similar scaffolds is essential. Although incredibly 
valuable, this approach can suffer from a lack of generality and predictability.  
 
1.5 Translation: 
Stereospecific translation of chirality is a valuable approach to diversity-oriented 
synthesis.  From the simplest perspective, this can involve bond formation distal to point 
chirality, or reaction upon a structural motif that precludes the formation of a racemic mixture, 
like epoxide ring opening. Although useful in certain applications, a more elegant approach 
involves translation of chirality through bond manipulation at the chiral carbon. Two examples 
of these types of transformations involve the utility of formal SN2 mechanisms and transition 
metal catalysis. 
The benzylic position of a chemical building block, common to many natural and 
therapeutic molecules, is of recent interest in synthesis.  This position has been known to behave 
somewhere between a formal C(sp2) and C(sp3) hybridized carbon, due to α-activation of the 
benzene ring.  The Kobayashi group accomplished the most recent development involving a 
stereospecific translation at this position (Figure 1.4-c).10 This represents a significant evolution 
of their work in 2016 regarding the displacement of α-unsaturated diethylphosphate leaving 
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groups (Figure 1.4-a).11 They generated a known diarylmethyllithium reagent, and observed 
clean inversion of starting material without the use of metal catalysis. By replacing the ethyl 
phosphate groups with phenyl, they were able to attack the carbon of interest selectively for 2° 
alkyl and saturated carbocyclic substrates (Figure 1.4).  This use of a formal SN2 mechanism 




Figure 1.4: Inversion for chiral translation. A formal SN2 mechanism is still relevant for the 
preparation of useful enantiopure chemical targets.  The Kobayashi group reports clean inversion 
of an allylic diethyl phosphate (a), but observed predominately by-product with fully saturated 
phosphates (b).  Replacing the ethyl groups with phenyl, they observed the desired selectivity 
(c). 
 
Another example of stereospecific translation requires the use of 2° organometallic 
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Inversion for chiral translation
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reaction has made it a very useful approach to synthesis. Modern research groups have achieved 
great success by implementing an enantioenriched organometallic reagent as a coupling partner. 
Cross-coupling reactions of this type encompass a wide set of chemical transformations, several 
of which will be discussed later in more detail. Due to the many challenges of such an approach, 
only a selection of these methods introduce three-dimensional complexity through general, 
predictable, stereospecific translations. However, the independence of steric or electronic effects 
allow for a more targeted, rational synthetic approach to enantioenriched products.   
 
1.5 Conclusion: 
For a modern world with challenging synthetic hurdles in agriculture, energy and 
medicine, it is imperative that we continue to develop chemistry to address them. The discovery 
and development of C(sp2)-C(sp2) cross coupling technology has been an undeniable boon to 
chemical synthesis, but if we rely too heavily on its simplicity and reliability, it may inherently 
bias our science. It has been shown that increased molecular complexity can lead to more 
efficient and productive chemical solutions, and historically robust manipulations are not 
sufficient.  
There are many valid synthetic approaches to diverse, complex, and structurally 
interesting molecules.  Of the most common techniques, each has its utility and limitations.  For 
constructing complex bonds to carbon, we implement stereospecific translation by combining the 
versatility of transition metal catalysis with the robustness of configurationally stable 
enantioenriched organometallic nucleophiles.  We believe this combination will result in easy 
access for the synthetic community to achieve general, rational, complexity in target molecules 
without the limitations of current methods.  
 13 
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2.1 Transition metal catalyzed cross-coupling reactions:  
The impact of transition metal catalyzed carbon-carbon cross-coupling reactions on 
synthetic organic chemistry is well known.  The reliability, versatility, and robustness of these 
types of reactions allow them to be utilized for all scales of synthesis, from academia to industry.  
While the cross coupling of C(sp2)-C(sp2) centers is well established across a wide variety of 
catalysts, conditions, and substrates, incorporation of a C(sp3) center still presents challenges. 
 A forward thinking review published this year, by Campeau and Hazari, chronicle a 
history of cross-coupling technology as evidence for their road map of future coupling 
techniques.1 Broadly speaking, cross-coupling reactions occur via transition metal catalysis.  
This discovery relied on the early observations that homo-coupling of Grignard reagents occur in 
the presence of a catalytic amount of first row transition metal salt and an oxidizing agent.  This 
led to the first example of a formal cross-coupling between alkenyl halides and Grignard 
reagents via iron catalysis in 1971.1 From there, the field specialized into the various named 
transition metal catalyzed cross-coupling reactions that have greatly impacted how we do 
synthesis.  This impact is the basis for the criticisms of Lovering and Brown in the last decade. 
When cross-coupling two C(sp2) centers, the generic catalytic cycle is invoked to describe the 
several fundamental transformations that occur (Figure 2.1). This cyclic mechanism, or subtle 
variation thereof, can be applied to several well-known organometallic named reactions.  The 
most notable are the Suzuki, Negishi, Kumada and Stille reactions. These transformations are 
named for the specific metallic handle on the nucleophilic coupling partner.   The unifying trait 
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of these reactions is the new C-C bond formed by reductive elimination of the two coupling 
partners from the transition metal center.  
 
 
Figure 2.1: The simplified catalytic cycle. Commonly used to describe the general 
transformations observed between transition metal catalyst, a C(sp2) hybridized organic 
electrophile, and C(sp2) hybridized organometallic nucleophile. 
 
It is well established that when using a palladium catalyst in a cross-coupling reaction, a 
series of oxidative addition, transmetallation, and reductive elimination occur.2 Oxidative 
addition can be thought of as a nucleophilic attack of the active palladium catalyst on the 
electrophilic coupling partner.  The transformation normally involves a pre-coordination of the 
metal to the pi system of the electrophile, followed by the insertion event.3 This results in 
oxidation of the metal center, which for palladium is typically Pd(0) to a Pd(II) species.  The Pd(II) 




























coupling partner to the electrophilic Pd(II) complex, which results in a second Pd(II) complex, 
which bears both of the intended coupling partners.  Mechanisms of transmetallation and 
perturbations that impact the transition state will be discussed in a later section.  Reductive 
elimination is the formal coupling event, in which a new C-C bond is formed, and the metal 
center is reduced back to the active state of Pd(0). The catalyst is now free to re-enter the cycle.  It 
is believed that each catalytic transformation is in dynamic equilibrium, and that a single 
perturbation to the system can affect the efficiency of the entire sequence of events. This general 
process is commonly limited to the use of C(sp2) coupling partners as attempts to integrate a 
C(sp3) coupling partner often results in no reaction or the formation of undesired byproducts.2 
It should be mentioned that there are alternative schemes to the traditional cross-coupling 
reaction involving an electrophile, nucleophile, and catalyst. Oxidative cross-coupling and cross-
electrophile-coupling are both metal catalyzed schemes that couple either two nucleophilic or 
two electrophilic reagents. Carbon-carbon and carbon-heteroatom bonds can be formed this way 
in a variety of hybridizations. Typically in both schemes, a super-stoichiometric amount of 
oxidant or reductant is added to promote the more appropriate reactive state of the transition 
metal. Homo-coupling is a common unproductive pathway for these reactions, which is possibly 
why they are considered under-investigated.  If this topic is of interest, the reader can follow up 
with Liu’s review on oxidative cross-coupling from 2011,4 or Everson’s review on cross-
electrophile coupling from 2014.5 
 
2.2 Cross-coupling a C(sp3) hybridized reagent: 
The addition of C(sp3) coupling partners to the catalytic cycle is becoming more 
commonplace, and protocols have been developed for primary, secondary, and to a lesser extent, 
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tertiary alkyl transfers.2 With the addition of alkyl systems into cross coupling reactions, it 
became possible to transfer selective chirality to the final products. This significant synthetic 
accomplishment will be discussed later in more detail. 
The primary hurdle to overcome when using palladium and a C(sp3) coupling partner is 
related to the transfer rate observed for various coupling groups. Alkynyl substituents typically 
transmetallate fastest.  This is primarily due to the impact of increased s-character on orbital 
overlap with the d-orbital of the transition metal during the transfer event.  The rate slows as s-
character decreases in aryl and vinyl systems.6 For C(sp3) systems, the differentiation is more 
about sterics.7 A primary system will transfer faster than a secondary system, with a tertiary 
system being the slowest. Normally, some form of activation is required to facilitate the transfer 
of a C(sp3) center. 
 Another challenge to overcome in attempting to couple any C(sp3) center is evident by 
observing the structure of an alkyl-bearing transition metal complex. When Pd(II) contains an 
alkyl group, a thermodynamically competitive mechanism observed is β-hydride elimination.  
This phenomenon unlocks a non-productive chain of transformations, which lead to elimination, 
isomerization, and racemization of the desired coupling product (Figure 2.2).  It has been shown 
that β-hydride elimination can be overcome by leveraging strongly activated coupling partners, 
or a finely tuned catalyst system. Although there are several methodologies currently under 
investigation, they all effectively subvert the β-hydride elimination pathway, and result in 






Figure 2.2: Cross-coupling a C(sp3) nucleophile. Describes the additional reactivity pathways 
for organometallic complexes that contain a β-hydrogen. 
 
For the sake of completion, it should be mentioned that C(sp3) electrophiles are currently 
being investigated in cross-coupling reactions. Editor Yasushi Nishihara reviewed the current use 
of alkyl electrophiles in a later section of the book Applied Cross-Coupling Reactions in 2013.3 
The section was prefaced with two fundamental complications regarding that approach.  First, 
there is significant difficulty in promoting the oxidative addition of a carbon electrophile that 
does not contain a pi system.  With no pre-coordination event, harsher conditions are required to 
force the insertion reaction to occur.  Second, the newly formed carbon-metal bond is susceptible 
to β-hydride elimination.  Several research groups have successfully navigated these 
limitations.3, 8, 9   This method is a valid approach to incorporate molecular complexity and was 
recently reviewed by Wu in 2018.10 
The earliest examples of transmetallation with a C(sp3) nucleophile were published in the 










































alkyl lithium, Grignard, zinc, aluminum, tin and boron reagents.11 The authors were able to avoid 
β-hydride elimination for 1° nucleophiles by implementing sufficiently bulky ligands on a nickel 
or palladium catalyst.  It was proposed that bulky ligands promote an accelerated rate of 
reductive elimination due to forced proximity of the coupling partners (Figure 2.3).   
Further developments in the field led to the use of secondary alkyl nucleophiles.   
Hayashi et al. reported a system in 1984 that was capable of coupling secondary alkyl zinc and 
Grignard reagents with organic halides using a bidentate ferrocene-based ligand system.12 At 
roughly the same time, advancements in tin and boron chemistry led to their utility in similar 
secondary systems.13   
 
 
Figure 2.3: Ligand crowding effect on reductive elimination. Non-bulky ligands are 
associated with a decreased rate of reductive elimination (a). Encumbered ligands restrict 
substituent mobility around palladium, and accelerate reductive elimination (b). 
 
The push towards tin and boron based nucleophiles was pursued for several reasons.  In 
the early work with secondary systems, strongly nucleophilic organometallic reagents were 
required to achieve transmetallation.  It was found that this limited the functional group 
compatibility associated with a useful cross-coupling reaction.  Additionally, the instability of 









leading to a lack of broad utility.  Tin and boron based nucleophiles are more stable, and promote 
a wider range of functional group tolerance.  
 
2.3 Enantiospecific cross-coupling of configurationally stable nucleophiles: 
When discussing the relative reactivity of the various metallic handles, it is important to 
mention the inverse relationship between nucleophilicity and configurational stability. 
Nucleophilicity increases along the set as the ionic character of the carbon-metal bond increases. 
As ionic character increases, a decrease in configurational stability is typically observed (Figure 
2.4).14 This facet is essential for understanding the methodologies associated with enantiospecific 
cross-coupling reactions.  Strong 2° alkyl nucleophiles are inherently easier to transmetallate, yet 
typically lead to racemic products. Alkylboron and alkyltin compounds capable of promoting 
transmetallation have been shown to efficiently translate chiral information into final products.   
 
 
Figure 2.4: Trends in chemical properties.  The general relationship between nucleophilicity 
and configurational stability observed for the most common metallic handles. 
 
 
As of 2015, there are several examples of in situ-generated configurationally stable 
lithium, Grignard, and zinc-based organometallic nucleophiles capable of achieving 
ionic character
M = B  <  Sn  <  Zn  <  Mg  <  Li
M = B  <  Sn  <  Zn  <  Mg  <  Li
nucleophilicity
configurational stability
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enantiospecific translation,15-22 but the processes lack generality and reliability. Additionally, 
these methods are limited by functional group compatibility of the substrate. It could also be 
argued that isolable and bench-top stable reagents are more conducive to broader utility in the 
synthetic community. Another approach includes the preparation and isolation of an 
enantioenriched organometallic building block, capable of rational incorporation of selective 
chirality at any stage of synthesis. 
The Suzuki reaction, developed in 1995 by Akira Suzuki and Norio Miyaura, is the most 
widely investigated cross-coupling reaction scheme.23 Suzuki reactions implement an activated 
organoboron(ate) for transmetallation.  Organoboron compounds are commercially available as a 
variety of useful chemical building blocks, and there are multiple reliable synthetic preparation 
methods. Jason Rygus and Cathleen Crudden published an incredibly thorough review of modern 
Suzuki cross-coupling reactions in 2017.24 They describe the wide variety of isolable 
organoboron compounds currently capable of enantiospecific translation.  Beginning in the early 
2000’s, both the Deng and Gevorgyan groups found that enantioenriched cyclopropyl substrates 
were compatible.25, 26  For the next almost two decades, this system inspired work with larger 
alicyclic,27-29 benzylic,30 allylic,31, 32 biarylmethyl,33 β- or γ- carbonyl containing,34-39 γ-
hydroxy,40, 41 and α-heteroatom containing40, 42, 43 organoboron reagents (Figure 2.5). It was 
found that activating/directing scaffolds were essential for reactivity. The reported 
transformations gave rise to systems of iterative Suzuki cross-coupling reactions,44, 45 which 
resulted in the invention of an automated “small-molecule synthesizer.”46 
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Figure 2.5: Organoboron scaffolds in stereospecific Suzuki reactions.  Developments in 2° 
organoboron compatibility have led to varied success in un-activated alicyclic systems (left).  
Activated systems have delivered great success in stereospecific arylation reactions (right). 
 
There is no doubt that Suzuki chemistry has greatly impacted the field of synthetic 
chemistry.  However, enantiospecific Suzuki reactions have multiple limitations. Control 
experiments have shown that if activating/directing groups are not present in the organoboron 
reagent, a corresponding drop in yield or enantiospecificity is observed.24 This can be explained 
by the aforementioned relationship between nucleophilicity and configurational stability.  Boron 
is the least nucleophilic of the commonly used metallic handles.  Therefore, activation within the 
alkyl group being transferred is required to promote effective transmetallation. This is a 
limitation of the inherent properties of the transfer group of interest, which suggests the 
possibility that boronate scaffolds not mentioned will have a lower chance of success.   
As of 2017, only one reaction scheme is capable of an enantiospecific Suzuki reaction 
that utilizes un-activated reagents that do not contain directing groups (Figure 2.6). The Biscoe 
group reported inversion of configuration using enantioenriched sec-butyl boronic acid and 






















system was inspired by the work of Molander and Dreher,27 and utilized a preformed P(t-Bu)3 




Figure 2.6: First enantiospecific arylation of an un-activated organoboron.  The conditions 
reported by the Biscoe group, utilizing an enantioenriched alkylboron nucleophile with no 
directing or activating groups present in the desired coupling fragment. 
 
 
Figure 2.7: Generic stereospecific mechanism.  An SE2 retentive mechanism is associated with 
a closed, cyclic transition state (top), while an SE2 invertive mechanism is associated with an 
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Another significant limitation to broad utility of stereospecific Suzuki couplings is the 
sensitivity of mechanism reported for the various activating/directing groups.  This phenomenon 
allows some boron nucleophiles to promote retentive products, while other, structurally similar 
nucleophiles promote inversion. Suzuki reactions involving benzylic and α-OBn containing 
boron nucleophiles specifically result in retention of configuration.24  This suggests a closed SE2 
mechanism.  The remaining activated substrates generally promote invertive products, 
suggesting an open SE2 mechanism (Figure 2.7).  
The Suginome group reported a synthetically useful example of this dichotomy in 2011.34 
They subjected the enantio-invertive cross-coupling of an α-amide alkylboron reagent to 
increasingly acidic additives, and reported an optimized 93%ee of retention in the final products. 
They propose pre-coordination of the amide carbonyl and the boronic ester prior to 
transmetallation results in inversion, while acidic additives disrupt the coordination event, which 
led to retention of configuration (Figure 2.8).  Although incredibly reliable for a variety of 
enantiospecific transformations, the Suzuki reaction is not necessarily the most versatile or the 





Figure 2.8: Variability in mechanism for enantiospecific Suzuki cross-coupling.  The amide 
carbonyl promotes an open invertive mechanism via boron activation (top). If an appropriate 
Lewis acid is present, the mechanism switches to closed retentive. 
 
2.4 Alkyltin nucleophiles for enantiospecific cross-coupling: 
Another method for cross-coupling isolable, configurationally stable organometallic 
nucleophiles is the Stille reaction.  Reactions that fall into this category implement an 
organostannane nucleophile.  The Stille reaction will be discussed more thoroughly due to its 
direct relevancy to this dissertation. 
Discovered in 1978 by John Stille and David Milstein, the Stille reaction has attracted 
considerable development.  From a practical standpoint, the utility of the Stille reaction is similar 
to that of the Suzuki reaction.  Often times, both reactions are valid, reliable approaches to forge 
the same chemical bond.  However, the Stille reaction is better known for robustness, selectivity, 
and mild conditions.  It is imperative that these conditions are met in total synthesis.  In 2014, 
Heravi reviewed the Stille reaction under the lens of application in very complex total synthesis 








































antibiotic etnangien (Figure 2.9). This relied on the coupling of two late-stage, very functionally 
dense components, which was achieved in 70% yield.   
 
 
Figure 2.9: Stille coupling in etnangein synthesis. The efficient late-stage cross-coupling of 
two functionally dense fragments in the total synthesis of the antibiotic etnangien. 
 
When utilizing a C(sp3) hybridized organostannane, there are additional complications to 
overcome in addition to those of the Suzuki reaction.  Organostannanes typically require four 
carbon substituents to reach the level of energy required for transmetallation.  For typical C(sp2) 
couplings, handles like tri-n-butyl, trimethyl, triethyl, etc. are used as less reactive place-holding 
substituents on tin (dummy ligands).  The more labile C(sp2) carbon will transfer selectively.  
Early success in transferring alkyl groups from tin relied on two methods; either the tetra-






















Stille coupling in etnangien synthesis
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useful material, or activation of the desired group by one of the methods mentioned previously 
(e.g., benzylic, α-heteroatom, etc.). In addition to this, there are very real concerns regarding the 
general toxicity of organostannane reagents.49   
 
2.5 Possible mechanisms: 
A closer look at mechanistic proposals is useful for a better understanding of 
enantiospecific cross-coupling via Stille reactions.  Cordovilla published a thorough review of 
literature regarding the Stille mechanism up to 2015.50 He proposes the more detailed mechanism 
shown in Figure 2.10. This mechanism rationalizes changes in selectivity attributed to ligand 
and additive effects by obeying the rules of coordination chemistry.  After an initial 
isomerization event, three potential routes of reactivity exist for the oxidative addition complex.   
First, the organostannane can displace a ligand to form a cyclic transition state (Figure 
2.10-a).  This is supported by DFT calculations by the author that suggest a tetra-coordinate 
palladium is more energetically favored than a concerted, penta-coordinate transition state.  
Experimentally, it has been found that strongly electronegative halide substituents and weakly 
binding ligands promote this pathway.  Second, the organostannane can displace a halide or 
leaving group substituent on palladium, which would directly lead to an open transition state 
(Figure 2.10-b).  Third, a neutral (solvent) substituent can replace the halide/leaving group prior 
to transmetallation, resulting in a cationic palladium species.  This complex is also believed to 
participate in an open transition state (Figure 2.10-c).  Open transition state mechanisms are 
associated with weakly coordinating anionic substituents (e.g., triflates), or strongly coordinating 




Figure 2.10: Detailed Stille catalytic cycle. The prototypical oxidative addition complex (1) has 
three potential pathways of reactivity; organometallic displacement of a ligand (a), displacement 
of an anionic substituent (b), or ligand substitution (c).  These pathways affect the transition state 
of transmetallation. 
 
The stereospecificity of products from the earliest examples of C(sp3)-C(sp2) Stille 
reactions with palladium as the sole catalyst showed that both mechanisms are reasonable.  A 
stereoretentive transformation is associated with a closed or cyclic transition state, while 




























































X = halide or triflate substituent
S = strong coordinating solvent
(1)
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acknowledge that even the more detailed mechanism is still probably an oversimplification of the 
complete mechanism. 
For enantiospecific Stille reactions that contain a copper additive, stereoretentive 
products are formed exclusively.50 Copper has a unique effect on the Stille reaction, and the 
relationship is not completely understood. Cordovilla proposes two different roles. First, copper 
is a known ligand scavenger.  In solution, it is possible that copper can accept a ligand during 
transition states where exogenous ligand can be detrimental.  In a closed mechanism, for 
example, excess ligand can compete for palladium coordination sites required for 
transmetallation.  As a ligand scavenger, copper does not participate in catalysis.  Copper has 
also been shown to participate as a co-catalyst.  The organostannane is proposed to 
transmetallate to copper, which in turn transmetallates to palladium.51 In all stereospecific 
transformations reviewed by Mee, copper is used in a higher mole % than palladium, so it is 
entirely possible that copper operates both roles.  
Interestingly, an investigation into the proposed cyclic transition state revealed the 
reversible nature of the Stille transmetallation event.52 In 2008, Espinet reported the retro-Stille 
reaction of a stannylhalide with the prototypical transmetallation complex of palladium (Figure 
2.11). They biased the palladium complex with carbon groups incapable of reductive 
elimination, and generated organostannane via reverse-transmetallation.  This result is notable 
because it confirms the proposed reversibility of transmetallation in the Stille reaction.  
Additionally, it alludes to the dynamic nature of this mechanism.  If reductive elimination is a 
sink that pushes the equilibrium in a productive direction, can other reaction conditions be used 




Figure 2.11: Retro-Stille reaction.  Reverse transmetallation can occur in a system when 
reductive elimination cannot.  For reactions where reductive elimination is an option, irreversible 
reductive elimination drives the equilibrium. 
 
 
2.6 Stereoretentive modified-Stille cross-coupling of 2°alkyl tricarbastannatranes: 
Tin handle: 
The first example of an enantiospecific cross-coupling of a completely unactivated 
2°organostannane was presented in Nature Chemistry by the Biscoe group in 2013.53 Their 
process was developed to combine isolable, enantioenriched tricarbastannatrane (stannatrane) 
nucleophiles, electronically diverse organic electrophiles, and mild, general reaction conditions 
(Figure 2.12).  This methodology was possible by leveraging two previously discussed concepts; 


























Figure 2.12:  Stereospecific modified-Stille reaction. Reported by Biscoe, this is the first 
example of a completely unactivated stereospecific transmetallation from tin. 
 
The Biscoe group was able to avoid the traditional challenges associated with 
organostannane transmetallation by utilizing a stannatrane backbone in their nucleophiles 
(Figure 2.13). This scaffold was discovered by Jurkschat in 1985 54, and was applied by Vedejs 
in 1992 for primary C(sp3) transmetallation.55 It is proposed that the lone pair on nitrogen 
donates into the tin valence system, and selectively activates the bonded carbon towards 
transmetallation. This form of activation is independent of the electronic and structural 
properties of the desired group itself. Additionally, a stannatrane scaffold precludes the need for 
dummy ligands, which increases the efficiency of the method. This solved the challenge 
associated with weak nucleophilicity of unactivated secondary alkylstannanes, without 
compromising the advantage of configurational stability. 
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Figure 2.13: Tricarbastannatrane handle.  The tin-chloride can be purchased commercially or 
prepared via tris-hydrozirconation of triallylamine, followed by treatment with dilute 
tintetrachloride (a).  Racemic 2° alkyl tricarbastannatranes can be prepared by reaction with an 
alkyl Grignard or lithium reagent (b). 
 
Catalyst system: 
Biscoe found that enantioenriched stannatranes were capable of transmetallation, and 
were able to protect the integrity of the chiral center with a finely tuned catalyst system. 
Phosphine ligands have been used extensively in metal catalyzed coupling reactions, and they 
have become incredibly specialized over the last decade.  The class of interest is the Buchwald 
ligands, which contain a biarylphosphine core.56 These multifunctional ligands have been tuned 
to promote the various stages in the catalytic cycle. The ligand that promoted the reactivity 
reported by Biscoe is known as Jackiephos, shown in Figure 2.14-a.  The phosphine in this 
ligand is considered relatively electron poor due to the fluorinated aryl groups present.  Electron-
poor phosphine ligands are typically associated with weak oxidative addition, yet Jackiephos still 
promotes effective insertion into organic electrophiles.  In a mono-ligated Pd(II) complex, the 

















to act as a cis-frozen pseudo-bidentate ligand, occupying both one and two coordination sites on 
palladium (Figure 2.14-b).    
 
 
Figure 2.14: JackiePhos.  The structure of the multifunctional Buchwald ligand, JackiePhos is 
shown (a).  Pseudo-bidentate coordination to palladium is made possible by rotation of P-C 
bond, which allows for unique ligand behavior (b). 
 
This characteristic is unique to the Buchwald ligands and has several effects on the 
catalytic cycle.  With the lower ring engaged, an open coordination site is protected from a 
ligand substitution event typically associated with an open transition state.  This allows for a 
closed transmetallation event, promoting a retentive mechanism.  
Cordovilla showed that coordinative isomerization of palladium can be detrimental.50  He 
cited experimental evidence to discuss how rapid cis-trans isomerization of the substituents on 
palladium give rise to non-productive complexes.  He argues that trans isomers formed during 
cross-coupling act as a palladium trap, as reductive elimination can only occur in the cis- 






























Jackiephos is thought to be too bulky to bis-ligate palladium in the active catalyst, and lower ring 
stabilization leads to the cis configuration exclusively. 
Lastly, the Biscoe system utilizes copper(I) chloride and potassium fluoride additives.  
They cite the rationale first proposed by Simon Mee in 2004 that discusses the synergistic effect 
copper salts and fluoride ions have on the Stille reaction.51 Mee acknowledged the role of copper 
as a ligand scavenger in ethereal solvents, but suggests that polar solvents promote its utility as a 
co-catalyst. Biscoe proposes a reversible transmetallation from tin to copper, which generates a 
more reactive organocuprate.  The corresponding tin-chloride is then trapped as the less soluble 




Figure 2.15: Copper and Fluoride synergy. Copper salts and fluoride ions have been shown to 
have a synergistic effect on the Stille reaction.  The rate acceleration is attributed to co-catalysis 
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2.7 Conclusion: 
The end goal for cross-coupling reaction methodology is mild reaction conditions that 
reliably join any two molecular fragments in a rational manner.  To that end, unsaturated systems 
have been thoroughly investigated, which led to an unprecedented expansion of utility.  So much 
so, in fact, that some argue our chemical discovery institutions are being biased by the simplicity, 
reliability, and robustness of these techniques.  Critics suggest diversity-oriented synthesis as a 
way to circumvent this potential bias. 
If the over-use of C(sp2) cross-coupling is indeed biasing our structural motifs, then why 
not adapt these same methods to accept more complexity?  Over the last decade, several prolific 
research groups are trying to achieve just that.  Adapting a cross-coupling reaction to accept 
complex organometallic nucleophiles is one important step in that direction. 
When coupling a C(sp2) electrophile with a C(sp3) nucleophile, the most common way to 
avoid unproductive side reactions is by utilizing a system that promotes both fast 
transmetallation and reductive elimination. More often than not, the coupling groups themselves 
are modified to accelerate both fundamental transformations, which inherently limits utility. 
However, modern developments of the Stille reaction have been shown to be incredibly general 
in scope. The applications of these developments are still under investigation.  This dissertation 
focuses on attempts to simplify the underlying methods involved, in order to accelerate the utility 
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3.1 Introduction:  
 The previous chapter introduced the first modified-Stille reaction capable of the 
enantiospecific cross-coupling of completely un-activated enantioenriched 2° alkylstannanes.  
This was perhaps the most significant development for both the Stille reaction and stereospecific 
translation of chirality in the last decade.  This work introduced an alternative, arguably superior, 
method to the Suzuki reaction for the formation of enantioenriched C(sp)2-C(sp)3 bonds. 
However, close inspection of the substrate scope will show that a suite of racemic alkyl 
stannatranes can participate in the reaction, but only a few examples of enantioenriched 
substrates were used to confirm the mechanistic proposal.1  
The rationale for this limitation is simple.  Interest in the preparation of enantioenriched 
organostannanes was limited because the species had relatively no synthetic value in cross-
coupling.  Prior to this modified-Stille technique, trimethyl or tri-n-butyl based stannanes were 
used to transfer a more labile substituent, and attempts to cross-couple a secondary system was 
fraught with challenges (refer to Chapter two, “Cross-coupling a C(sp)3 nucleophile” and 
“Alkyltin nucleophiles for enantiospecific cross-coupling”).  With a limited set of established 
preparation methods, the Biscoe group was able to confirm stereospecificity using two 





Figure 3.1: Enantioenriched stannatranes.  In 2013, Biscoe reported the use of these 
enantioenriched organostannanes in enantiospecific cross-coupling.  
 
3.2 Substrate limitations: 
From a diversity-oriented synthesis perspective, critics of the generality of this method 
could point to the limited enantioenriched substrate scope.  This is an inappropriate judgment, 
however, because the true limitation lies with the preparation of starting materials. We believe 
the substrate compatibility of this cross-coupling method to be very general, and that a wider 
array of enantioenriched tin-based nucleophiles are needed to prove it.  The development of a 
proper synthetic method to prepare enantioenriched 2° alkylstannatranes is the main focus of this 
thesis work. 
The typical preparation of a racemic alkylstannatrane is the reaction of an alkyl 
lithium/Grignard reagent with 5-chloro-1-aza-5-stanna-bicyclo[3.3.3]undecane (Chapter two, 
Figure 12).  This method does not typically require purification. It was used to prepare eight of 





















this approach.  Alkyl lithium reagents are not conducive to diverse functionality, and under 
normal conditions do not produce optically active products. One solution reported was the 
implementation of preparatory scale chiral chromatography (Chapter one, “separation”).  Biscoe 
reported that compound 1 was prepared racemic in 79% yield, and resolution resulted in an 
enantioenrichment of 94% ee with a maximum yield of 41%. Racemic compound 2 was prepared 
with a yield of 80%, and resolved to 99% ee with a maximum yield of 40%.1  
A second solution reported the use of a chiral induction approach (Chapter one, 
“induction”). Compound 2 was also prepared in 93%ee directly, with the use of inherently chiral 
(-)-sparteine.  Beak showed that (-)-sparteine directs lithiation at the pro-S α-N position of 
pyrrolidine (Figure 3.2).2  
 
 
Figure 3.2: Methods for functional stannatrane preparation.  These two methods represent 

















































Figure 3.3: Formation of Sn-C bond.  The three typical methods to form a tin-carbon bond; a 
carbon nucleophile with tin-halide (a), hydro-stannylation of an alkene or alkyne (b), or a tin 
nucleophile with a carbon electrophile. 
 
3.3 Formal research project: 
 The modified-Stille reaction represents a method to achieve general, rational, complexity 
in target molecules, but the limitations described were a major bottleneck for broad utility within 
the synthetic community. Therefore, our formal research goal was to develop a synthetic method 
to prepare optically active 2° alkylcarbastanatranes to simplify the modified-Stille reaction. 
 
3.4 Literature review: 
Because our target scaffold was relatively unexplored, we began our search in the text.  It 
was found that there are really only three reliable techniques to generate a tin-carbon bond 
(Figure 3.3).3 The carbon-nucleophile approach had already been investigated thoroughly by our 
group. This approach describes the Beak lithiation and the formation of racemates requiring 
separation.  Although there are examples of stereospecific inversion by a 2° carbon nucleophile,4 














hydrostannylation approach seemed promising at first.  Initially we envisioned a 
hydrostannylation/hydrogenation sequence from an alkyne.  The literature is flush with methods 
of enantiospecific hydrogenation, and both procedures are moderately functional group tolerant.  
However, the approach relies partially on an isolable stannylhydride, which we have been unable 
to isolate for stannatrane.  It is believed that nitrogen-activation in the backbone results in a 
hydride that is too unstable to be handled, so we abandoned the approach for now.  
Tin-metallation was previously unexplored in our group.  Davies references the 
successful use of tin-lithium, tin-sodium, and tin-potassium in his text.3 Use of lithium was 
chosen due to its broader application in the literature.5 The primary method to prepare 
stannyllithium is deprotonation of tin-hydride.  This method is reliable for various trialkyl-tin 
species, but was incompatible with stannatrane.  The cleavage of a tin-tin dimer has also been 
reported, but for similar stability reasons could not be explored further.  The approach we were 
most interested in was the direct single electron transfer method using tin-chloride and lithium 
metal (Figure 3.4). 
 
 
Figure 3.4: Tin lithiation.  The three common ways to lithiate tin is by deprotonation of tin-















We came to this conclusion after a thorough review of the literature, when we came 
across two extremely promising reports that utilize this approach. Traylor in 1981 showed that 
optically active alkylstannanes would result from a two-step synthesis from butanol derivatives 
(Figure 3.5).6 A chiral alcohol was activated to tosylate before nucleophilic inversion of the 
leaving group with a trimethyl tin anion.  Although the enantiomer analysis is just assumed, he 
reported almost complete inversion of stereochemistry in the tetraalkyl tin product. He prepared 
the trimethyltin anion by the addition of trimethyltin chloride to a cooled THF mixture of lithium 
wire.  
 
Figure 3.5: Traylor preparation of alkylstannane.  Traylor prepared an optically active 
tetraalkyltin using inversion of an alkyl electrophile with trimethylstannyllithium.  
Enantiospecificity was approximated as 98%es from the reported alcohol and invoking a formal 
SN2 mechanism.   
 
Figure 3.6: Naphthalide catalyzed reduction of stannyl halide.  Using an excess of lithium 


















Although effective for his investigation, this route to tin-lithium reagents was plagued by 
very low reaction yield, unstable reagent solutions, and the formation of several toxic 
byproducts. Another work, by the Uchiyama group in 2015, reported a superior preparation of 
tin-lithium reagents.  This group prepared stable solutions of trimethyl, triphenyl, and tributyl 
stannyl lithium, using an SET mechanism from a THF solution of naphthalide radical anion 
(Figure 3.6).  They were able to show that catalytic naphthalene, in a THF mixture of lithium 
metal, was able to reduce both stannyl chloride and the di-tin analogues to a highly reactive tin 
anion.  They showed this reagent resulted in excellent NMR yields when trapped with an alkyl 
electrophile.7 With these works in mind, we set out to adapt a naphthalide-catalysis procedure to 




An Uchiyama protocol can reliably convert optically active carbon electrophiles into 
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Development of a tricarbastannatrane nucleophile: 
4.1 Approach: 
 With our knowledge from the literature in hand, we designed an investigation that would 
determine the validity of our hypothesis.  We noted the electrophiles compatible with the 
Uchiyama protocol, summarized in Figure 4.1.  He reported essentially quantitative yields using 
iodomethane, benzyl bromide, allyl chloride, and trimethylsilyl chloride.1 We noticed that there 
were no examples of secondary alkyl electrophiles, and the leaving groups were exclusively 
halides. 
Although alkyl halides are useful substrates in synthesis, we quickly focused our 
attention on alkyl sulfonate electrophiles.  This decision was made for several reasons. Primarily, 
carbon-halogen bonds are known to lack stability in the presence of radicals, which is not the 
case for sulfonates.  If we are to adapt this protocol for 2° electrophiles, we need to ensure little 
to no racemization will occur. Secondly, from a utility standpoint, enantioenriched alkyl 
sulfonates are trivial to prepare from commercially available alcohols. The third consideration 
we needed to make was the structural and electronic differences between the reported tin 
chlorides and carbastannatranes chloride.  Uchiyama reported similar results with his standard 
conditions for trimethyl, tri-n-butyl, and triphenyl tin chloride. Comparison of the 1H NMR 
spectra of methyl-tri-n-butyltin and methylstannatrane shows a significant up-field shift for the 
CH3 signal of methylstannatrane.  This is evidence that nitrogen activation in the stannatrane 
backbone increases the electron density of tin, potentially making it harder to reduce. 
 48 
 
Figure 4.1: Scope of electrophiles compatible with tin-lithium:  Uchiyama reported high 
yields for primary alkyl and silicon halides.1   
 
 
Figure 4.2: Initial development.  Uchiyama protocol was reproduced and applied to racemic 






























Scope of electrophiles reported by Uchiyama
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4.2 Initial development and challenges: 
 A preliminary set of experiments was used to determine whether or not this methodology 
would result in a workable synthetic approach.  The Uchiyama procedure was implemented with 
tri-n-butyltin chloride and trapped with a variety of on-hand electrophiles (Figure 4.2).  Success 
with iodomethane gave us confidence to begin screening sulfonates.  We were pleased to observe 
little difference in reactivity based on the leaving group. Once the procedure was validated for 2° 
alkyl sulfonates, we began to explore the generation of a tricarbastannatrane nucleophile. Our 
initial results were discouraging, as we observed no reaction between sec-butyl mesylate and 
stannatrane lithium prepared by Uchiyama’s conditions (Figure 4.3-a). We decided to switch our 
substrate to iodomethane and more thoroughly investigate the reaction conditions. We found that 
significantly increasing the amount of naphthalene and lithium could result in the target product.  
The positive result was quite clear via proton NMR, due to the characteristic proton shift of the 
methyl group at -0.3ppm in CDCl3.  These results encouraged us to screen against more useful 
electrophiles (Figure 4.3-b).  
While still in small scale, we began to probe the stereochemistry of alkylstannatrane 
formation with substrate 1 shown in Figure 4.4.  This compound had been fully characterized, 
and facile enantiomer separation with a strong UV-vis signal made it an ideal candidate for 
optimization.  Analysis of our first crude reaction resulted in 60% es for the two-step reaction. 
This was extremely encouraging, and we continued with this substrate for our optimization 





Figure 4.3: Stannatrane lithium development. Harsher reaction conditions were required to 
promote the reduction of stannatrane chloride 
 
Figure 4.4: Stereochemical probe.  The preparation and stereochemical analysis of crude alkyl 
stannatrane 1. Separation of the racemate (a), compared to inversion (b). 
50% Naphthalene
Excess Li(0)




THF, rt, < 3 h
Cl N Sn Li N Sn




















DCM, 0 ºC - rt
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The crude reaction contained several unknown impurities alongside excess alkyl mesylate 
and naphthalene, so we explored purification techniques.  Racemic stannatrane preparations are 
normally clean enough to use without purification.   Alkyl stannatranes are typically viscous oils, 
so we knew crystallization was not a valid approach. We attempted typical column 
chromatography techniques, but observed significant decomposition.  We attributed this to the 
known acidity of silica gel.  The backbone activation that allows alkylstannatranes to participate 
in transmetallation also promotes side reactions under oxidative conditions.  This will be 
discussed in more detail in Chapter Six.  Previous reports have highlighted the acidity of silica 
gel, so we tried several techniques to modify acidity, including trace TEA in the mobile phase, a 
silica/K2CO3 gel mixture, and various additions of alumina gel, but we could not suppress 
decomposition and remove impurities within the same system.  Reverse-phase C18 




 In early development, we realized the conditions in Figure 3-b were clearly not optimal. 
We observed very low calibrated yields, and became concerned when several trials inexplicably 
failed completely. In order to gain a better understanding of the reaction, we initially optimized 
for reproducibility. 
 A THF solution of tin-lithium presents as dark green/black and opaque, but the presence 
of this color was found not to be deterministic.  Trapping with an electrophile at the instance of 
color yields no product.  We undertook several strict rate experiments to determine the optimal 
reaction condition (Figure 4.5).  The generation of color seemed to indicate an initiation reaction 
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(T1), but additional time was required to generate useful quantities of anion (T1 + time) (trial 1 
and trial 3).  This can be rationalized by the initial generation of a stannatrane dimer, followed by 
a slower, second reduction to an anion.  Additionally, we found that once generated, the reaction 
with an electrophile was fast (trial 3 and trial 5), but still not reproducible (trial 1, 3, and 6).  
We then started to probe the role of each reagent in the initial mixture. Starting with 
lithium, we observed peak reactivity somewhere around 2 hours.  We subjected a pre-made 
solution of Sn-Li to additional contact with lithium, and noted a decrease in yield.  We also noted 
a rapid rate increase in color generation with the addition of higher concentrations of 
naphthalene. Interested by this, we set out to understand the real concentration of naphthalide is 
in solution. If naphthalide behaves as a stable radical, directly reducing the tin-chloride, we 
would expect to see formation of stoichiometric tin-lithium when more than 2 equivalents of 
naphthalide are prepared.  
Naphthalide was pre-formed in THF using an excess of lithium under 1x and 2x 
concentrations, and allowed to stir overnight.  To the resulting black solutions was added enough 
tin-chloride to result in 3 equiv.  and 6 equiv. of naphthalide.  The reactions were allowed to stir 
for 4 h at rt, and were quenched with iodomethane. The reactions were found to contain no 
product.  This was evidence that the real concentration of naphthalide is very low, and there 
might be an equilibrium reaction between the lithium naphthalide and corresponding lithium 
metal plus naphthalene (Figure 4.6).  If this is true when using a large excess of lithium metal, 
the resulting equilibrium could lead to incredibly high surface area lithium metal suspended in 
solution, along side the tin-lithium generated.  
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Figure 4.5: Time optimization. A visualization of the reaction scheme is reported (a). T0 is 
defined as the time of solvent injection.  T1 is defined as the time that a dark colored opaque 
solution is observed (b). Conditions in blue refer to the generation of Sn-Li, while conditions in 
green refer to the inversion reaction with Sn-Li (c). 
 
 
















Trial	 T2(min)	 T2+ time	 E+ + time	 temp (°C)	 NMR Conv %	
1	 18	 1hr	 1 h	 rt	 50	
2	 18	 2hr	 1 h	 rt	 60	
3	 18	 3hr	 3 h	 rt	 80	
4	 18	 3hr	 3 h	 -4	 75	
5	 18	 3hr	 20 min	 rt	 80	
6	 < 30	 50min	 2 h	 rt	 80	
7	 < 30	 50min	 4 h	 rt	 80	
8	 < 30	 50min	 0.5 h	 50	 80	
9	 < 30	 50min	 4 h	 50	 80	
1.0 eq
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Figure 4.6: Equilibrium reaction.  The possible equilibrium between naphthalide and 
lithium/naphthalene.  In an environment with excess lithium, could lead to high surface area 
lithium metal in solution.  
 
Additionally, we found our magnetic PTFE stirbars were being destroyed by the reaction 
conditions.  In order to remove unknown variables, we tried sonication as a method of mixing. 
Sonication at 45 °C resulted in faster initiation times, and removed the uncertainty of side 
reactions with PTFE.  Signs of reproducibility began to emerge, so we reduced the amount of 
naphthalene/lithium to 10% and 2.2 eq. respectively.  We found the new preparation to be 
superior, and were pleased to observe reliability in our method among multiple trials. 
 
4.4 Stereospecificity: 
 The next optimization we targeted was the enantiospecificity (% es) of the inversion.  % 
es is a more valuable tool for quantification of stereocontrol, because it isolates racemization to a 
specific synthetic step. % es is defined as the enantioenrichment ratio of products to reactants (% 
ee products/ % ee reactants).  A typical confirmation of stereospecificity involves several 
instrumental steps that rely on analytical chiral resolution.  Chiral resolution of the racemic 
starting material and corresponding racemic products must be acceptable prior to a 
stereochemical analysis.  This way, we can define a method that will quantify the enantiomer 




product with known methods and resolved the enantiomers with a Chiralcel OJ-RH chiral 
column. 
 The reproducibility optimizations had little to no effect on enantiospecificity, which 
varied around 55-80%es.  We then began to run the inversion reaction in non-polar solutions of 
mesylate, and quickly found encouraging results.  By adding the THF solution of stannatrane 
lithium to an n-hexane or ethyl ether solution of mesylate, we could completely suppress 
racemization and confirm 100%es from the starting chiral alcohol (Figure7). It’s possible that 
less polar solvents disrupt unproductive Sn-Li aggregation states. 
 
 
Figure 4.7:  Solvent screen.  The results from a solvent effect investigation.  It was found that 








THF, 45 °C, 3h
Solvent Screen
N Sn PhN Sn N SnCl Li
1.5 eq
Solvent	 mL	 Cal NMR	 ee%	
1	 THF	 0.5 THF	      74	 74	
2	 THF	 1.25 THF	      54	 76	
3	 0.5 n-hex	 0.5 n-hex	      68	 >99	




 This chapter will focus on the first goal of our hypothesis, the preparation of 
enantioenriched 2° alkylstannatranes. Prior to this investigation, alkylstannatrane synthesis could 
be considered prohibitively expensive.  Prep-scale resolution of racemates added significant wait 
times to any planned investigation, and generally led to optically active molecules without 
defined stereochemistry. These limitations resulted in starting material that was precious and 
difficult to obtain. We developed a method to prepare them reliably in-house, with defined 
stereochemistry, and were able to obtain useful quantities of several known compounds.  
Additionally, we used this method to easily generate novel molecules difficult or impossible to 
make via known methods.  This allowed us to investigate the second goal of our hypothesis, the 
simplification of stereospecific transformations of novel tin nucleophiles.  These transformations 




Control of reproducibility and enantiospecificity encouraged us to begin implementing 
the Sn-Li procedure at scale.  Having confirmed the formation of compound 1 in 50% isolated 
yield in 99%es on small scale, we shifted our attention to an enantioenriched sec-butyl system.  
Sec-butyl carbastannatrane is a deceptively difficult target for cross-coupling. Unactivated 
secondary systems are difficult to transmetallate, and sec-butyl is arguably the least activated 2° 
chiral substituent possible.  The electronic and steric similarity of the two groups on the chiral 
carbon make enantiodifferentiation difficult, and enantiomer resolution at scale is highly 
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unlikely. To date, there is no alternative method to prepare this type of enantiopure product.  We 
observed complete inversion and acceptable yield for compound 2 and 3 (Figure 5.1). 
 
 
Figure 5.1: Primary scale up of enantioenriched alkylstannatrane.  Our initial scale up 
results for the 2 mmol reaction of optically active alkyl mesylates.  *Enantiospecificity of sec-




 A potential criticism of the modified-Stille cross-coupling system is that many of the 
acyclic 2° tin compounds used contain an α-methyl group.  Although doubtful, it is possible 
more internal positions on an unactivated nucleophile could hinder the quick transmetallation our 
arylation protocol relies on.  It is also possible that the transmetallation complex, now bulkier 
due to the more internal position, could begin to show signs of isomerization. We decided to 
probe this using an octane nucleophile.  If there were dependence, the cross-coupling results of 
the 1, 2, 3, and 4 position on octane would reveal it.  The confirmation of n-octane transfer was 
10% Naphthalene
2.2 eq. Li(0)
THF, 45 °C, 3h
N Sn Ph
N Sn Cl N Sn Li
n-hexane, rt, 1 h
(R)-4-phenylbutanyl)
mesylate
n-hexane, rt, 1 h





















unnecessary, because Vedejs had successfully coupled an n-butyl group with a variety of aryl 
bromides using the stannatrane scaffold in 1992.1  
 We already had evidence that the 2 position was stereospecific, so we targeted the three 
position of octane for enantiomer analysis.  The Biscoe group had also confirmed excellent yield 
for the racemic cross-coupling of the 3 position, but due to difficulties in chiral resolution, was 
unable to confirm enantiospecificity. We implemented the tin-lithium procedure with racemic 3-
octyl mesylate to prepare compound 4.  The inversion went smoothly and we observed 50% 
yield (Figure 5.2). The first step in the stereospecificity proof, the necessary resolution of the 
racemate, has failed. Indirect analysis by resolution of cross-coupling derivatives has also failed.  
Enantiomer analysis of this compound is ongoing. We believe, similar to sec-butyl groups, that 






Figure 5.2: 3-octyl stannatrane. The racemic mesylate led to the target product in acceptable 
yield.  Attempts to resolve the alcohol, mesylate, stannatrane, and four of its cross-coupling 




OMs 1.5 eq Sn-Li
THF, rt, 2 h
Et Pent
N
Sn 4, 50% yield
3-ocyl stannatrane
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5.3 Silyl-Protected alcohol 5: 
Another nucleophilic substrate of interest is the primary alcohol derivative of sec-butyl-
stannatrane, compound (6) shown in Figure 5.3.  The cross-coupling of this substrate would 
emphasize the functional group compatibility of the modified-Stille reaction.  Starting from 
commercially available 1,3-butanediol, we employed an established two-step procedure to 
acquire the TBDMS protected, enantioenriched 2° alkyl mesylate. The inversion with Sn-Li also 
proceeded smoothly. Compound 5 was then subjected to a known deprotection protocol. We 
observed an 85% yield for the deprotection step, and a direct enantiomer analysis revealed an 
enantiospecificity of 99%.  
 
 
Figure 5.3: Synthesis of enantioenriched alcohol.  The target alcohol was prepared in 4 steps 








































Success with the new classes of substrate encouraged us to investigate the tolerance of tin 
lithium inversion to areas of unsaturation.  From a total synthesis perspective, it is valuable if 
cross-coupling techniques can introduce handles for further chemical manipulation.  With this in 
mind, we targeted a terminal and a substituted alkene, and obtained the commercially available 
4-penten-2-ol, and 6-methyl-5-hepten-2-ol. We observed compounds 7 and 8 in yields of 25% 
and 55% respectively (Figure 5.4).  We attribute the decrease in yield for 7 to the potential for 
deprotonation/elimination of the alkylmesylate.  We suspect there to be competing elimination in 
all of our tin-lithium reactions, which could be attributed to the basicity of the tin anion.  No 
efforts to probe this specific phenomenon have begun yet. Attempts to resolve compound 7 and 8 
directly have failed.  Separation of a derivative of compound 8 has been achieved, allowing for 




Figure 5.4: Inversion of alkene-containing electrophiles. We observed 25 and 55% yield for 
the inversion of a terminal and internal alkenyl mesylate.  *Enantiospecificity of internal alkene 
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Inversion of alkene-containing electrophiles
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5.5 Ester: 
 An ester-containing nucleophile is another valuable substrate from a total synthesis 
perspective.  Like the alkenes, this would introduce a useful chemical handle for further 
derivatization.  Our previous method for obtaining a stannatrane ester relied on multiple 
synthetic steps and chiral prep-HPLC separation of the racemate (Figure 5.5).  Starting from the 
mesylate of the commercially available ethyl 3-hydroxybutyrate, we prepared the zinc iodide, 
and quenched with stannatrane chloride.  The material was then outsourced for enantiomeric 
separation.  Although the method was successful, the four steps plus enantiomeric separation was 
not conducive to a process with common synthetic utility. 
 
Figure 5.5: Synthesis of ester-containing nucleophile. The prior method to obtain the 
compound 10.  The commercially available alcohol was activated to a sulfonate with known 
methods.  The resulting mesylate was then substituted with sodium iodide to form the 
alkyliodide.  Insertion with zinc metal led to the alkylzinc iodide, which was then quenched with 
stannatrane chloride (a). Racemization of final product is found with the direct inversion of 



























We set out to implement the tin-lithium procedure in one step from compound 9. We 
quickly found that decomposition of the mesylate is the prominent transformation, and observed 
calibrated yields of 0-5% of alkyl tin using our standard conditions.  Discouraged by this, we 
went back to the literature and found precedent discussing several methods to attenuate the 
reactivity of tin-lithium. Some examples of interest include multidentate-ligation with alkyl 
amine, tin-zincate, tin-cuprate, and tin-magnesium compounds.2-8  These methods will be 
discussed in a later section in more detail. 
 Substitution of the compound 9 using the standard tin-lithium conditions is prohibitively 
low yielding, but the reaction with tin-diethylzincate resulted in compound 10 with an isolated 
yield of 60%. Disappointingly, enantiomer analysis revealed complete racemization. When 
utilizing tin-zincate with electrophiles that do not contain a carbonyl, we discovered 
racemization did not occur.   
 
Figure 5.6: Tin-zincate substitution reaction. Vastly different reactivity is observed for 
substitution of an ester-containing electrophile.  Superior yield is observed in the racemic 
substitution using a novel stannatrane-zincate, but the process does not lead to enantiopure target 


























Attempts to control enantiopurity have failed.  Optimization of solvent, temperature, and 
reaction time have led to products with a maximum of 50%ee (Figure 5.6).  Although 
elimination is still possible, we believe the tin-lithium reacts directly with the carbonyl, resulting 
in very low yields.  Reaction with tin-zincate results in a higher overall yield, but the mechanism 
is not stereospecific.  Racemization with tin-zincate might be attributed to a pre-coordination 
event between the carbonyl and zinc.  Although compound 10 was not prepared with a high % 
ee, this method is still an improvement.  Our previous method was reduced to two steps, and the 
target enantiomer can be generated in a higher overall ratio. 
 
5.6 Derivatization of alkylstannatranes: 
 Success with alkene- and alcohol-containing substrates allowed for chemical 
manipulation post stannatrane installation.  Previous experiments in the lab have shown the Sn-C 
bond to be stable to reductive conditions.  An example of this is the formal reduction of the ester-
stannatrane with lithium aluminum hydride, which will be discussed in a later section. 
 With compound 5, we wanted to know if protecting group manipulation was possible.  
We already knew silicon based protecting groups were undisturbed by inversion and cross-
coupling conditions.  We also knew the stannatrane backbone was not disturbed by the silyl-
deprotection protocol.   With this in mind, we attempted a one pot protecting group substitution 
with benzoyl chloride (Figure 5.7).  We achieved an isolated yield of 88% of compound 11, and 
confirmed stereospecificity of 99% es after hydrolysis of the protecting group.  This important 
substrate not only highlights the stability of alkylstannatrane to reductive conditions, it 




Figure 5.7: Protecting group manipulation. We highlight stannatrane backbone reaction 
stability by preparing an orthogonal protecting group in one pot from the TBDMS protected 
alcohol.  We isolated this compound in 88% yield with a confirmed enantiospecificity of 99%. 
 
 
In addition to protecting group manipulation, we targeted compound 7 for addition 
reactions.  We found that diborylation was possible in the presence of potassium carbonate and 
water in t-butanol solvent.  This reaction afforded compound 12 in 71% yield with a dr of 1:1.2 




Figure 5.8: Diborylation of alkene. A racemic, alkene-containing stannatrane was successfully 







1) 1.2 eq. TBAF
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5.7 Alternative sources of tin anion: 
As previously mentioned, our successful preparation of the tin anion opened the door to 
other metal-based tin nucleophiles.  It has been previously reported that anionic tin is capable of 
transmetallation from lithium to various other metals.  The more established transformations are 
that between tin and zinc. First described in 1966 by Noltes, and further developed by Nozaki in 
1984, various bonds between tin and zinc have been used for addition reactions to alkynes.4, 5  
The concept of attenuating the reactivity of the tin nucleophile via transmetallation was 
extremely attractive to us.   
We also found precedent for the less well-known reactivity of tin-cuprate and tin-
magnesium compounds.  The first example of a synthetically useful tin-copper based reagent was 
by Piers, in 1978.7 He was able to transmetallate from lithium to copper, and use the resulting 
reagent for conjugate addition reactions. By direct comparison, he was able to show the 
divergent substrate reactivity between tin-cuprate and tin-lithium (Figure 5.9). He observed 
incomplete conversion and/or di-addition when using tin-lithium and substrates represented in 
Figure 9-a.  Addition of 1 equiv. of copper phenylthiolate to a cold solution of tin-lithium 
resulted in excellent yields for the same substrates.  Conversely, he reported a superior yield with 
tin-lithium when using reagents represented in Figure 9-c. He also reported several examples of 







Figure 5.9: Stannyl lithium vs. cuprate reactivity. The addition of PhSCu to a solution of 
stannyl lithium results in divergent reactivity of conjugate addition reactions.7 *Yield of target 
not reported, investigation references either predominant di-addition or recovery of starting 
materials. 
 
Tamborski and Soloski reported a magnesium-based source of tin in 1961.  They 
described the structure of this compound as [(Ph)3Sn]2Mg, but did not report much in the way of 
synthetic utility.8 More importantly, their work led to the development of (Ph)3SnMgBr by 
Creemers in 1969.3 This was further developed in Valade in 1971 for additions to unsaturated 
ketones.6 We predicted similar functional group compatibility problems using stannatrane as a 



























discovered by Nozaki in 1984, this reagent was used in stannyl-metallation reactions with 
terminal acetylenes.5  
Perhaps the better-known possible modifications to lithium reagents come in the form of 
alkyl amine ligation. Although the data can sometimes be contradictory, Collum highlighted 
several advantages to using alkyl amine ligands for reactions using carbon-based lithium 
reagents (Figure 10). Published in 1992, he discussed the impact of TMEDA as a modifier for 
organolithium reactivity.2 His review questioned the commonly accepted mechanistic rationale; 
that evidence of strong solvation, low aggregation, and high reactivity are individually accepted 
as evidence of the other two.  Regardless of mechanism, the results using amine ligation for 
stabilization and robustness via lithium coordination seemed a valuable system to try.  If 
stannatrane lithium exists in an aggregate state like the carbon example in Figure 5.10, perhaps 
use of a coordinating ligand would be beneficial. We predicted our moderate yields would 
improve, and that racemization pathways might be reduced or suppressed by the addition of 
alkylamine coordinating groups on lithium.  
 
 
Figure 5.10: TMEDA and lithium aggregates. The addition of amine ligands has a beneficial 
effect on carbolithium nucleophiles.  It is proposed that naturally occurring conglomerate states 
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 With all these possible modifications in mind, we targeted zinc, magnesium and nitrogen 
as the most likely methods of attenuation (Figure 5.11).  Using compound 19 as a model 
substrate, we were able to compare the reactivity and stereospecificity of the six unique tin 
anions.  
We found little difference in yield or % es when using compound 13 or 14.  We found a 
significant decrease in yield when using compound 15. All other sources resulted in a slight to 
significant reduction in NMR yield. We found enantiospecificity remained intact for all sources 
except for the tridentate PMDTA (Figure 5.12). Moving forward with the more functionalized 
compound 9, we found that compound 14 gave a vastly improved yield, but resulted in a 
disappointing amount of racemization in the final product (Figure 5.13).  Additional 
nucleophilic sources of tin are still being investigated in these reactions. 
 
Figure 5.11: Transmetallation from lithium. A solution of tin-lithium was subjected to 
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Figure 5.12: Inversion with alternate sources of tin. The six tin anions were used with the 
model substrate to probe yield and enantiopurity of the target stannatrane. 
 
 
Figure 5.13: Inversion with functional electrophile. The reactivity of nucleophiles with an 
















NEtO OMs EtO1.2 eq. Sn-X
solvent, rtO O
Inversion with functional electrophile
9
Sn	Source	 yield	%	 solvent	 ee%	
13	 <	5	 THF	 NA	
14	 60	 THF	 NA	
14	 NA	 n-hexane	 50	
14	 NA	 ether	 0	
14	 NA	 THF	 0	
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5.8 Inversion limitations: 
Ideally, our lab would utilize this process for a wide range of enantioenriched 
electrophiles for which inversion is a valid mechanism.  To a degree, we have accomplished that 
goal.  Our system can tolerate various positions of branched alkanes, substituted or terminal 
alkenes, and silyl protected alcohols.  It is also useful in reducing the total number of synthetic 
steps to form some of our more interesting cross-coupling nucleophiles, while simultaneously 
reducing our dependence on chiral prep-HPLC. 
 
 
Figure 5.14: Incompatible scaffolds.  The incompatible carbon electrophiles fall into three 
groups; electrophiles that result in unstable alkylstannatranes (a), do not participate in the 
reaction (b), or those that decompose completely (c). 
 
During our electrophile investigation, we discovered several classes of compounds with 
which our current system is not compatible (Figure 5.14).  Perhaps the most important limitation 
we found is with electrophiles that contain a carbonyl. The literature reports tin-anion reactivity 
at the carbonyl of aldehydes, and our own experience with compound 10 shows complications 





















Another limitation we found was our work with cyclic and heterocyclic structures.  We 
observed compatibility with the alicyclic structures of cyclohexyl and cyclopentyl mesylate.  We 
found these compounds formed the expected products with calibrated HPLC yields in line with 
our expectations.  Further pursuing of the mesylates from 4-tert-butylcyclohexanol and ethyl 3-
hydroxycyclohexane-1-carboxylate, we observed no reaction (Figure 14 group-b).  This is 
evidence that the tricarbastannatrane anion is too bulky to overcome 1,3-diaxial hydrogen 
interactions. 
Other structures of interest to us are common heterocycles (Figure 14 group-a). We’ve 
previously highlighted the stability and utility of stannatrane nucleophiles containing α-
heteroatoms in cyclic structures, so we looked at scaffolds containing β-heteroatoms.  Results 
with group-a electrophiles were discouraging. We observed the 60-80% NMR yields in the crude 
reactions, but isolation and handling led to complete decomposition.   
   
5.9 Scope: 
 We have directly prepared several enantioenriched alkylstannatrane nucleophiles suitable 
for stereospecific transformations (Figure 5.15).  We have explored the 2 and 3 position of 
completely un-activated carbon chains, substituted and terminal alkenes, and a silyl protected 
alcohol (Figure 5.15-a).  Additionally, this process resulted in access to the free alcohol, the 
benzoyl protected alcohol, and the di-borylated alkene (Figure 5.15-b).   In future investigations, 
we will more thoroughly evaluate the inversion of electrophiles containing protected aldehydes, 
ketones, amides, and begin to explore nucleophilic tin in addition reactions.   
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Figure 5.15: Scope of 2° alkyl stannatranes prepared by inversion.  Access to these 
compounds have been achieved by inversion (a, c), or a derivatization that depends on the 
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Simplification of stereospecific transformations: 
 The Suzuki reaction has had an undeniable impact on the ability to forge a variety of 
enantiospecific bonds.  However, the various limitations discussed in Chapter two describe the 
structural limitations of that approach.  The modified-Stille reaction has been shown capable of 
avoiding those mechanistic and substrate limitations. The preparation of organostannanes has not 
been investigated nearly as thoroughly as that of organoboron, which has resulted in relatively 
little utility in synthesis.  Additionally, the methods that were established relied on harsh 
conditions and expensive separations. The first goal of the hypothesis was to develop an 
alternative synthesis of alkylstannane targets of interest, and that goal was accomplished. 
The second goal of the hypothesis, however, is to elucidate a possible effect on the 
broader utility of tin-based stereospecific transformations.  The stannatrane scaffold has been 
found to uniquely activate a general scope of 2°alkyl coupling partners in stereospecific arylation 
cross-coupling reactions 1.  Additionally, our lab discovered they participate in acylation cross-
coupling and electrophilic halogenation reactions with excellent stereospecificity.2, 3  This 
chapter focuses on the impact of the tin-lithium development on the ability to easily implement 
stereospecific transformations from tin. 
 
6.1 Mechanistic determination via stereospecificity and absolute configuration: 
 The overarching theme of this dissertation is predictable, versatile, stereospecific 
transformations. To assign mechanistic information to a specific reaction, stereospecificity of the 
reaction must be determined.  The analysis techniques typically performed are chiral HPLC, GC, 
and to a lesser extent, optical rotation. In order to assign stereospecificity for organostannane 
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reactions, a several-step synthetic process is typically employed.  A racemic alkyltin is prepared, 
and the enantiomers are resolved analytically. An enantioenriched sample is then prepared, and 
the single enantiomer is confirmed with the same technique.  The organostannanes are then 
subjected to a reaction, and a resolution method for the products is developed.   We then observe 
the peak ratios for the enantioenriched products and starting material, and assign a % es value (% 
ee product / % ee starting material).  This value accurately describes the degree to which a 
reaction has not racemized during the specified transformations. This is evidence of 
stereospecificity, but not mechanism.  In order to rationally incorporate a chiral group in 
synthesis, we need the ability to assign an invertive or retentive mechanism for the 
transformation.   
Absolute configuration analysis of the starting material and product can result in 
mechanistic insight.  However, this process is not trivial.  Several of the common techniques 
include X-ray crystallography, derivatization followed by NMR, circular dichroism (CD) or 
empirical correlations from the literature.4-7 Each of these techniques is a broad, independent 
scientific field, so will only be mentioned in the context of the applicability to our methods.   
Prior to the development of tin-lithium, our lab found it difficult to confirm the absolute 
configuration of alkylstannatranes.  We could independently confirm proper resolution of the 
racemate, but were unable to implement the above-mentioned techniques for a variety of reasons.   
The majority of alkylstannatranes present as viscous oils, so that precluded XRD as an option.  
We attempted several vibrational circular dichroism (VCD) analyses, but it proved to be less 
accurate with complex tin compounds.  The tin-lithium reaction allows us to define the 
stereochemistry of alkyltins by assigning inversion through SN2 from the starting alcohol.  We 
can then implement one of the above-mentioned techniques on the more well-behaved organic 
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cross-coupling products.2, 3 We used this method to confirm the absolute configuration of 
compound 1.  
 
 
Figure 6.1: Proof of absolute configuration.  Starting from commercially available alcohols 























We wanted to compare the single peak from a prep-HPLC resolution of with that of the 
same compound from a tin-lithium reaction.  For ease of resolution, we chose to target 
compound 2. As mentioned before, a large advantage to using stannatrane is that it seems 
infinitely stable to reductive conditions.  This permits functional group manipulation after the 
tricarbastannatrane backbone is installed. We reduced both a racemic and prep-HPLC 
enantiopure sample of compound 1 with lithium aluminum hydride (Figure 1-a), and resolved the 
enantiomers with a Chiralpak-IA column.  We then compared the trace to that from a reaction 
that utilized tin-lithium (Figure 1-b).  We determined the absolute configuration for peak 2 to be 
(S) (Figure 6.1). This method has greatly reduced the difficulty in assigning stereochemistry to 
our starting substrates, and is the basis for our mechanistic proposals. 
 
6.2 Acylation: 
The arylation reaction developed in 2013 showcased the reactivity and configurational 
stability of unactivated alkylstannatranes.1 Our lab then began to exploit additional reaction 
pathways. During the early development of the Stille reaction, acyl-chloride reagents were found 
to be acceptable coupling partners.8, 9 These reactions were limited to the typical stannanes 
previously discussed (Chapter two, “Alkyltin nucleophiles for enantiospecific cross-coupling”).  
This adaptation was developed further for the stereospecific cross-coupling of alkyltin species, 







Figure 6.2: Enantioenriched ketone synthesis.  To prepare enantioenriched kentones, an 
alternative to the stereospecific enolate reaction (a) is the cross-coupling of an organometallic 
nucleophile with an acyl-halide (b). 
 
Our lab began to pursue an adaptation of the acylation reaction to capitalize on the 
superiority of carbastannatrane as a metallic handle.  The total transformation of such an 
approach results in the selective generation of α-substituted ketones, a product typically formed 
by an asymmetric enolate reaction (Figure 6.2).  Asymmetric enolate chemistry implements a 
catalyst or chiral auxiliary to control deprotonation, facial attack, and chemoselectivity. Chiral 
information is imprinted on the substrate via enantiodifferentiation between the two possible 
transition states of enantiomer formation (Figure 6.2-a).  The limitations of this method were 
previously discussed (Chapter one, “induction”).   The ability to couple an acyl group 
stereospecifically via cross-coupling would represent a general alternative method to synthesize 
α-substituted ketones (Figure 6.2-b).  
The first example of this type of bond formation was developed by Falck in 1994 (Figure 
6.3).11 He successfully coupled a wide variety of acyl chloride electrophiles and α-heteroatom 
containing organostannanes with a palladium/copper cocatalyst system.  He reported an 


















stereoretention. Inspired by these results, our lab developed the first example of a stereospecific 
cross-coupling of an unactivated alkyl tin reagent with an acyl electrophile (Figure 6.4).3  
 
 
Figure 6.3: Falck acylation of activated stannanes. Falck discovered the enantioselective 




Figure 6.4: Stereospecific acylation of unactivated alkylstannanes. Biscoe reported the 




We found that oxidative addition with palladium tetrakis proceeded smoothly between 
the C-X bond of an acyl chloride and the more stable thioester.  In the presence of copper 
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Stereospecific acylation of unactivated alkylstannanes
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from stannatrane.  Reductive elimination resulted in α-substituted ketones with little to no trace 
of isomerization or racemization.3 Additionally, we were able to achieve two examples of the 
first unactivated transfer of a tertiary center from tin using a palladium/Jackiephos catalyst. 
In order to highlight the generality and rationality of this transformation, we implemented 
the stannatrane-lithium procedure to generate several enantioenriched nucleophiles with defined 
absolute configuration (Figure 6.5).  These compounds, a long side the nucleophiles we prepared 
with traditional methods, allowed for the elaborate substrate scope for stereospecific acylation 
(Figure 6.6).  We were able to show that both unactivated (Figure 6.6-a) and activated (Figure 
6.6-b) enantioenriched alkylstannatranes result in retentive cross-coupling products. 
 
 
Figure 6.5: Preparation of enantioenriched alkylstannatranes. The use of stannatrane-lithium 
to easily generate enantioenriched starting materials with defined stereochemistry. This allowed 
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Figure 6.6: Scope of enantiospecific acylation. With conditions from Figure 4, we generated a 
scope of enantioenriched coupling products from starting materials generated by stannatrane-
lithium (a), and traditional methods (b).  
 
Perhaps the most explicit showcase of the generality and predictability in acylation 
coupling was with the thioester of (S)-Naproxen (Figure 6.7).  We decided to probe individually 
with both (R) and (S) sec-butyl stannatrane (compounds 3, 4).  The lack of functionality or 












































method.  The Naproxen thioester contains a chiral center beta to the bond cleaved during 
oxidative addition. In theory, the proximal chiral group could impact the desired selectivity of 
acylation. We obtained each diastereomer of the Naproxen derivative selectively. As expected, 
we found proximal chirality did not impact stereoselectivity.   
 
 
Figure 6.7: Selective acylation for Naproxen derivatives. Using a palladium/Jackiephos 
catalyst, we selectively generated each diastereomer of the Naproxen derivative by translation of 
chiral information dictated solely by the alkylstannatrane. 
 
 
6.3 Electrophilic halogenation: 
 As discussed previously, the structural and electronic forces that promote 
transmetallation from stannatrane also make it reactive to oxidative conditions.  This limits the 
ability to perform distal oxidative chemical manipulations with the goal of keeping the 
stannatrane backbone intact.  However, the Sn-C bond is predictably reactive to electrophilic 
halogen sources.  In 2017, we discovered a rare example of a transition metal-free stereospecific 















Selective acylation of Naproxen derivatives
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was found to be amenable to the incorporation of chlorine, bromine, and iodine as well.  The 
ability to quickly and cheaply generate enantiodefined 2° alkylstannatranes was essential for the 
complete investigation. 
 Fluorination of 2° substrates has been of recent interest to the synthetic community.12-15  
This is due to the historical difficulty in selectively incorporating fluorine into complex 
molecules, and the growing importance of fluorine containing drug targets.16 One approach to 
generate an enantioenriched C-F bond is the translative deoxyfluorination of an enantioenriched 
alcohol.15, 17 It has been applied with great success in complex drug targets, but suffers from a 
lack of selectivity in the presence of multiple potential reaction sites.  A second approach 
involves the reliance on a transition metal catalyst.13, 14 These transformations proceed through a 
radical mechanism predominately, and stereospecificity in the final products are uncertain. 
 An alternative route to stereospecific fluorination is the combination of an organometallic 
nucleophile and an electrophilic source of fluorine.  Aggarwal has pioneered the use of 
enantioenriched phenyl-lithium activated organoboron nucleophiles in this type of reaction 
(Figure 6.8).18 This method was successful for the formation of 1°, 2° and 3° fluorides, and was 
proven invertive for several 2° centers.  The scope included azides, protected alcohols, alkenes, 
and tert-butyl esters, and an example of a cholesterol derivative fluorinated in high 
diastereomeric ratio (d.r.).18 The major limitation of this method is the reliance on a pre-






Figure 6.8: Stereospecific electrophilic fluorination of activated organoboron nucleophiles.  
Aggarwal successfully implemented selectfluor II and styrene to fluoronate an enantioenriched 
organoboron nucleophile.  The reaction relies on pre-activation to the boron “ate” complex by 
the addition of phenyl-lithium.   
 
On the same subject, Ritter utilized a similar fluorinating agent for the electrophilic 
halogenation of aryl-tri-n-butylstannanes.19 This process relied on a silver additive to 
successfully fluorinate C(sp2) carbon bonds from tin (Figure 6.9).  This supporting evidence 




Figure 6.9: Electrophilic fluorination of arylstannanes.  Ritter showed that arylstannanes 
were capable of fluorination reactions using a selectfluor derivative in the presence of super-
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Electrophilic fluorination of arylstannanes
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With the work of Ritter and Aggarwal in mind, we began to probe various stannatrane 
nucleophiles for reactivity.2 Our preliminary results showed that primary stannatranes under 
Ritter’s conditions afforded product in 28% yield (Figure 6.10-a).  Removal of silver triflate in a 
control experiment surprisingly afforded the better yield of 64% (Figure 6.10-b).  The more 
optimal conditions were applied to the racemic model substrate 2 for further optimization and 
control reactions (Figure 6.10-c).   
 
 
Figure 6.10: Electrophilic fluorination of alkylstannatrane. Evidence of desired reactivity 
(a,b) led us to optimize the more synthetically valuable secondary systems (c). 
 
Our optimized conditions proved capable of fluorinating unactivated primary, secondary, 
benzylic, and heteroatom-containing stannatrane-based nucleophiles (Figure 6.11).2   
Additionally, the replacement of selectfluor with electrophilic sources of chlorine, bromine, and 
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Electrophilic fluorination of alkylstannatrane
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Figure 6.11: Electrophilic fluorination of 1° and 2° alkylstannatranes.  Several examples are 
reported of electrophilic fluorination, a reaction reliant entirely on activation through the 
stannatrane backbone. 
 
Figure 6.12: Electrophilic halogenation of 1° and 2° alkylstannatranes. 1° and 2° 
alkylstannatranes smoothly underwent halogen substitution in the presence of electrophilic 
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Electrophilic halogenation of 1º and 2º alkylstannatranes
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Attempts to probe stereospecificity of this reaction initially resulted in a non-negligible 
amount of racemization in the final products.  Aggarwal has shown that the addition of a radical 
trap can suppress racemization in the fluorination of activated organoboron nucleophiles.18 We 
employed styrene, and observed a concomitant increase in stereospecificity (Figure 6.13).  
Relying on stereochemical definition made possible with stannatrane-lithium, we were able to 
assign an invertive pathway through an SE2 mechanism (Chapter 2 “Enantiospecific cross-




Figure 6.13: Stereospecific electrophilic halogenation of alkylstannanes. The addition of 
styrene helped reduce racemization in the stereospecific electrophilic halogenation of 
alkylstannatrane nucleophiles. * addition of 0.5 equiv. of pyridine led to optimized 
enantiospecificity.   
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6.4 Arylation: 
 As the development of stannatrane-lithium proceeded, we began to realize the arylation 
chemistry from 2013 deserved a deeper look.  A more thorough investigation into the electronic 
effects of the electrophile on stereofidelity, compatible coupling partners, and insights into the 
overall synthetic utility of a stannatrane backbone is currently underway.  What follows is a 
summary of this project to date. 
 
Electronic effects on arylation stereofidelity: 
 Although previous work by our group suggested the generality of electrophile scope, the 
scarcity of our tin nucleophiles precluded a more systematic investigation.  We decided to probe 
how the electronics of the aryl-bromide electrophiles effect the stereochemistry of cross coupling 
products.  We chose (S)-(+)-sec-butyl tricarbastannatrane as the probe because it was the most 
simple, least activated substrate (Figure 6.14).  
 
Figure 6.14: Arylation of s-Bu-stannatrane. We decided to probe the electronic effects of the 














In order to assign absolute configuration of the starting material, we chose to derivatize 
via cross coupling with a deactivated (electron rich) aryl bromide. We observed an average of 
98% ee for sec-butyl anisole after 3 runs.  This confirms that the minimum % ee of the starting 
material is 98%.  The (R)-(−)-sec-butyl mesylate was assigned as the alcohol at 99% ee by 
chiral-GC, which results in an overall enantiospecificity (es) of alkyltin formation of 99%.  
We then expanded the set of aryl bromides to include the highly activated 4-
bromonitrobenzene and two electronically neutral substrates. It was found that in a total of 9 
trials, we achieved greater than 80% calibrated GC yield, with an average es of 98%. The results 
are reported in Figure 6.15. This aligned well with our expectations, and further supports the 
generality of this method. 
 
 
Figure 6.15: Electronic effect on stereofidelity. Aryl-bromides with different electronic effects 
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From a utility perspective, these results indicate that translation of chiral information 
from a commercially available alcohol is incorporated directly into the final product of a cross-
coupling reaction with total stereofidelity over three steps.  Due to the abundance of 
commercially available chiral alcohols, this work has the potential to broadly impact organic 
synthesis. 
 
6.5 Summary of compatible coupling partners: 
 As discussed previously, stannatrane-lithium has allowed us to cheaply and efficiently 
prepare 2° enantioenriched alkylstannatranes with a defined absolute configuration (Figure 
6.16).  The results from these nucleophiles participation in arylation cross-coupling reactions are 
still ongoing.  We believe previous evidence of clean inversion of alkyl electrophiles precludes 
the possibility of racemization in formed alkylstannatranes.  We define the stereochemistry as the 
inverse of the chiral alcohols. The major bottleneck to this investigation is the analytical 
resolution of the cross-coupling products.  We are constantly improving our chiral-HPLC 
methods for separation, and expect the complete investigation to be published this year.  
 Compounds 5-8 have been chosen for the initial arylation work (Figure 6.17).  These 
compounds have been chosen as the linchpin of this investigation due to their significant 
structural or functional differences to previously published tin nucleophiles.  Our results have 
been encouraging. Racemic compound 5 has been shown to cross-couple with a diverse set of 
aryl-bromides on small scale with isolated yields of 50-80%.  All attempts to resolve the 










Figure 6.17: Selected alkylstannatranes for arylation investigation.  These compounds have 
been chosen for immediate investigation for compatibility in arylation cross-coupling.  
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Figure 6.18: Stereospecific arylation of compound 6. Although direct resolution of compound 
5 has failed, comparison of the % ee of the starting alcohol (99% ee) and final coupling product 
(98% ee) allow us to assign 99% es for the total transformation of compound 6. 
 
Compound 6 has resulted in cross-coupling products easily resolved with chiral-HPLC.  
We successfully confirmed the starting alcohol at 99% ee, but have been unable to directly 
measure the enantioenrichment of compound 6.  Confirmation of a single enantiomer peak after 
cross-coupling allows us to infer a total three-step enantiospecificity of 99%es.  Compounds 7 
and 8 have only just started to be investigated.  Both compounds have been found to cross-
couple in good yield on small scale.  Compound 7 results in coupling products easily resolved, 
and stereospecificity assignments are currently being done.  The coupling of compound 8 is 
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“An Uchiyama protocol can reliably convert optically active carbon electrophiles into 
enantioenriched 2° alkyl stannatranes to simplify tin-based stereospecific transformations.” 
The above statement has governed the entirety of this dissertation; from rationale, to 
development, application, and results.  In short, it is hoped that this work is convincing evidence 
of success in this area. 
 
Complete control of the chemical space is the ongoing challenge of research chemists.  In 
historical attempts to meet that goal, we have discovered chemical solutions to many problems 
associated with an industrialized world.  Agriculture, energy, and medicine, possibly the three 
most important pillars of society, are undeniably tied to the successes and failures of chemistry. 
Therefore, the future of these industries is equally tied to our work. 
In an effort to manipulate chemical space with better control, Ei-ichi Negishi, Kenkichi 
Sonogashira, Richard Heck, Makoto Kumada, Akira Suzuki and John Stille developed incredibly 
robust and reliable methods to join unsaturated chemical fragments through the manipulation and 
attenuation of palladium catalysis.  Their work in organometallic chemistry has revolutionized 
the way carbon bonds are formed in synthesis.  This work has been so impactful to modern 
synthesis; it is rare to come across a complex multi-step synthesis without at least one reference 
to a cross-coupling reaction. 
In the last decade, several authors have published evidence of structural bias that occurs 
by dependence on palladium based cross-coupling reactions.  Their overarching criticism relies 
on one main avenue of thought; that modern organopalladium chemistry is not conducive to the 
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saturated complexity associated with target molecules of the future.  Although there are many 
potential approaches to combat this structural bias, several prolific research groups have taken 
the stance that adapting transition-metal catalyst systems to accept saturated coupling fragments 
is the most logical solution. 
Selective incorporation of saturated fragments via transition metal catalysis comes with a 
variety of challenges.  Configurational stability, nucleophilicity, and β-hydride elimination are 
perhaps the greatest hurdles to overcome.  The Suzuki and Stille cross-coupling reactions seem 
uniquely adept at avoiding these pitfalls.  The most state-of-the-art applications of both reactions 
seem quite capable of the desired reactivity. 
The major drawbacks in Suzuki chemistry are the limitations in generality and 
predictability associated with stereospecific transformations.  Often times the intended coupling 
partner is limited by structural and electronic requirements that promote selective 
transmetallation.  The mechanism of transmetallation is sensitive to these subtle changes as well, 
which can result in a complete and unexpected reversal of chiral translation among similar 
scaffolds.  While the Stille reaction has been found to be much more general and predictable in 
scope, it has suffered from a historical lack of interest in stereospecific transformations for 
several reasons. 
Until recently, the Stille reaction was limited to the same structural and electronic 
limitations as the Suzuki reaction.  C(sp3) centers participated in transmetallation only if 
activation requirements within the coupling partner of interest were met.  The modified-Stille 
reaction published in 2013 by the Biscoe group applied the reaction in a more general scope by 
modifying the tin-handle and implementing an optimized catalyst system.  This development 
unlocked saturated, completely unactivated coupling partners as compatible reagents for the 
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stereospecific arylation, acylation, and fluorination of C(sp3) centers.  However, this reactivity 
was so novel that preparation of compatible tin compounds was extremely limited.  As is stood, 
this major bottleneck severely reduced the utility of the modified-Stille reaction by the broader 
synthetic community. 
Our previous synthesis of alkylstannatranes implemented carbon based anions with a 
limited ability to produce enantioenriched final products.  We then relied on the prep-scale 
HPLC resolution of racemates to obtain small amounts of compatible starting material for 
stereospecific cross-coupling.  This process was time-consuming, inefficient, and quite 
expensive. 
We found that a modified-Uchiyama reduction of carbastannatrane chloride generates an 
appropriate anion for the clean inversion of carbon electrophiles.   This method was used to 
prepare a suite of stereodefined enantioenriched alkylstannatrane nucleophiles cheaply and 
efficiently, which greatly impacted our ability to investigate the unique reactivity of these 
reagents.  This development is major progress toward the general utility of tin-based 
stereospecific transformations to create complex molecules with stereodefined chirality. 
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General Reagent Information 
 
BDH brand ethyl ether was purchased from VWR.  EMD brand Omnisolv THF (unstabilized) 
was also purchased from VWR.  These solvents were transferred to separate 20 L solvent-
delivery kegs and vigorously purged with argon for 2 h. The solvents were further purified by 
passing them under argon pressure through two packed columns of neutral alumina. s-BuLi (1.4 
M in cyclohexane) and isopropylmagnesium chloride (2.0 M in ether) were purchased from 
SigmaAldrich. 5-Chloro-1-aza-5-stannabicyclo[3.3.3]undecane was purchased from 
SigmaAldrich or prepared via the method of Vedejs.1 Pd(PPh3)4 was purchased from Strem. 
Anhydrous acetonitrile (Sigma-Aldrich) was purged with argon prior to use.  Grignard reagents 
were prepared from their corresponding alkyl chlorides or bromides using a literature procedure.2 
Thioesters were prepared from their corresponding carboxylic acids or acyl chlorides using a 
literature procedure.3 Molarities of Grignard reagents were determined using iodine titration.4  
Reagents and solvents were used as received unless otherwise noted.  Flash chromatography was 
performed using Silicycle silica gel (ultra pure grade).  Reverse-phase chromatography was 
performed using C18 silica gel from Silicycle (17% carbon, 40-63 mm) or from Acros (23% 
carbon, 40-63 mm). 
 
General Analytical Information  
 
All compounds were characterized by 1H NMR and 13C NMR spectroscopy. Copies of the 1H 
and 13C spectra for all new compounds can be found at the end of the Supporting Information.  
All previously unreported compounds were additionally characterized by high resolution MS. 
Nuclear Magnetic Resonance spectra were recorded on a Bruker 300 or Varian 500 MHz 
instrument.  All 1H NMR experiments are reported in δ units, parts per million (ppm), and were 
measured relative to the signals for residual chloroform (7.26 ppm).  All 13C NMR spectra are 
reported in ppm relative to deuterochloroform (77.23 ppm), and were obtained with 1H 
decoupling. High resolution MS analyses were performed on an Agilent 6520 Q-TOF 
instrument.  All GC analyses were performed on a Shimadzu GC-2010 gas chromatograph with 
an FID detector using a 25 m x 0.20 mm capillary column with cross-linked methyl siloxane as 
the stationary phase, or using a 30 m x 0.32 mm chiral column (Rt®-βDEXsm from Restek).  All 
GC yields were calibrated using dodecane or tetradecane as an internal standard. Chiral HPLC 
analyses were performed on a Shimadzu Prominence HPLC system with binary mobile phase 
pumps and UV-vis detector (LC-20AB, SPD-20A) using an OJ-RH (4.6 mm x 150 mm; particle 
size: 5 µm) chiral column (Daicel Chemical Ind., Ltd), an IA-3 (4.6 mm x 150 mm; particle size: 
3 µm) chiral column (Daicel Chemical Ind., Ltd), or an IA (4.6 mm x 150 mm; particle size: 5 
µm) chiral column (Daicel Chemical Ind., Ltd).  VCD analysis was performed by BioTools, Inc 
(Jupiter, Fl).  Preparative HPLC separations were performed by Chiral Technologies, Inc.  Thin 
layer chromatography was performed using EMD millipore normal phase silica-coated glass 










General procedure A  for the preparation of racemic secondary alkylcarbastannatranes. 
 
All reactions were performed in oven-dried glassware under an atmosphere of Ar.  sec-
Alkyllithium, sec-alkylmagnesium or sec-alkylzinc reagents (1.5–3.0 equiv) were added to the 
suspension of 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane1 (1 equiv) in anhydrous solvent at 
-78 °C. The resulting mixture was stirred at -78 °C for 3 h, allowed to warm to room 
temperature, and stirred overnight.  The reaction mixture was poured into a separatory funnel 
containing a mixture of water and ether. The organic layer was separated, washed with brine, 
dried over Na2SO4, and filtered. Solvent was removed under reduced pressure and dried in vacuo 
to provide the crude product.  The crude secondary alkyl tin reagents were used without 
purification, or following purification via Kugelrohr distillation or C18 chromatography. 
Homocoupling from Grignard formation constituted the major residual byproduct in the crude 
product. 
 
General procedure B  for cross-coupling reactions.  
 
Pd(PPh3)4 (2 mol %) and CuCl (2 equiv) were weighed out on the benchtop in an oven-dried test 
tube with stir bar. With stirring begun, the septum screw top tube was evacuated (80 mTorr) and 
backfilled three times with argon using a needle attached to a vacuum manifold. The tin reagent 
(1.1 equiv) and acyl chloride (1 equiv) were then added to the test tube via microsyringe, 
followed by degassed CH3CN (1 mL for 0.3 mmol scale). If the acyl chloride was a solid, it was 
weighed out on the benchtop alongside the other solids. The tube was sealed using electrical 
tape, and heated to 60 °C for 12 h. The reaction mixture was cooled to rt, diluted with ether, and 
washed with brine.  The organic layer was dried over Na2SO4, filtered, and concentrated to 
provide the crude product. The crude product was purified by column chromatography. 
 
General procedure C  for cross-coupling reactions with heterocyclic acyl chlorides. 
 
Pd(PPh3)4 (2 mol %) and CuCl (2 equiv) were weighed out on the benchtop in an oven-dried 
Schlenk tube with stir bar. With stirring begun, the Schlenk tube was evacuated (80 mTorr) and 
backfilled three times with argon using a needle attached to a vacuum manifold. The tin reagent 
(1.1 equiv) and acyl chloride (1 equiv) was then added to the Schlenk tube via microsyringe, 
followed by degassed CH3CN (1 mL for 0.3 mmol scale). If the acyl chloride was a solid, it was 
weighed out on the benchtop alongside the other solids. The Schlenk tube was sealed with a 
Teflon stopper, and heated to 60 °C for 12 h. The reaction mixture was cooled to rt, diluted with 
ether, and washed with brine.  The organic layer was dried over Na2SO4, filtered, and 
concentrated to provide the crude product. The crude product was purified by column 
chromatography. 
 
General procedure D  for cross-coupling reactions with t-butyl carbastannatrane. 
 
Pd(dba)2 (5 mol %), Jackiephos (10 mol %), CuCl (2 equiv), and t-butyl carbastannatrane (1.1 
equiv) were weighed out on the benchtop into an oven-dried Schlenk tube with stir bar. With 
stirring begun, the Schlenk tube was evacuated (80 mTorr) and backfilled three times with argon 
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using a needle attached to a vacuum manifold. The acyl chloride (1 equiv) was then added to the 
Schlenk tube via microsyringe, followed by degassed CH3CN (1 mL for 0.3 mmol scale). If the 
acyl chloride was a solid, it was weighed out on the benchtop alongside the other solids. The 
Schlenk tube was sealed with a Teflon stopper, and heated to 60 °C for 12 h. The reaction 
mixture was cooled to rt, diluted with ether, and washed with brine.  The organic layer was dried 
over Na2SO4, filtered, and concentrated to provide the crude product. The crude product was 
purified by column chromatography. 
 
General procedure E  for cross-coupling reactions with thioesters. 
 
Pd(PPh3)4 (2-5 mol %), CuCl (2 equiv), and thioester (1 equiv) were weighed out on the 
benchtop into an oven-dried Schlenk tube with stir bar. With stirring begun, the Schlenk tube 
was evacuated (80 mTorr) and backfilled three times with argon using a needle attached to a 
vacuum manifold. The tin reagent (1.1 equiv) was then added to the Schlenk tube via 
microsyringe, followed by degassed CH3CN (1 mL for 0.2 or 0.3 mmol scale). The Schlenk tube 
was sealed with a Teflon stopper, and heated to 60 °C for 12 h. The reaction mixture was cooled 
to rt, diluted with ethyl acetate, and washed with brine.  The organic layer was dried over 
Na2SO4, filtered, and concentrated to provide the crude product. The crude product was purified 
by column chromatography. 
 
General procedure F for the preparation of optically active secondary alkylcarbastannatranes.5 
 
To an oven dried round bottom flask with stirbar, 5-chloro-1-aza-5-stanna-
bicyclo[3.3.3]undecane (588 mg, 2 mmol)  and naphthalene (128 mg, 1 mmol) were added.  The 
flask was evacuated (<100 mtorr) and backfilled with argon three times.  With the flask under a 
flow of argon, the septum was removed and lithium granules (free of oil) were added (250 mg, 
35 mmol). This was followed by two additional evacuation/backfill cycles. Anhydrous THF (40 
mL) was added to the flask via syringe, and the mixture was stirred at room temperature. The 
solution turned dark green/black within 30 min.  Upon color change, the solution was stirred at 
room temperature for an additional hour.  In a separate 100 mL flask under argon, with stirbar 
and rubber septum, the optically active alkyl mesylate (1.2–1.5 equiv) was dissolved in 
anhydrous THF (20 mL).  The mesylate solution was heated to 60 °C.  The stannatrane lithium 
mixture was removed from the excess lithium via cannula or needle/syringe, and transferred 
dropwise to the mesylate solution over 5 mins. The reaction stirred at 60 °C for an additional 
hour. The reaction mixture was extracted with ethyl ether (60 mL), followed by brine (100 mL), 
and dried over Na2SO4. The reaction solution was filtered and concentrated to provide the crude 
product. The crude product was purified (40–50% isolated yield) by C18 silica (80/20 
acetonitrile/water to 100% acetonitrile), fractions analyzed using HPLC (220/254 nm) or reverse-



































entry variations from above GC yield (%)
1           CuCl w/ 1 equiv. Bu4NCl                                          < 5
5           CuBr w/ 1 equiv. Bu4NCl                                         < 5
CuCN instead of CuCl                                               10
3           CuCN w/ 1 equiv. Bu4NCl                                        < 5
4
2
CuBr instead of CuCl                                                49
+
Pd(PPh3)4 (2 mol %)
CuCl (2 equiv)










 6           No Cu(I) / 1 equiv. Bu4NCl                                      < 5
7
8
1,4-dioxane instead of CH3CN















5-(sec-Butyl)-1-aza-5-stannabicyclo[3.3.3]undecane.5 General procedure A was employed 
using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (2.94 g, 10.0 mmol) in ether (40 mL) and 
s-BuLi (1.4 M in cyclohexane, 15 mL, 21 mmol). A yellow oil (3.18 g, 99%) was isolated. 1H 
NMR (500 MHz, CDCl3) δ: 2.35 (t, J = 6 Hz, 6H), 1.64 (app. quint, J = 6 Hz, 6H), 1.41-1.51 (m, 
3H), 1.05 (d, J = 7.5 Hz, 3H), 0.86 (t, J = 7 Hz, 3H), 0.63 (t, J = 6.5 Hz, 6H) ppm. 13C NMR 
(125 MHz, CDCl3) δ: 55.0, 29.4, 26.7, 23.7, 18.5, 14.8, 5.7 ppm.  
 
(R)- and (S)-5-(sec-Butyl)-1-aza-5-stannabicyclo[3.3.3]undecane. The general procedure F 
was employed using  (S)-(sec-butyl) mesylate or  (R)-(sec-butyl) mesylate (430 µL, 3 mmol). A 
pale yellow oil (40–50%) was isolated.  Enantiomeric excess of product ranged from 91–99% ee 






5-(iso-Propyl)-1-aza-5-stannabicyclo[3.3.3]undecane.6 General procedure A was employed 
using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (1.47 g, 5.0 mmol) in ether (20 mL) and 
isopropylmagnesium chloride (2.0 M in ether, 7.5 mL, 15 mmol). A yellow oil (1.41 g, 95%) 
was isolated. 1H NMR (500 MHz, CDCl3) δ: 2.38 (t, J = 6 Hz, 6H), 1.67 (app. quint, J = 6 Hz, 
6H), 1.09 (d, J = 7.5 Hz, 6H), 0.70-0.76 (m, 1H), 0.65 (t, J = 6.5 Hz, 6H) ppm. 13C NMR (125 





5-(Tetrahydro-2H-pyran-4-yl)-1-aza-5-stannabicyclo[3.3.3]undecane.6 General procedure A 
was employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.88 g, 3.0 mmol) in THF 
(30 mL) and (tetrahydro-2H-pyran-4-yl)magnesium chloride (0.62 M in THF, 7 mL, 4.3 mmol). 
A pale yellow solid (983 mg, 95%) was isolated. 1H NMR (500 MHz, CDCl3) δ: 3.87 (m, 2H), 
3.33 (dt, J = 11, 2 Hz, 2H), 2.36 (t, J = 6 Hz, 6H), 1.64 (app. quint, J = 6 Hz, 6H), 1.50-1.55 (m, 
4H), 0.89-0.95 (m, 1H), 0.64 (t, J = 6.5 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3) δ: 71.0, 54.8, 












5-(4-Phenylbutan-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane.6 General procedure A was 
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (1.65 g, 5.6 mmol) in THF (50 
mL) and (4-phenylbutan-2-yl)magnesium chloride (0.28 M in THF, 23 mL, 6.4 mmol).  A pale 
yellow oil (1.74 g, 79%) was isolated. 1H NMR (500 MHz, CDCl3) δ: 7.25-7.28 (m, 2H), 7.16-
7.19 (m, 3H), 2.50-2.65 (m, 2H), 2.36 (t, J = 6 Hz, 6H), 1.76-1.81 (m, 1H), 1.65 (app. quint, J = 
6 Hz, 6H), 1.23-1.39 (m, 1H), 1.13 (d, J = 7.5 Hz, 3H), 0.79 (quart, J = 7.5 Hz, 1H), 0.67 (t, J = 
6.5 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3) δ: 143.9, 128.6, 128.3, 125.5, 54.9, 39.0, 36.5, 
24.2, 23.6, 18.6, 5.6 ppm.  
 
(S)-5-(4-Phenylbutan-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane (19). General procedure F 
was employed using (R)-(4-phenylbutan-2-yl)mesylate (500 µL, 2.4 mmol). A pale yellow oil 
(320 mg, 40%) was isolated. Enantiomeric excess of product ranged from 91–99% ee between 
different runs.  Enantiomers could also be separated on a preparative scale using a Chiralpak OJ-





Ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)butanoate (20).6  General procedure A 
was employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.88 g, 3.0 mmol) in DMF 
(8 mL) and (4-ethoxy-4-oxobutan-2-yl)zinc iodide (0.61 M in DMF, 10 mL, 6.1 mmol). An 
orange oil (509 mg, 45%) was isolated. 1H NMR (500 MHz, CDCl3) δ: 4.09 (quart, J = 7 Hz, 
2H), 2.39-2.43 (m, 1H), 2.35 (t, J = 6 Hz, 6H), 2.23-2.27 (m, 1H), 1.64 (app. quint, J = 6 Hz, 
6H), 1.24 (t, J = 7 Hz, 3H), 1.02-1.13 (m, 4H), 0.65 (t, J = 6.5 Hz, 6H) ppm. 13C NMR (125 
MHz, CDCl3) δ: 175.5, 60.0, 54.9, 40.7, 23.5, 19.8, 18.4, 14.6, 5.2 ppm. Enantiomers were 






5-(3-Phenylpropyl)-1-aza-5-stannabicyclo[3.3.3]undecane. General procedure A was 
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (294 mg, 1 mmol) in THF (5 
mL) and 3-phenylpropylmagnesium chloride (0.31 M in THF, 10 mL, 3.1 mmol). A yellow oil 
(189 mg, 50%) was isolated. 1H NMR (500 MHz, CDCl3) δ: 7.27-7.14 (m, 5H), 2.53 (t, J = 7.5 
Hz, 2H), 2.36 (t, J = 6.2 Hz, 6H), 1.69 (quint, J = 6 Hz, 2H), 1.62 (app. quint, J = 6 Hz, 6H), 0.64 









128.3, 125.5, 54.9, 41.5, 29.9, 23.6, 16.4, 6.8 ppm. HRMS (ES+): Calcd (116Sn) (M-Na)+ 
394.1246; Found (116Sn) 394.1251. 
                                          
                                                      
 
 
5-(1-Phenylpropyl)-1-aza-5-stannabicyclo[3.3.3]undecane (21). General procedure A was 
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (206 mg, 0.7 mmol)  in THF (5 
mL), and 1-phenylethyl magnesium chloride (0.21 M in THF, 10 mL, 2.1 mmol). A pale yellow 
oil (100 mg, 38%) was isolated and stored under argon.   1H NMR (500 MHz, CDCl3) δ: 7.17-
6.87 (m, 5H), 2.32 (t, J = 6 Hz, 6H), 2.03-1.70 (m, 3H), 1.61 (app. quint, J = 6 Hz, 6H), 0.92 (t, J 
= 7.5 Hz, 3H), 0.61 (t, J = 6 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3) δ: 149.8, 128.0, 125.8, 
121.8, 54.8, 43.0, 25.0, 23.6, 15.5, 5.9 ppm. HRMS (ES+): Calcd (116Sn) (M-Na)+ 402.1220; 
Found (116Sn) 402.1226. Enantiomers were separated on a preparative scale using a Chiralcel OJ-





5-(tert-Butyl)-1-aza-5-stannabicyclo[3.3.3]undecane. General procedure A was employed 
using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (588 mg, 2.0 mmol) in THF (20 mL) and t-
butyl lithium (1.4 M in ether, 4.3 mL, 6 mmol). A pale yellow solid (0.35 g, 56%) was isolated. 
1H NMR (500 MHz, CDCl3) δ: 2.35 (t, J = 6 Hz, 6H), 1.65 (app. quint, J = 6 Hz, 6H), 0.92 (s, 
9H), 0.63 (t, J = 6 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3) δ: 54.8, 30.3, 23.7, 4.2 ppm.  
 
                                                
 
 
1-(Furan-2-yl)-4-phenylbutan-1-one (4).  General procedure C was employed using 2-furoyl 
chloride (39 mg, 0.3 mmol) and 5-(3-phenylpropyl)-1-aza-5-stannabicyclo[3.3.3]undecane (125 
mg, 0.33 mmol).  A yellow liquid (86 mg, 89%) was isolated by column chromatography (90:10 
pentane/MTBE). 1H NMR (300 MHz, CDCl3): δ 7.57-7.56 (dd, J = 1.8, 3 Hz, 1H), 7.29-7.13 (m, 
6H), 6.52-6.51 (dd, J = 1.8, 3 Hz, 1H), 2.84 (t, J = 7.5 Hz, 2H), 2.71 (t, J = 7.5 Hz, 2H), 2.06 (q, 
J = 7.5 Hz, 2H) ppm. 13C NMR (125 MHz, CDCl3): δ 189.6, 153.0, 146.4, 141.8, 128.7, 128.6, 

















Phenyl(tetrahydro-2H-pyran-4-yl)methanone (5).11  General procedure B was employed using 
benzoyl chloride (42 mg, 0.3 mmol) and 5-(tetrahydro-2H-pyran-4-yl)-1-aza-5-
stannabicyclo[3.3.3]undecane (113 mg, 0.33 mmol).  A white solid (52 mg, 91%) was isolated 
by column chromatography (94:6 hexanes/ether). 1H NMR (300 MHz, CDCl3): δ 7.96-7.93 (m, 
2H), 4.09-4.03 (m, 2H), 3.61-3.45 (m, 3H), 1.96-1.76 (m, 4H) ppm. 13C NMR (75 MHz, CDCl3): 




1-(Benzo[b]thiophen-2-yl)-2-methylpropan-1-one (6).  General procedure C was employed 
using benzo[b]thiophene-2-carbonyl chloride (55 mg, 0.3 mmol) and 5-(iso-propyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (100 mg, 0.33 mmol).  A yellow liquid (42 mg, 68%) was isolated 
by column chromatography (95:5 hexanes/ether). 1H NMR (300 MHz, CDCl3): 7.97 (s, 1H), 
7.91-7.86 (m, 2H), 7.49-7.38 (m, 2H), 3.60 – 3.46 (septet, J = 7 Hz, 1H), 1.31-1.29 (d, J = 6 Hz, 
6H). 13C NMR (75 MHz, CDCl3) δ 199.2, 143.3, 142.7, 139.43, 128.8, 127.5, 126.1, 125.2, 





1-(Benzofuran-2-yl)-2-methylpropan-1-one (7).9  General procedure C was employed using 
benzofuran-2-carbonyl chloride (54 mg, 0.3 mmol) and 5-(iso-propyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (100 mg, 0.33 mmol).  A yellow liquid (38 mg, 68%) was isolated 
by column chromatography (95:5 hexanes/ether). 1H NMR (300 MHz, CDCl3): δ 7.71 (d, J = 9 
Hz, 1H), 7.59 (dd, J = 1, 9 Hz, 1H), 7.52 (d, J = 1 Hz, 1H), 7.47 (dt, J = 3, 5 Hz, 1H), 7.33 – 7.28 
(m, 1H), 3.48 (heptet, J = 6.5 Hz, 1H), 1.28 (d, J = 6 Hz, 6H) ppm. 13C NMR (75 MHz, CDCl3): 




2-Methyl-1-(o-tolyl)butan-1-one (8). General procedure C was employed using o-toluoyl 
















0.33 mmol).  A yellow liquid (47 mg, 89%) was isolated by column chromatography (99:1 
hexanes/ether). 1H NMR (300 MHz, CDCl3): δ 7.54-7.22 (m, 4H), 3.25-3.14 (hex, J = 6.6 Hz, 
1H), 2.44 (s, 3H), 1.89-1.75 (m, 1H), 1.53-1.39 (m, 1H), 1.18 (d, J = 6 Hz, 3H), 0.95 (t, J = 7.5 
Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): 209.3, 139.3, 137.8, 130.9, 127.8, 125.7, 45.8, 26.4, 





(S)-2-Methyl-1-(o-tolyl)butan-1-one (22). General procedure C was employed using o-toluoyl 
chloride (31 mg, 0.2 mmol) and 5-(sec-butyl)-1-aza-5-stannabicyclo[3.3.3]undecane (68 mg, 
0.22 mmol, 99% ee).  A yellow liquid (27.5 mg, 78%, 99% ee) was isolated by column 
chromatography. [a]20D (c 1.00, CHCl3) = +12.4º.   % ee was determined using an OJ-RH 







3-Methyl-1-phenylheptan-4-one (9).  General procedure B was employed using butyryl 
chloride (32 mg, 0.3 mmol) and 5-(4-phenylbutan-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane 
(129 mg, 0.33 mmol).  A colorless oil (48 mg, 79%) was isolated by column chromatography 
(94:6 hexanes/ether). 1H NMR (300 MHz, CDCl3): δ 7.31-7.15 (m, 5H), 2.60-2.37 (m, 5H), 2.00 
(m, 1H), 1.69-1.53 (m, 3H), 1.13-1.10 (d, J = 9 Hz, 3H), 0.91 (t, J = 7.5 Hz, 3H) ppm. 13C NMR 
(75 MHz, CDCl3): 214.7, 142.0, 128.61, 128.58, 126.1, 45.9, 43.3, 34.7, 33.7, 17.3, 16.7, 14.0 





2,4-Dimethyl-6-phenylhexan-3-one (10).  General procedure B was employed using isobutyryl 
chloride (32 mg, 0.3 mmol) and 5-(4-phenylbutan-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane 
(129 mg, 0.33 mmol).  A yellow oil (55 mg, 89%) was isolated by column chromatography (94:6 
hexanes/ether). 1H NMR (300 MHz, CDCl3): δ 7.31-7.15 (m, 5H), 2.76-2.67 (m, 2H), 2.59-2.53 













CDCl3): 218.3, 142.1, 128.61, 128.55, 126.1, 44.1, 39.8, 34.8, 33.8, 18.62, 18.59, 17.10 ppm. 




(S)-2,4-Dimethyl-6-phenylhexan-3-one (25).  General procedure B was employed using 
isobutyryl chloride (21.3 mg, 0.2 mmol) and (S)-5-(4-phenylbutan-2-yl)-1-aza-5-
stannabicyclo[3.3.3]undecane (86 mg, 0.22 mmol, 98% ee).  A yellow oil (35 mg, 85%, 91% ee) 
was isolated by column chromatography (94:6 hexanes/ether). [a]20D (c 1.00, CHCl3) = +15.7º.  
% ee was determined using an IA (250x4.6) HPLC column with a 65%:35% [19:1 v/v 




1-(3-Chlorophenyl)-2-methylpropan-1-one (11).8  General procedure B was employed using 3-
chlorobenzoyl chloride (53 mg, 0.3 mmol) and 5-(iso-propyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (100 mg, 0.33 mmol).  A yellow liquid (47 mg, 86%) was isolated 
by column chromatography (95:5 hexanes/ether). 1H NMR (300 MHz, CDCl3): δ 7.92 (t, J = 1.8 
Hz, 1H), 7.83-7.80 (m, 1H), 7.53-7.52 (m, 1H), 7.41 (t, J = 8.0 Hz, 1H), 3.49 (sept, J = 6.8 Hz, 
1H), 1.21 (d, J = 6.8 Hz, 6H) ppm. 13C NMR (75 MHz, CDCl3): 203.3, 138.0, 135.0, 132.8, 




1-(4-Chlorophenyl)-2-methylpropan-1-one (12).12  General procedure B was employed using 
4-chlorobenzoyl chloride (53 mg, 0.3 mmol) and 5-(iso-propyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (100 mg, 0.33 mmol).  A yellow liquid (44 mg, 81%) was isolated 
by column chromatography (94:6 hexanes/ether). 1H NMR (300 MHz, CDCl3): δ 7.89 (d, J = 9 
Hz, 2H), 7.43 (d, J = 9 Hz, 2H), 3.50 (septet, J = 7 Hz, 1H), 1.21 (d, J = 9 Hz, 6H) ppm. 13C 





















1-(Benzo[d][1,3]dioxol-5-yl)-2-methylpropan-1-one (13).8  General procedure B was employed 
using piperonyloyl chloride (55 mg, 0.3 mmol) and 5-(iso-propyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (100 mg, 0.33 mmol).  A yellow liquid (55.3 mg, 96%) was 
isolated by column chromatography (90:10 pentane/MTBE). 1H NMR (300 MHz, CDCl3): δ 7.49 
(dd, J = 8.1, 1.7 Hz, 1H), 7.37 (d, J = 1.7 Hz, 1H), 6.78 (d, J = 8.3 Hz, 1H), 5.97 (s, 2H), 3.39 
(sept, J = 6.8 Hz, 1H), 1.12 (d, J = 6.9 Hz, 6H); ppm. 13C NMR (75 MHz, CDCl3): δ 202.6, 




Benzo[b]thiophen-2-yl(tetrahydro-2H-pyran-4-yl)methanone (14).  General procedure C was 
employed using benzo[b]thiophene-2-carbonyl chloride (55 mg, 0.3 mmol) and 5-(tetrahydro-
2H-pyran-4-yl)-1-aza-5-stannabicyclo[3.3.3]undecane (113 mg, 0.33 mmol). A pale yellow solid 
(51 mg, 69%) was isolated by column chromatography (97:3 hexanes/ether). 1H NMR (300 
MHz, CDCl3): δ 7.99 (s, 1H), 7.91-7.87 (m, 2H), 7.51-7.39 (m, 2H), 4.13-4.07 (m, 2H), 3.63-
3.44 (m, 3H), 2.06-1.84 (m, 4H) ppm. 13C NMR (75 MHz, CDCl3): 196.2, 142.6, 142.5, 139.1, 
128.80, 127.5, 125.9, 125.1, 123.0, 67.2, 44.2, 29.3 ppm. HRMS (ES+): Calcd (M-Na)+ 
269.0612; Found 269.0615. 
 
                                            
 
 
1-(4-Methoxyphenyl)-2,2-dimethylpropan-1-one (15).14  General procedure D was employed 
using 4-methoxybenzoyl chloride (51 mg, 0.3 mmol) and 5-(tert-butyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (104 mg, 0.33 mmol).  A colorless liquid (24 mg, 42%) was 
isolated by column chromatography (90:10 hexanes/ether). 1H NMR (500 MHz, CDCl3): δ 7.85 
(d, J = 9.0 Hz, 2H), 6.90 (d, J = 9.0 Hz, 2H), 3.85 (s, 3H) 1.37 (s, 9H) ppm. 13C NMR (75 MHz, 





2-Methyl-1-(naphthalen-2-yl)butan-1-one (16).10  General procedure B was employed using 2-
naphthoyl chloride (57 mg, 0.3 mmol) and 5-(sec-butyl)-1-aza-5-stannabicyclo[3.3.3]undecane 
(104 mg, 0.33 mmol).  An orange liquid (48 mg, 75%) was isolated by column chromatography 
(93:7 hexanes/EtOAc). 1H NMR (300 MHz, CDCl3): δ 8.47 (s, 1H), 8.06-7.87 (m, 4H), 7.57 











1H), 1.26 (d, J = 6 Hz, 3H), 0.96 (t, J = 6 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 204.7, 




2,2-Dimethyl-1-(naphthalen-2-yl)propan-1-one (17).12 General procedure D was employed 
using 2-naphthoyl chloride (57 mg, 0.3 mmol) and 5-(tert-butyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (104 mg, 0.33 mmol).  A pale yellow solid (44 mg, 69%) was 
isolated by column chromatography (95:5 hexanes/EtOAc). 1H NMR (300 MHz, CDCl3): δ 8.24 
(s, 1H), 7.93-7.77 (m, 4H), 7.59-7.51 (m, 2H), 1.43 (s, 9H) ppm. 13C NMR (75 MHz, CDCl3): 




1-(Benzofuran-2-yl)-2-phenylbutan-1-one (23).  General procedure C was employed using 
benzofuran-2-carbonyl chloride (36 mg, 0.2 mmol) and (S)-5-(sec-butyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (68 mg, 0.22mmol, 91% ee).  A colorless oil (27 mg, 67%, 88% 
ee) was isolated by column chromatography (99:1 hexanes/ether). [a]20D (c 1.00, CHCl3) = 
+3.2º. % ee was determined using an IA (250x4.6) HPLC column with a 60%:40% 
methanol:water eluent. 1H NMR (300 MHz, CDCl3): δ 7.71 (d, J = 7.5 Hz, 1H), 7.60-7.44 (m, 
3H), 7.31 (dt, J = 3, 7.5 Hz, 1H), 3.32 (sextet, J = 6.6 Hz, 1H), 1.94-1.82 (m, 1H), 1.63-1.49 (m, 
1H), 1.25 (d, J = 6 Hz, 3H), 0.96 (t, J = 7.5 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): 195.50, 
155.63, 152.11, 128.07, 127.10, 123.83, 123.20, 112.80, 112.45, 36.70, 18.79 ppm. HRMS 





1,4-Diphenyl-2-methyl-1-butanone (24).15  General procedure B (acyl chloride) was employed 
using benzoyl chloride (17 mg, 0.1 mmol) and (S)-5-(4-phenylbutan-2-yl)-1-aza-5-
stannabicyclo[3.3.3]undecane (43 mg, 0.11mmol, 99% ee).  A colorless oil (18.5 mg, 78%, 99% 
ee) was isolated by column chromatography (95:5 hexanes/ether). [a]20D (c 1.00, CHCl3) = 
+27.8º.  % ee was determined using an IA (250x4.6) HPLC column with a 80%:20% [19:1 v/v 
methanol/acetonitrile]:sodium phosphate buffer (25mM, pH 7.8) eluent. 1H NMR (300 MHz, 
CDCl3): δ 7.88-7.85 (m, 2H), 7.58-7.52 (m, 1H), 7.46-7.41 (m, 2H), 7.31-7.16 (m, 5H), 3.47 










= 6.8 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): 204.3, 142.0, 136.8, 133.1, 128.8, 128.7, 128.6, 
128.5, 126.1, 39.9,  35.4, 33.7, 17.5 ppm.  
 
General procedure E (thioester) was employed using Pd(PPh3)4 (2 mol %), CuCl (2 equiv), S-
phenyl benzothioate (42.8 mg, 0.2 mmol) and (S)-5-(4-phenylbutan-2-yl)-1-aza-5-
stannabicyclo[3.3.3]undecane (86 mg, 0.22 mmol, 91% ee).  A colorless oil (38.5 mg, 81%, 90% 
ee) was isolated by column chromatography (95:5 hexanes/ether). % ee was determined using an 
IA (250x4.6) HPLC column with a 75%:25% methanol:sodium phosphate buffer (25mM, pH 





1-(Isoxazol-5-yl)-2-methyl-4-phenylbutan-1-one (26).  General procedure C was employed 
using isoxazole-5-carbonyl chloride (26.3 mg, 0.2 mmol) and 5-(4-phenylbutan-2-yl)-1-aza-5-
stannabicyclo[3.3.3]undecane (86 mg, 0.22 mmol, 95% ee).  A colorless oil (34.4 mg, 75%, 99% 
ee) was isolated by column chromatography (75:25 hexanes/ether). [a]20D (c 1.00, CHCl3) = 
+18.0º.  % ee was determined using an OJ-RH (150x4.6) HPLC column with a 70%:30% [19:1 
v/v methanol/acetonitrile]:water eluent. 1H NMR (300 MHz, CDCl3): δ 8.34 (d, J = 3.0 Hz, 1H), 
7.27-7.14 (m, 1H), 6.85 (d, J = 3Hz, 5H), 3.38 (sextet, J = 7.2 Hz, 1H), 2.65 (t, J = 6 Hz, 2H), 
2.25-2.12 (m, 1H), 1.88-1.73 (m, 1H), 1.28 (d, J = 6 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): 
193.0, 166.0, 150.9, 141.5, 128.7, 128.6, 126.3, 107.4, 42.9, 34.4, 33.6, 16.5 ppm. HRMS (ES+): 





Ethyl 3-methyl-4-(naphthalen-2-yl)-4-oxobutanoate (29).  General procedure B was employed 
using 2-naphthoyl chloride (57 mg, 0.3 mmol) and ethyl 3-(1-aza-5-
stannabicyclo[3.3.3]undecan-5-yl)butanoate (123 mg, 0.33 mmol).  A colorless oil (49 mg, 71%) 
was isolated by column chromatography (90:10 hexanes/ether). For the enantioenriched 
carbastannatrane variant, general procedure B was employed using 2-naphthoyl chloride (0.05 
mmol) and ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)butanoate (0.055 mmol, 97% ee).  
The product yield (75%, 96% ee) was determined by calibrated gas chromatography. % ee was 
determined using an OJ-RH (150x4.6) HPLC column with a 70%:30% [19:1 v/v 
methanol/acetonitrile]:sodium phosphate buffer (25mM, pH 7.8) eluent.  1H NMR (300 MHz, 
CDCl3): δ 8.53 (br s, 1H), 8.06-7.87 (m, 4H), 7.58 (dquintet, J = 1.8, 7.5 Hz, 2H), 4.16-4.07 (m, 
3H), 3.06-2.97 (dd, J = 9, 18 Hz, 1H), 2.55-2.47 (dd, J = 6, 18 Hz, 1H), 1.29 (d, J = 6.0 Hz, 3H), 
1.21 (t, J = 6.0 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): 203.0, 172.6, 135.8, 133.5, 132.8, 
130.2, 129.8, 128.8, 128.7, 128.0, 127.0, 124.5, 60.8, 37.9, 37.5, 18.3, 14.4 ppm. HRMS (ES+): 














Ethyl 4-(furan-2-yl)-3-methyl-4-oxobutanoate (27).  General procedure C was employed using 
2-furoyl chloride (39 mg, 0.3 mmol) and ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-
yl)butanoate (123 mg, 0.33 mmol).  A colorless oil (50 mg, 79%) was isolated by column 
chromatography (80:20 hexanes/EtOAc). For the enantioenriched carbastannatrane variant, 
general procedure C was employed using 2-furoyl chloride (0.05 mmol) and ethyl 3-(1-aza-5-
stannabicyclo[3.3.3]undecan-5-yl)butanoate (0.055 mmol, 97% ee). The product yield (78%, 
96% ee) was determined by calibrated gas chromatography. % ee was determined using an IA 
(250x4.6) HPLC column with a 50%:50% [19:1 v/v methanol/acetonitrile]:sodium phosphate 
buffer (25mM, pH 7.8) eluent.   1H NMR (300 MHz, CDCl3): δ 7.60 (br s, 1H), 7.24 (d, J = 3 
Hz, 1H), 6.55-6.53 (dd, J = 3, 3 Hz, 1H), 4.09(q, J = 6.0 Hz, 2H), 3.72 (sextet, J = 6.6 Hz, 1H), 
2.95-2.87 (dd, J = 9, 15 Hz, 1H), 2.46-2.38 (dd, J = 6, 18 Hz, 1H), 1.25-1.17 (m, 6H) ppm. 13C 
NMR (75 MHz, CDCl3): 203.0, 172.6, 135.8, 133.5, 132.8, 130.2, 129.8, 128.8, 128.7, 128.0, 
127.0, 124.5, 60.8, 37.9, 37.5, 18.3, 14.4 ppm. 13C NMR (125 MHz, CDCl3): 191.8, 172.3, 
152.2, 146.7, 117.8, 112.5, 60.8, 38.1, 37.3, 17.8, 14.3 ppm. HRMS (ES+): Calcd (M-H)+ 





Ethyl 4-(4-chlorophenyl)-3-methyl-4-oxobutanoate (28).16  General procedure C was 
employed using 4-chlorobenzoyl chloride (53 mg, 0.3 mmol) and ethyl 3-(1-aza-5-
stannabicyclo[3.3.3]undecan-5-yl)butanoate (123 mg, 0.33 mmol).  A colorless oil (71 mg, 93%) 
was isolated by column chromatography (90:10 hexanes/ether). For the enantioenriched 
carbastannatrane variant, general procedure C was employed using 4-chlorobenzoyl chloride 
(0.05 mmol) and ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)butanoate (0.055 mmol, 
99% ee). The product yield (93%, 99% ee) was determined by calibrated gas chromatography. % 
ee was determined using an IA (250x4.6) HPLC column with a 70%:30% methanol:sodium 
phosphate buffer (25mM, pH 7.8) eluent. 1H NMR (300 MHz, CDCl3): δ 7.94 (d, J = 9.0 Hz, 
2H), 7.46 (d, J = 9.0 Hz, 2H), 4.12 (q, J = 7.0 Hz, 2H), 3.89 (sextet, J = 7.2 Hz, 1H), 3.00-2.91 
(dd, J = 9, 18 Hz, 1H), 2.49-2.41 (dd, J = 6, 18 Hz, 1H), 1.23-1.18 (m, 6H) ppm. 13C NMR (75 
MHz, CDCl3): 201.9, 172.4, 139.7, 134.5, 130.1, 129.2, 60.8, 37.7, 37.4, 18.0, 14.3 ppm.   
 













1-(Benzofuran-2-yl)-2-phenylbutan-1-one (30).  General procedure C was employed using 
benzofuran-2-carbonyl chloride (54 mg, 0.3 mmol) and 5-(1-phenylpropyl)-1-aza-5-
stannabicyclo[3.3.3]undecane (125 mg, 0.33 mmol). A yellow oil (63 mg, 80%) was isolated by 
column chromatography (95:5 hexanes/ether). For the enantioenriched carbastannatrane variant, 
general procedure C was employed using benzofuran-2-carbonyl chloride (0.05 mmol) and 5-(1-
phenylpropyl)-1-aza-5-stannabicyclo[3.3.3]undecane (0.055 mmol, 99% ee). The product yield 
(78%, 97% ee) was determined by calibrated gas chromatography.  % ee was determined using 
an OJ-RH (150x4.6) HPLC column with a 80%:20% [19:1 v/v methanol/acetonitrile]:sodium 
phosphate buffer (25mM, pH 7.8) eluent.  1H NMR (300 MHz, CDCl3): δ 7.66-7.22 (m, 10H), 
4.40 (t, J = 7.5 Hz, 1H), 2.30-2.21 (m, 1H), 1.93-1.86 (m, 1H), 0.94 (t, J = 7.5 Hz, 3H) ppm. 13C 
NMR (75 MHz, CDCl3): 191.3, 155.8, 152.7, 139.2, 129.02, 128.6, 128.4, 127.4, 127.3, 124.0, 
123.5, 113.7, 112.7, 56.3, 26.5, 12.5 ppm. HRMS (ES+): Calcd (M-Na)+ 287.1048; Found 





1-(Benzo[b]thiophen-2-yl)-2-phenylbutan-1-one (31).  General procedure C was employed 
using benzo[b]thiophene-2-carbonyl chloride (55 mg, 0.3 mmol) and 5-(1-phenylpropyl)-1-aza-
5-stannabicyclo[3.3.3]undecane (125 mg, 0.33 mmol).  A pale yellow solid (51 mg, 69%) was 
isolated by column chromatography (97:3 hexanes/ether).  For the enantioenriched 
carbastannatrane variant, general procedure C was employed using benzo[b]thiophene-2-
carbonyl chloride (0.05 mmol) and 5-(1-phenylpropyl)-1-aza-5-stannabicyclo[3.3.3]undecane 
(0.055 mmol, 99% ee). The product yield (71%, 99% ee) was determined by calibrated gas 
chromatography. % ee was determined using an OJ-RH (150x4.6) HPLC column with a 
80%:20% [19:1 v/v methanol/acetonitrile] : sodium phosphate buffer (25mM, pH 7.8) eluent.  1H 
NMR (300 MHz, CDCl3): δ 7.66-7.22 (m, 10H), 4.40 (t, J = 7.5 Hz, 1H), 2.30-2.21 (m, 1H), 
1.93-1.86 (m, 1H), 0.94 (t, J = 7.5 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): 191.3, 155.8, 
152.7, 139.2, 129.0, 128.6, 128.4, 127.4, 127.3, 124.0, 123.5, 113.7, 112.7, 56.3, 26.5, 12.5 ppm. 

















(2S,4R)-2-(6-methoxynaphthalen-2-yl)-4-methylhexan-3-one (syn-34).   General procedure E 
was employed using Pd(dba)2 (5 mol %), Jackiephos (7 mol %), CuCl (2 equiv), S-phenyl (S)-2-
(6-methoxynaphthalen-2-yl)propanethioate (64.5 mg, 0.2 mmol, >99% ee) and (R)-5-(sec-butyl)-
1-aza-5-stannabicyclo[3.3.3]undecane (80.4 mg, 0.26 mmol, 99% ee).  A white solid (32.5 mg, 
60%, 49:1 dr) was isolated by column chromatography (97:3 hexanes/ether). [a]20D (c 1.00, 
CHCl3) = +183.9º.
 1H NMR (300 MHz, CDCl3): δ 7.71-7.62 (m, 3H), 7.32-7.29 (dd, J = 3, 9 Hz 
,1H), 7.17-7.11 (m, 2H), 4.03 (q, J = 6 Hz, 1H), 3.91 (s, 3H), 2.58 (app. sextet, J = 8.4 Hz, 1H), 
1.61-1.44 (m, 4H), 1.22 (app. heptet, J = 6 Hz, 1H), 1.07 (d, J = 6 Hz, 1H), 0.89-0.79 (m, 1H), 
0.55 (t, J = 7.5 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): 214.49, 157.84, 135.64, 133.84, 
129.38, 129.26, 127.51, 126.97, 126.85, 119.25, 106.81, 55.51, 51.56, 46.57, 25.63, 18.27, 17.48, 





(2S,4S)-2-(6-methoxynaphthalen-2-yl)-4-methylhexan-3-one (anti-34).   General procedure E 
was employed using Pd(dba)2 (5 mol %), Jackiephos (7 mol %), CuCl (2 equiv), S-phenyl (S)-2-
(6-methoxynaphthalen-2-yl)propanethioate (64.5 mg, 0.2 mmol, >99% ee) and (S)-5-(sec-butyl)-
1-aza-5-stannabicyclo[3.3.3]undecane (80.4 mg, 0.26 mmol, 91% ee).  A pale yellow solid (35 
mg, 65%, 22:1 dr) was isolated by column chromatography (97:3 hexanes/ether. [a]20D (c 1.00, 
CHCl3) = +160.9º. 
1H NMR (300 MHz, CDCl3): δ 7.71-7.61 (m, 3H), 7.31-7.28 (dd, J = 3, 9 Hz 
,1H), 7.17-7.11 (m, 2H), 3.98 (q, J = 5.25 Hz, 1H), 3.92 (s, 3H), 2,61 (sextet, J = 6.6 Hz, 1H), 
1.65 (heptet, J = 7 Hz, 1H), 1.47-1.32 (m, 4H), 1.07 (d, J = 6 Hz, 1H), 0.89-0.84 (m, 6H) ppm. 
13C NMR (75 MHz, CDCl3): 215.03, 157.87, 135.91, 133.83, 129.38, 129.29, 127.59, 126.92, 
126.82, 119.30, 106.81, 55.54, 52.65, 46.29, 27.13, 18.11, 16.30, 11.89 ppm. HRMS (ES+): 
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Column IA-3mm 150x4.6 
Mobile Phase 100 : 0.1 Hexane : IPA 
























Column Chiralcel OJ-H 250x4.6 
Mobile Phase 95 : 5  Methanol : Water 























Column Chiralcel OJ-H 250x4.6 
Mobile Phase 95 : 5  Methanol : Water 



















    
CONDITIONS 
Column IA 250x4.6 
m-Phase 57% : 43% Methanol : Water 
Flow 1.3 mL/min 
























Column IA 250x4.6 
Mobile Phase 75% : 25% Methanol : Sodium phosphate buffer (25mM, pH 7.8) 
Flow 1 mL/min 
Detector 210 nm 
Temp 25°C 
                    
O
CH3












Column IA 250x4.6 
Mobile Phase 80% : 20%  [19:1 v/v Methanol/Acetonitrile] : Sodium phosphate 
buffer (25mM, pH 7.8) 
Flow 1 mL/min 













Column OJ-RH 150x4.6 
Mobile Phase 70% : 30% [19:1 v/v Methanol/Acetonitrile] : Water  
Flow 1.0 mL/min 



















Column OJ-RH 150x4.6 
Mobile Phase 70% : 30%  [19:1 v/v Methanol/Acetonitrile] : Sodium phosphate 
buffer (25mM, pH 7.8) 
Flow 0.8 mL/min 
















Column OJ-RH 150x4.6 
Mobile Phase 80% : 20%  [19:1 v/v Methanol/Acetonitrile] : Sodium phosphate 
buffer (25mM, pH 7.8) 
Flow 1 mL/min 














Column OJ-RH 150x4.6 
Mobile Phase 80% : 20%  [19:1 v/v Methanol/Acetonitrile] : Sodium phosphate 
buffer (25mM, pH 7.8) 
Flow 0.4 mL/min 














Column  IA 250x4.6 
Mobile Phase 70% : 30% Methanol : Sodium phosphate buffer (25mM, pH 7.8)  
Flow 1.0 mL/min 

















Column IA 250x4.6 
Mobile Phase 65% : 35% [19:1 v/v Methanol/Acetonitrile] : Water  
Flow 1.0 mL/min 


















Column IA 250x4.6 
Mobile Phase 50% : 50%   [19:1 v/v Methanol/Acetonitrile] : Water 
Flow 0.6 mL/min 


















Column OJ-RH 150x4.6 
Mobile Phase 55% : 45%  Methanol : Water 
Flow 1.2 mL/min 

















Column IA 250x4.6 
Mobile Phase  60% : 40% Methanol : Water 
Flow 1.2 mL/min 



































Column IA 250x4.6 
m-Phase  45% : 55%  Acetonitrile : Sodium phosphate buffer (25mM, pH 
7.8) 
Flow 1.2 mL/min 
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Table 1. Numerical comparison describing the similarity in the range of 1300-1800 cm-1 between 
the calculated IR and VCD spectra for the (R) enantiomer at the B3LYP/6-31G(d) level and the 










 scaling factor 0.96 
 IR similarity (%) 65.9 
(R) a∑ (%) 51.1406 
 b∆ (%) 43.915 
 Confidence Level (%) 90 
 
a∑: single VCD similarity, gives the similarity between the calculated and observed VCD spectra.  
b∆: enatiomeric similarity index, gives the difference between the values of ∑ for both enantiomers 
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GENERAL INFORMATION  
Customer 
Sales Order Number 
CUNY 
2015.147B 
Sample code (Our ref.) PhenAcyl 
Sample description (Your ref.) PhenAcul 
VCD-spectrometer ChiralIR w/ DualPEM 
Report prepared by Bo Wang 
Report validated and signed by Rina K Dukor 
Date Nov. 12, 2015 
RESULTS  
Absolute Configuration of PhenAcyl is (R). Confidence Level: 90 % 
MEASUREMENT PARAMETERS  
Concentration 5.7 mg/0.15mL 
Solvent CDCl3 
Resolution 4 cm-1 
PEM setting 1400 cm–1 
Number of scans/Measurement time 6 hours 
Sample cell BaF2 
Path length 100 µm 
CALCULATION DETAILS  
Gaussian version Gaussian 09 
Total low-energy conformer used for Boltzmann sum 13 
Methodology and basis set for DFT calculations B3LYP/6-31G(d) 
Enantiomer used for calculation  (R) 
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PhenAcyl  in CDCl
3
 
IR (lower frame) and VCD (upper frame) spectra of PhenAcyl in CDCl3 (6.4mg/0.15mL); 0.1mm 
path-length cell with BaF2 windows; 11 h collection for samples and solvent; instrument optimized at 
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IR (lower frame) and VCD (upper frame) spectra observed for PhenAcyl (right axes) compared with 
calculated Boltzmann-averaged spectra of the  calculated conformations for the (R)- configuration, 
(left axes). 
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1. General Reagent/Analytical Information 
 
BDH brand ethyl ether was purchased from VWR. EMD brand Omnisolv THF (unstabilized) 
was also purchased from VWR. These solvents were transferred to separate 20 L solvent-
delivery kegs and vigorously purged with argon for 2 h. The solvents were further purified by 
passing them under argon pressure through two packed columns of neutral alumina. 5-chloro-1-
aza-5-stannabicyclo[3.3.3]undecane and Selectfluor I were purchased from Sigma-Aldrich. 
Acetonitrile (Sigma-Aldrich) was purged with argon prior to use. Grignard reagents were 
prepared from their corresponding alkyl chlorides or bromides using a literature procedure[1]. 
Molarities of Grignard reagents and zinc reagents were determined using iodine titration[2]. 
Optically active alkylcarbastannatranes were prepared via preparatory chiral HPLC of the 
racemate or using a previously reported literature procedure.[3] Reagents and solvents were used 
as received unless otherwise noted. Flash chromatography was performed using Silicycle silica 
gel (ultra-pure grade). 
 
All NMR spectra were obtained on a Varian 500 (500 MHz for 1H and 125 MHz for 13C), a 
Varian 300 (282 MHz for 19F) or a Bruker 300 (300 MHz for 1H, 75 MHz for 13C and 282 MHz 
for 19F). All previously unreported compounds were additionally characterized by high resolution 
MS. All 1H NMR experiments are reported in δ units, parts per million (ppm), and were 
measured relative to the signals for residual chloroform (7.26 ppm) unless otherwise noted. The 
following abbreviations are used to express the multiplicities: s = singlet; d = doublet; t = triplet; 
m = multiplet; br = broad, app = apparent. All 13C NMR spectra are reported in ppm relative to 
deuterochloroform (77.23 ppm), and were obtained with 1H decoupling. High resolution MS 
analyses were performed on an Agilent 6520 Q-TOF instrument. All GC analyses were 
performed on a Shimadzu GC-2010 gas chromatograph with an FID detector using a 25 m x 0.20 
mm capillary column with cross-linked methyl siloxane as the stationary phase, or using a 30 m 
x 0.32 mm chiral column (Rt®-βDEXsm from RESTEK). All low boiling point fluoride 
compounds were confirmed by GCMS on Shimadzu GC-MS QP2010S or high resolution MS. 
All GC yields were calibrated using dodecane or tetradecane as an internal standard. Chiral 
HPLC analyses were performed using a Shimadzu Prominence HPLC system with binary mobile 
phase pumps and UV-vis detector (LC-20AB, SPD-20A) using an OJ-RH (dimensions: 4.6 mm 
x 150 mm; particle size: 5 µm) chiral column (DAICEL CHEMICAL IND., LTD.), or an IA 




2. General Procedure Information 
 
Preparation of alkylcarbastannatranes:  
 
General procedure A (preparation of achiral and racemic alkylcarbastannatranes): 
Grignard reagents were prepared from the corresponding alkyl chlorides. All reactions were 
performed in oven-dried glassware under an atmosphere of Ar.  The alkylmagnesium reagent (or 
alkylzinc reagent for ethyl butanoate nucleophile) (2.0-3.0 equiv) was added to a suspension of 
5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane1 (1 equiv) in THF at -78 °C. The resulting 
mixture was stirred at -78 °C for 3 h, allowed to warm to room temperature, and stirred 
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overnight.  The reaction mixture was poured into a separatory funnel containing a mixture of 
water and ether. The organic layer was separated, washed with brine, dried over Na2SO4, and 
filtered. Solvent was removed under reduced pressure, and the remaining compound was dried in 
vacuo to provide the crude product.  The crude alkyltin reagents were used without purification, 
or following purification via Kugelrohr distillation or C18 chromatography. Homocoupling from 
Grignard formation constituted the major residual byproduct in the crude product. 
 
General procedure B (preparation of enantioenriched alkylcarbastannatranes): 
To an oven-dried round bottom flask containing a stirbar, 5-chloro-1-aza-5-stanna-
bicyclo[3.3.3]undecane (588 mg, 2 mmol) and naphthalene (128 mg, 1 mmol) were added.  The 
flask was evacuated (<100 mtorr) and backfilled with argon three times.  With the flask under a 
flow of argon, the septum was removed and lithium granules (free of oil) (250 mg, 35 mmol) 
were added. This was followed by two additional evacuation/backfill cycles. Anhydrous THF 
(40 mL) was added to the flask via syringe, and the mixture was stirred at room temperature. The 
solution turned dark green/black within 30 min.  Upon color change, the solution was stirred at 
room temperature for an additional hour.  In a separate 100 mL flask under argon, with stirbar 
and rubber septum, the optically active alkyl mesylate (1.2–1.5 equiv) was dissolved in 
anhydrous THF (20 mL).  The mesylate solution was heated to 60 °C.  The stannatrane lithium 
mixture was removed from the excess lithium via cannula or needle/syringe, and transferred 
dropwise to the mesylate solution over 5 mins. The reaction stirred at 60 °C for an additional 
hour. The reaction mixture was extracted with ethyl ether (60 mL), followed by brine (100 mL), 
and dried over Na2SO4. The reaction solution was filtered and concentrated to provide the crude 
product. The crude product was purified (40–50% isolated yield) by C18 silica (80/20 
acetonitrile/water to 100% acetonitrile), fractions analyzed using HPLC (220/254 nm) or reverse-
phase TLC.  
 
Halogenation of racemic alkylcarbastannatranes: 
 
General procedure C: 
To an oven-dried screw-top test tube equipped with a stirbar, alkylcarbastannatrane (0.25 mmol) 
and halogenation reagent (1.5 equiv of Selectfluor I, trichloroisocyanuric acid, N-
bromosuccinimide, or iodine) were added. The test tube was sealed with a screw-top septum and 
electrical tape. The reaction tube was evacuated (ca. 100 mtorr) and backfilled with argon 3 
times using a needle attached to a vacuum manifold. Acetonitrile (1 mL) was added via syringe, 
and the reaction mixture was allowed to stir (5 min–1 h) at rt. Once the reaction was complete, 
water (0.5 mL) was added to the reaction mixture. For fluorination reactions, the resulting 
solution was additionally diluted by ethyl acetate (0.2 mL). Fluorobenzene (0.2 mmol) was 
added as an internal 19F NMR standard, and the solution was analyzed by unlocked 19F NMR 
spectroscopy and GCMS. For volatile alkyl fluorides, calibrated yields were obtained by 19F 
NMR and GC to ensure accuracy of measurement. For other halogenation reactions, the reaction 
mixture was diluted with ether and washed with brine. The organic layer was dried over Na2SO4, 
filtered, and concentrated to provide the crude product. The crude reaction products were 
purified by flash column chromatography (diethyl ether/pentane). 
 
Fluorination of enantioenriched alkylcarbastannatranes: 
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General procedure D: 
To an oven-dried screw-top test tube equipped with a stirbar, the enantioenriched 
alkylcarbastannatrane (0.1 mmol) was added. The test tube was sealed with a screw-top septum 
and electrical tape. The reaction tube was evacuated (ca. 100 mtorr) and backfilled with argon 3 
times, anhydrous pyridine (0.5 equiv.) was added, and the reaction mixture was then cooled to -5 
ºC in a NaCl/ice bath.  A solution of Selectfluor I (1.5 equiv) in acetonitrile (1.1 mL) and styrene 
(1 equiv) was added via syringe. After the reaction stirred for 2 h at -5 ºC, water (0.2 mL) was 
added. Fluorobenzene (0.05 mmol) was added as an internal standard, and the solution was 
analyzed by unlocked 19F NMR spectroscopy. The ee value was determined by HPLC or chiral 
GC analysis. 
 
Halogenation (Cl, Br and I) of enantioenriched alkylcarbastannatranes: 
 
General procedure E: 
To an oven-dried screw-top test tube equipped with a stirbar, the enantioenriched 
alkylcarbastannatrane (0.1 mmol) was added. The test tube was sealed with a screw-top septum 
and electrical tape. The reaction tube was evacuated (ca. 100 mtorr) and backfilled with argon 3 
times, then cooled to -5 ºC in a NaCl/ice bath. A solution containing the halogenation reagent 
[trichloroisocyanuric acid (0.15 mmol) in CH3CN (1 mL), N-bromosuccinimide (0.15 mmol) in 
CH3CN (1 mL), or N-iodosuccinimide (0.15 mmol) in 1 mL THF] was added dropwise via 
syringe. After the reaction stirred for 3 h at -5 ºC, water (0.2 mL) was added. The organic layer 
was used for GC and HPLC analysis. The GC yield was determined using tetradecane as an 
internal calibration standard. The ee value was determined by HPLC or chiral GC analysis.  
 
 








1-(4-Phenylbutan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (5).[1] General procedure A 
was employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (1.35 mmol) and (4-
phenylbutan-2-yl)magnesium chloride (4 mmol). A yellow liquid (0.413 g, 78%) was isolated. 
1H NMR (500 MHz, CDCl3): δ 7.25-7.28 (m, 2H), 7.16-7.19 (m, 3H), 2.50-2.65 (m, 2H), 2.36 (t, 
J = 6.0 Hz, 6H), 1.68-1.81 (m, 2H), 1.65 (quint, J = 6.0 Hz, 6H), 1.13 (d, J = 7.5 Hz, 3H), 0.79 
(quart, J = 7.5 Hz, 1H), 0.67 (t, J = 6.5 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3): δ 143.9, 














1-(Dodecan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3]undecane. General procedure A was employed 
using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (1.5 mmol) and dodecan-2-ylmagnesium 
chloride (4.4 mmol). A yellow liquid (0.482 g, 75%) was isolated. 1H NMR (500 MHz, CDCl3): 
d 2.34 (t, J = 5.75 Hz, 6H), 1.63 (app. quint, J = 6.6 Hz, 6H), 1.45-1.13 (m, 18H), 1.04 (d, J = 
1.51, 3H), 0.88 (t, J = 6.6 Hz, 3H), 0.72 (m, 1H), 0.62 (t, J = 6.7 Hz, 6H) ppm; 13C NMR (125 
MHz, CDCl3): δ 54.9, 36.6, 32.2, 30.2, 30.1, 29.98, 29.90, 29.6, 24.2, 23.65, 23.55, 22.94, 18.9, 







Ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)butanoate.[1] General procedure A was 
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (3 mmol) and (4-ethoxy-4-
oxobutan-2-yl)zinc iodide (6.1 mmol). An yellow oil (509 mg, 45%) was isolated.  1H NMR 
(500 MHz, CDCl3): δ 4.09 (quart, J = 7.0 Hz, 2H), 2.40 (m, 1H), 2.35 (t, J = 6.0 Hz, 6H), 2.25 
(m, 1H), 1.64 (app. quint, J = 6 Hz, 6H), 1.24 (t, J = 7.0 Hz, 3H), 1.02-1.13 (m, 4H), 0.65 (t, J = 
6.5 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3): δ 175.5, 60.0, 54.9, 40.7, 23.5, 19.8, 18.4, 14.6, 
5.2 ppm. 
 
The ester derivative could also be prepared using a zincated stannatrane nucleophile via the 
following process: Under argon, stannatrane lithium (1 equiv) (prepared via general procedure 
B) was added to a 2 M solution of Et2Zn in ether (1 equiv) at 0 ºC. This mixture was allow to stir 
at 0 ºC for 30 min. It was then added to a solution of ethyl 3-((methylsulfonyl)oxy)butanoate in 
hexanes, and allowed to stir overnight at rt. The reaction mixture was washed with water, and 
extracted with ether three times.  The combined organic layers were dried over Na2SO4, filtered, 
concentrated under reduced pressure, and purified by reverse phase flash chromatography (100% 






5-(Tetrahydro-2H-pyran-4-yl)-1-aza-5-stannabicyclo[3.3.3]undecane.[1] General procedure A 
was employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.42 mmol) and 
(tetrahydro-2H-pyran-4-yl)magnesium chloride (1.26 mmol). A pale yellow solid (121 mg, 84%) 
was isolated. 1H NMR (500 MHz, CDCl3): δ 3.87 (m, 2H), 3.33 (dt, J = 11.0, 2.0 Hz, 2H), 2.36 
(t, J = 6 Hz, 6H), 1.64 (app. quint, J = 6.0 Hz, 6H), 1.50-1.65 (m, 4H), 0.90 (tt, J = 12.5, 4.0 Hz, 















5-(1-Phenylethyl)-1-aza-5-stannabicyclo[3.3.3]undecane.[1] General procedure A was 
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.3 mmol) and (1-
phenylethyl)magnesium chloride (1.5 mmol). A yellow oil (90 mg, 82%) was isolated. 1H NMR 
(500 MHz, CDCl3): δ 7.15 (t, J = 7.5 Hz, 2H), 6.90-7.00 (m, 3H), 2.30 (t, J = 6.0 Hz, 6H), 2.21 
(quart, J = 7.5 Hz, 1H), 1.61 (app. quint, J = 6.0 Hz, 6H), 1.44 (d, J = 7.5 Hz, 3H), 0.61 (dt, J = 
6.5, 3 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3): δ 151.5, 128.0, 124.9, 121.7, 54.7, 32.7, 23.5, 







1-(3-Phenylpropyl)-5-aza-1-stanna-bicyclo[3.3.3]undecane.[3] General procedure A was 
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.88 mmol)  and (3-
phenylpropyl)magnesium chloride (2.5 mmol). A yellow liquid (274 mg, 82%) was isolated. 1H 
NMR (500 MHz, CDCl3) δ: 7.27-7.14 (m, 5H), 2.53 (t, J = 7.5 Hz, 2H), 2.36 (t, J = 6.2 Hz, 6H), 
1.69 (app. quint, J = 6 Hz, 2H), 1.62 (app. quint, J = 6 Hz, 6H), 0.64 (t, J = 6 Hz, 6H), 0.48 (t, J 
= 6.0 Hz, 2H) ppm. 13C NMR (125 MHz, CDCl3) δ: 143.6, 128.7, 128.3, 125.5, 54.9, 41.5, 29.9, 









1-Decyl-5-aza-1-stanna-bicyclo[3.3.3]undecane (4). General procedure A was employed using 
5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (2 mmol) decylmagnesium chloride (5 mmol). A 
pale yellow solid (538 mg, 67%) was isolated. 1H NMR (500 MHz, CDCl3): δ 2.36 (t, J = 5.5 
Hz, 6H), 1.63 (app. quint, J = 6.2 Hz, 6H), 1.26 (m, 16H), 0.88 (t, J = 6.8 Hz, 3H), 0.62 (t, J = 
6.6 Hz, 6H); 0.40 (t, J = 8 Hz, 2H) ppm; 13C NMR (125 MHz, CDCl3): δ 55.0, 34.9, 32.2, 29.96, 










1-(4-tert-Butylbenzyl)-5-aza-1-stanna-bicyclo[3.3.3]undecane. General procedure A was 
employed using 5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane (0.5 mmol) and (4-tert-








1H NMR (500 MHz, CDCl3): δ 7.11 (d, J = 8.3 Hz, 2H), 6.81 (d, J = 8.1 Hz, 2H), 2.33 (t, J = 5.7 
Hz, 6H), 1.90 (s, 2H), 1.62 (app. quint, J = 6.6 Hz, 6H), 1.27 (s, 9H), 0.64 (t, J = 6.7 Hz, 6H) 
ppm. 13C NMR (125 MHz, CDCl3): δ 144.0, 143.3, 128.2, 126.0, 125.4, 124.9, 54.8, 34.3, 31.8, 








5-(Pent-4-en-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane.  General procedure B was employed 
using (1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)lithium (9 mmol, 1.5 equiv.) and pent-4-en-2-yl 
methanesulfonate (6 mmol, 1 equiv.). The reaction stirred at 25 °C for 3 hours. The reaction 
mixture was extracted with ethyl ether (60 mL), followed by brine (100 mL), and dried over 
Na2SO4. The reaction solution was filtered and concentrated to provide the crude product. The 
crude product was purified by C18 silica (100% acetonitrile). A colorless liquid (305 mg, 15%) 
was isolated. 1H NMR (300 MHz, CDCl3): 5.83-5.69 (m, 1H), 4.96-4.86 (m, 2H), 2.35 (t, J = 5.8 
Hz, 6H), 2.27-2.05 (m, 2H), 1.68- 1.60 (m, 6H), 1.04 (d, J = 7.5 Hz, 3H), 0.82-0.69 (m, 1H), 
0.64 (t, J = 6.5 Hz, 6H) ppm; 13C NMR (75 MHz, CDCl3): 140.8, 113.7, 77.43, 54.9, 40.7, 23.6, 









nabicyclo[3.3.3]undecane.  To an oven-dried test tube with screw-top septum, 5-(pent-4-en-2-
yl)-1-aza-5-stannabicyclo[3.3.3]undecane (0.4 mmol, 1 equiv.), K2CO3 (1.6 mmol, 4 equiv.) and 
(Bpin)2 (1.2 mmol, 3 equiv.) was added. The reaction tube was evacuated and backfilled with 
argon three times. With the tube under a positive pressure of argon, t-BuOH (anhydrous, 1 mL) 
and H2O (degassed, 25 µL) were added. The reaction mixture was stirred at 60 oC for 12 h, 
washed with water and extracted with ether 3 times. The combined organic layers were dried 
over Na2SO4, filtered, concentrated under reduced pressure, and purified by reverse phase flash 
column chromatography (100% CH3CN). A colorless liquid (165 mg, 71%) was isolated. The dr 
for the product is 1:1.2. 1H NMR (300 MHz, CDCl3): 2.33 (t, J = 5.4 Hz, 6 H), 1.66-1.61 (m, 
7H), 1.51-1.34 (m, 1H), 1.22 (d, J = 1.3 Hz, 24H), 1.06 -0.98 (m, 3H), 0.83-0.72 (m, 4H), 0.65-
0.61 (m, 6H) ppm; 13C NMR (75 MHz, toluene- d8): δ 82.6, 82.5, 54.93 (minor), 54.92 (major), 
40.8, 40.3, 25.13, 25.11, 25.09, 25.05, 25.03, 24.98, 24.96, 24.94, 24.08, 23.94 (minor), 23.92 
(major), 23.7, 22.5, 19.0, 18.7, 5.45 (minor), 5.39 (major) ppm. HRMS (ESI): Calcd (M-Na)+ 












3-(5-Aza-1-stanna-bicyclo[3.3.3]undecan-1-yl)butan-1-ol.  To an oven-dried vial with a 
stirbar, ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl)butanoate (0.5 mmol) and LiAlH4 (4 
mmol) were added. The vial was sealed with a screw-top septum and electrical tape. The reaction 
vessel was evacuated (ca. 100 mtorr) and backfilled with argon 3 times. Then, dry ether (2 mL) 
was added via syringe. The reaction was stirred overnight at room temperature. The reaction was 
quenched with an aqueous solution of NaH2PO4 solution and extracted with hexane 3 times. The 
combined organic layers were dried over Na2SO4, filtered, concentrated under reduced pressure. 
A colorless liquid (141 mg, 85%) was isolated. 1H NMR (500 MHz, CDCl3): δ 3.61 (q, J = 5.6 
Hz, 2H), 2.36 (t, J = 5.5 Hz, 6H), 1.75 (m, 1H), 1.65 (quint, J = 5.9 Hz, 6H), 1.16 (m, 1H), 1.07 
(d, J = 7.5 Hz, 3H), 0.76 (m, 1H), 0.65 (t, J = 6.6 Hz, 6H) ppm. 13C NMR(125 MHz, CDCl3): δ 
63.3, 54.9, 39.2, 23.6, 19.1, 18.2, 5.4 ppm. HRMS (ES+): Calcd (M-H)+ 326.1219; Found 
326.1219. 
 
(S)-3-(5-Aza-1-stanna-bicyclo[3.3.3]undecan-1-yl)butan-1-ol The preceding procedure was 
employed using (S)-3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl) butanoate (0.15 equiv) and 
LiAlH4 (1.2 mmol). A colorless liquid (44 mg, 88%) was isolated. 
 
 







To a round bottom flask, 4-(dimethylamino)pyridine (DMAP, 0.5 mmol, 10 mol %), tert-
butyldimethylsilyl chloride (TBDMSCl, 6 mmol, 1.2 equiv), triethylamine (TEA, 10 mmol, 2 
equiv), (R)-butane-1,3-diol (5 mmol, or butane-1,3-diol for racemic reaction), and 
dichloromethane (DCM, 30 mL) were added. The reaction was stirred overnight at room 
temperature. The reaction was quenched by water and extracted with DCM three times. The 
combined organic layers were dried over Na2SO4, filtered, concentrated under reduced pressure, 



























(1:9). A colorless liquid (868 mg, 85%) was isolated. 1H NMR (300 MHz, CDCl3): δ 4.02 (m, 
1H), 3.85 (m, 2H), 3.36 (br s, 1H), 1.65 (m, 2H), 1.19 (d, J = 6.3 Hz, 3H), 0.90 (s, 9H), 0.08 (s, 




To a round bottom flask, (R)-4-((tert-butyldimethylsilyl)oxy)butan-2-ol (3 mmol, 4-((tert-
butyldimethylsilyl)oxy)butan-2-ol for racemic reaction), TEA (6 mmol, 2 equiv), and anhydrous 
diethyl ether (20 mL) were added. The reaction flask was cooled to 0 ºC and mesyl chloride (4.5 
mmol, 1.5 equiv) was added. The reaction was allowed to warm to room temperature and stirred 
overnight. The reaction was quenched by water and extracted with ether three times. The 
combined organic layers were dried over Na2SO4, filtered, concentrated under reduced pressure, 
and purified by purified by flash column chromatography (ethyl acetate/hexane = 1:9). A 
colorless liquid (771 mg, 91%) was isolated. 1H NMR (300 MHz, CDCl3): δ 4.95 (m, 1H), 3.71 
(m, 2H), 3.0 (s, 3H), 1.84 (m, 2H), 1.47 (d, J = 6.3 Hz, 3H), 0.89 (s, 9H), 0.06 (s, 6H) ppm. 13C 




General procedure B was followed.[3] The mixture was purified by reverse phase flash column 
chromatography (DCM/CH3CN = 1:9). A light yellow oil was isolated (Yield: 40%). The ee 
value (97% ee) was determined after deprotection to 3-(5-aza-1-stanna-bicyclo[3.3.3]undecan-1-
yl)butan-1-ol. 1H NMR (300 MHz, CDCl3): δ 3.56 (m, 2H), 2.35 (t, J = 5.7 Hz, 6H), 1.65 (m, 
8H), 1.06 (d, J = 7.2 Hz, 2H), 0.89 (s, 10H), 0.64 (t, J = 6.7 Hz, 6H), 0.049 (s, 6H) ppm. 13C 
NMR (75 MHz, CDCl3): δ 64.1, 54.9, 39.5, 26.3, 26.3, 26.2, 23.6, 19.6, 18.7, 18.6, 5.4, -4.8, -4.8 




(S)-5-(4-((tert-butyldimethylsilyl)oxy)butan-2-yl)-1-aza-5-stannabicyclo[3.3.3] undecane (0.01 
mmol) and THF (0.2 mL) were combined in a 3 mL vial. The vial was cooled to 0 ºC, and TBAF 
(1.2 equiv, 1M in THF) was added dropwise. The reaction was allowed to stir at 0 ºC for 30 min, 
and then at room temperature for 3 h. The reaction was quenched with water and extracted with 
ether three times. The combined organic layers were dried over Na2SO4, filtered, concentrated 
under reduced pressure. The ee value (97% ee) was determined by HPLC analysis. The NMR 













(S)-3-(1-Aza-5-stannabicyclo[3.3.3]undecan-5-yl)butyl benzoate (S3). 
(S)-5-(4-((tert-butyldimethylsilyl)oxy)butan-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane (0.2 
mmol) (or (5-(4-((tert-butyldimethylsilyl)oxy)butan-2-yl)-1-aza- 5-stannabicyclo[3.3.3]undecane 
for the racemic reaction) and THF (0.5 mL) were combined in a 3 mL vial.  Tetra-n-
butylammonium fluoride (TBAF 0.24 mmol, 1.2 equiv, 1M in THF) was added dropwise to the 
vial at rt. The reaction was stirred for 30 min at 0 ºC, and then for 3 h at room temperature. 
Triethylamine (0.8 mmol, 4 equiv) and benzoyl chloride (0.8 mmol, 4 equiv) were then added to 
the reaction, which was allowed to stir overnight at rt. The reaction was washed by NaHCO3 
(aq.) and extracted with ether three times. The combined organic layers were dried over Na2SO4, 
filtered, concentrated under reduced pressure, and purified by purified by reverse phase flash 
column chromatography (100% CH3CN). A colorless liquid (77 mg, 88%) was isolated. The ee 
value (97% ee) was determined following hydrolysis to 3-(5-aza-1-stanna-
bicyclo[3.3.3]undecan-1-yl)butan-1-ol. 1H NMR (300 MHz, CDCl3): δ 8.05 (m, 2H), 7.54 (m, 
1H), 7.43 (m, 2H), 4.30 (t, J = 6.7Hz, 2H), 2.36 (t, J = 5.9 Hz, 6H), 2.0-1.81 (m, 2H), 1.65 (m, 
6H), 1.13 (d, J = 7.5 Hz, 3H), 0.89-0.80 (m, 1H), 0.68 (t, J = 6.7 Hz, 6H) ppm. 13C NMR (75 
MHz, CDCl3): δ 167.0, 132.8, 131.0, 129.8, 128.5, 65.8, 54.9, 35.0, 23.6, 19.8, 18.4, 5.3 ppm. 
HRMS (ES+): Calcd (M-Na)+ 452.1301; Found 452.1315.  
 
 
(3-Fluorobutyl)benzene (10). General procedure C was performed using 1-(4-phenylbutan-2-
yl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and Selectfluor I (0.375 mmol). The 
fluorinated product was formed in 64% yield as determined by 19F NMR spectroscopic analysis 
of the crude reaction mixture. 19F NMR (ethyl acetate/ acetonitrile, 282 MHz): δ -173.0 (m). 19F 
NMR spectra are referenced based on the internal standard fluorobenzene, which is set at –113.6 
ppm. The identity of the product was further confirmed by GCMS analysis. EIMS: m/z (%) = 
152.10 (31.02), 132.05 (1.26), 117.05 (13.84), 105.05 (9.18), 91.05 (100). 92.05 (60.77), 
77.05 (7.86), 65.05 (13.11), 51.05 (5.37), 39.05 (5.6). 
 
(R)-(3-Fluorobutyl)benzene (29). General procedure D was performed using enantioenriched 1-
(4-phenylbutan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.1 mmol) and Selectfluor I (0.15 
mmol). Water was added to quench the reaction. The organic layer was run on HPLC to 
determine ee value. The fluorinated product was formed in 56% yield as determined by 19F NMR 
spectroscopic analysis of the crude reaction mixture.  
 
 
(1-Fluoroethyl)benzene (11). General procedure C was performed using 5-(1-Phenylethyl)-1-











fluorinated product was formed in 55% yield as determined by 19F NMR spectroscopic analysis 
of the crude reaction mixture. 19F NMR (ethyl acetate/ acetonitrile, 282 MHz): δ -166.9 (m). 19F 
NMR spectra are referenced based on the internal standard fluorobenzene, which is set at –113.6 
ppm. The identity of the product was further confirmed by GCMS analysis. m/z (%) = 124.1 
(36.53), 109.05 (100), 103.05 (8.69), 83.5 (8.94), 77.05 (8.44), 63.05 (2.77), 51.05 (9.8), 39.05 
(3.55). 
 
2-Fluorododecane (12). General procedure C was performed using 1-(dodecan-2- yl)-5-aza-1-
stanna-bicyclo[3.3.3]undecane (0.25 mmol) and Selectfluor I (0.375 mmol). The fluorinated 
product was formed in 60% yield as determined by 19F NMR spectroscopic analysis of the crude 
reaction mixture. 19F NMR (ethyl acetate/ acetonitrile, 282 MHz): δ -171.6 (m). 19F NMR spectra 
are referenced based on the internal standard fluorobenzene, which is set at –113.6 ppm. The 
identity of the product was further confirmed by GCMS analysis. m/z (%) = 180.1 (0.02), 
168.15 (2.36), 140.1 (5.13), 125.1 (8.24), 111.1 (20.55), 98.1 (17.43), 97.1 (49.9), 84.1 (38), 83.1 
(63.93), 82.1 (18.45) 71.1 (24.14), 70.1 (66.43), 69.1 (79.52), 57.1 (73.51), 56.1 (64.51), 55.1 
(88.1), 43.1 (100), 42.1 (24.14), 41.1 (72.35).  
 
 
Ethyl 3-fluorobutanoate (13). General procedure C was performed using ethyl 3-(1-aza-5-
stannabicyclo[3.3.3]undecan-5-yl) butanoate (0.25 mmol) Selectfluor I (0.375 mmol). The 
fluorinated product was formed in 64% yield as determined by 19F NMR spectroscopic analysis 
of the crude reaction mixture. 19F NMR (ethyl acetate/ acetonitrile, 282 MHz): δ -172.0 (m). 19F 
NMR spectra are referenced based on the internal standard fluorobenzene, which is set at –113.6 
ppm. The identity of the product was further confirmed by GCMS analysis. m/z (%) = 134.05 
(0.19), 114.05 (5.07), 107.05 (19.46), 99.05 (7.99), 89.05 (100), 87.05 (11.65), 86.05 (9.53), 
73.05 (7.52), 69.05 (12.68), 61.05 (42.88), 60 (15.83), 55.1 (5.68), 47.05 (17.48), 45.1 (26.38), 
43.5 (20.87), 42.1 (42.33), 41.1 (22.66), 39.05 (6.4), 35.1 (0.01).  
 
(R)-Ethyl-3-fluorobutanoate (31). General procedure D was performed using enantioenriched 
ethyl 3-(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl) butanoate (0.1 mmol) and Selectfluor I (0.15 
mmol). Water was added to quench the reaction. The organic layer was run on chiral GC to 
determine ee value. The fluorinated product was formed in 49% yield as determined by 19F NMR 




3-Fluorobutan-1-ol (14). General procedure C was performed using 3-(5-aza-1-stanna-
bicyclo[3.3.3]undecan-1-yl)butan-1-ol (0.25 mmol) Selectfluor I (0.375 mmol). After the 
reaction was complete, triethylamine (2 mmol, 8 equiv) and benzoyl chloride (1 mmol, 4 equiv) 












benzoate was formed in 50% yield as determined by 19F NMR spectroscopic analysis of the 
crude reaction mixture. The reaction was washed by water and extracted with ether 3 times. The 
combined organic layers were dried over Na2SO4, filtered, concentrated under reduced pressure, 
and purified by purified by flash column chromatography. 3-Fluorobutyl benzoate (20) is 
isolated as a colorless liquid. See characterization data for 20 below. 
(R)-3-Fluorobutan-1-ol (30). General procedure D was performed using enantioenriched 3-(5-
aza-1-stanna-bicyclo[3.3.3]undecan-1-yl) butan-1-ol (0.1 mmol) and Selectfluor I (0.15 mmol). 
After the reaction was complete, triethylamine (0.8 mmol, 8 equiv) and benzoyl chloride (0.4 
mmol, 4 equiv) were added to the reaction. It was stirred overnight. The reaction was washed by 
water and extracted with ether 3 times. The combined organic layers were dried over Na2SO4, 
filtered, concentrated under reduced pressure and purified by purified by flash column 
chromatography. 3-Fluorobutylbenzoate was isolated as the colorless liquid and run on HPLC to 
determine ee value. The fluorinated product was formed in 59% yield as determined by 19F NMR 





2,2'-(4-fluoropentane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (15). General 
procedure C was employed using 5-(4,5- bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-
2-yl)-1-aza-5-stanna-bicyclo[3.3.3]undecane (0.1 mmol) and Selectfluor I (0.15 mmol) in 
acetonitrile (0.5 mL). The reaction was washed by water and extracted with ether 3 times. The 
combined organic layers were dried over Na2SO4, filtered, concentrated under reduced pressure 
and purified by purified by flash column chromatography (ether/hexane = 15:85). A colorless 
liquid (20 mg, 58%) was isolated. 1H NMR (300 MHz, CDCl3): δ 4.86-4.75 (m, 0.45H) and 
4.69-4.59 (m, 0.55H) indicates a diastereomeric ratio of 1:1.2, 1.95-1.40 (m, 2H), 1.31 (m, 3H), 
1.22 (s, 24H), 1.01-0.75 (m, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 91.7 (d, J = 21.4 Hz, 
major), 89.6 (d, J = 21.8 Hz, minor), 83.2, 77.4, 41.24, 41.13, 40.97, 40.86, 25.11, 25.10, 25.05, 
25.03, 25.02, 25, 24.97, 24.93, 21.65 (minor), 21.35 (major) ppm. . 19F NMR (282 MHz, CDCl3): 





(3-Fluoropropyl)benzene (16). General procedure C was performed using 1- (3- phenylpropyl)-
5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and Selectfluor I (0.375 mmol). The 
fluorinated product was formed in 52% yield as determined by 19F NMR spectroscopic analysis 
of the crude reaction mixture. 19F NMR (ethyl acetate/ acetonitrile, 282 MHz): δ -219.5 (m). 19F 
NMR spectra are referenced based on the internal standard fluorobenzene, which is set at -113.6 
ppm. The identity of the product was further confirmed by GCMS analysis. m/z (%) = 138.1 









1-Fluorodecane (17). General procedure C was performed using 1-decyl-5-aza-1-stanna-
bicyclo[3.3.3]undecane (0.25 mmol) and Selectfluor I (0.375 mmol). The fluorinated product 
was formed in 66% yield as determined by 19F NMR spectroscopic analysis of the crude reaction 
mixture. 19F NMR (ethyl acetate/ acetonitrile, 282 MHz): δ -217.8 (m). 19F NMR spectra are 
referenced based on the internal standard fluorobenzene, which is set at -113.6 ppm. The identity 
of the product was further confirmed by GCMS analysis. m/z (%) = 160.10 (0.18), 111.10 
(10.15), 97.10 (18.91), 85.10 (15.39), 75 (5.51), 69.05 (35.52), 57.10 (68.19), 55.05 (51.08), 
61.05 (10.30), 43.1 (100), 41.1 (56.9), 39.05 (9.93).  
 
 
1-(tert-Butyl)-4-(fluoromethyl)benzene (18). General procedure C was performed using 1-
(4-tert-butylbenzyl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and Selectfluor I (0.375 
mmol). The fluorinated product was formed in 56% yield as determined by 19F NMR 
spectroscopic analysis of the crude reaction mixture. 19F NMR (ethyl acetate/ acetonitrile, 282 
MHz): δ -204.2 (m). 19F NMR spectra are referenced based on the internal standard 
fluorobenzene, which is set at -113.6 ppm. The identity of the product was further confirmed by 
GCMS analysis. m/z (%) = 166.1 (21.51), 152.1 (11.14), 151.1 (100), 
135.05 (4.28), 123.05 (38.56), 116.05 (2.52), 103.05 (4.8), 91.05 (21.99), 77(4.39), 63 (2.19), 
57 (2.55), 51.05 (2.90), 41.05 (14.34), 39 (5.66).  
 
 
4-Fluorotetrahydro-2H-pyran (19). General procedure C was performed using 5-(tetrahydro-
2H-pyran-4-yl)-1-aza-5-stannabicyclo[3.3.3]undecane (0.25 mmol) and Selectfluor I (0.375 
mmol). The fluorinated product was formed in 53% yield as determined by 19F NMR 
spectroscopic analysis of the crude reaction mixture. 19F NMR (ethyl acetate/ acetonitrile, 282 
MHz): δ -176.5 (m). 19F NMR spectra are referenced based on the internal standard 
fluorobenzene, which is set at -113.6 ppm. The identity of the product was further confirmed by 
HRMS analysis. HRMS (ES+): Calcd (M)+ 104.0637; Found 104.0640.  
 
 
3-Fluorobutyl benzoate (20).[6]  General procedure C was performed using 3-(1-aza-5-
stannabicyclo[3.3.3]undecan-5-yl) butyl benzoate (0.25 mmol) and Selectfluor I (0.375 mmol). 
A colorless liquid (34 mg, 70%) was isolated. 1H NMR (500 MHz, CDCl3): δ 8.04 (d, J = 9.5 
Hz, 2H), 7.58-7.55 (m, 1H), 7.46-7.43 (m, 2H), 4.90 (dm, J = 47.9 Hz, 1H), δ 4.51 – 4.41 (m, 
2H), 2.15 – 1.97 (m, 2H), 1.42 (dd, J = 23.9, 6.2 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3): δ 
166.6, 133.2, 130.4, 129.7, 128.6, 88.0 (d, J = 146.9 Hz), 61.2, 36.3 (d, J = 12.3 Hz), 21.3 (d, J = 










(R)-3-Fluorobutyl benzoate (32). General procedure D was performed using enantioenriched 3-
(1-aza-5-stannabicyclo[3.3.3]undecan-5-yl) butyl benzoate (0.1 mmol) Selectfluor I (0.15 
mmol). After the reaction was done, water was added to quench the reaction. The combined 
organic layers were dried over Na2SO4, filtered, concentrated under reduced pressure, and 
purified by purified by flash column chromatography.  3-fluorobutyl benzoate is isolated as the 




tert-Butyl(3-fluorobutoxy)dimethylsilane (21). General procedure C was performed using 5-(4-
((tert-butyldimethylsilyl)oxy)butan-2-yl)-1-aza-5-stannabicyclo [3.3.3]undecane (0.25 mmol) 
and Selectfluor I (0.375 mmol). The fluorinated product was formed in 62% yield as determined 
by 19F NMR spectroscopic analysis of the crude reaction mixture. The reaction was washed by 
water and extracted with ether 3 times. The combined organic layers were dried over Na2SO4, 
filtered, concentrated under reduced pressure, and purified by flash column chromatography. 
tert-Butyl(3-fluorobutoxy)dimethylsilane is isolated as the colorless liquid. 1H NMR (300 MHz, 
CDCl3): δ 4.97-4.70 (m, 1H), 3.72 (m, 2H), 1.93-1.62 (m, 2H), 1.34 (dd, J = 24.1, 6.2 Hz, 3H), 
0.93(s, 9H), 0.059 (s, 6H) ppm. 13C NMR (75 MHz, CDCl3): δ 88.2 (d, J = 162.3 Hz) 58.2 (d, J 
= 5.5 Hz), 40.3 (d, J = 20.4 Hz), 26.1, 21.4 (d, J = 22.3 Hz), 18.5, -5.19, -5.20 ppm. 19F NMR 
(282 MHz, CDCl3): δ -175.66 ppm (1F). HRMS (ES+): Calcd (M-Na)+ 229.1400; Found 
229.1405.  
(R)-tert-Butyl(3-fluorobutoxy)dimethylsilane (33). General procedure D was performed using enantioenriched 5-
(4-((tert-butyldimethylsilyl) oxy) butan-2-yl)-1- aza-5-stannabicyclo[3.3.3]undecane (0.1 mmol) and Selectfluor I 
(0.15 mmol). After the reaction was done, TBAF (0.12 mmol, 1.2 equiv) was added to the reaction vial at 0 ºC. It 
was stirred for 30 min at 0 ºC, then 3h at room temperature. Triethylamine (0.8 mmol, 8 equiv) and benzoyl chloride 
(0.4 mmol, 4 equiv) were added to the reaction. It was stirred overnight. The reaction was washed by water and 
extracted with ether 3 times. The combined organic layers were dried over Na2SO4, filtered, concentrated under 
reduced pressure and purified by purified by flash column chromatography. 3-fluorobutyl benzoate was isolated as 
the colorless liquid and run on HPLC to determine ee value. The fluorinated product was formed in 59% yield as 
determined by 19F NMR spectroscopic analysis of the crude reaction mixture.  
 
1-(3-Chloropropyl)benzene (22).[7]  General procedure C was employed using 1-(3-
phenylpropyl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and trichloroisocyanuric acid 
(0.375 mmol). A colorless liquid (25 mg, 65%) was isolated. 1H NMR (500 MHz, CDCl3): δ 
7.31-7.28 (m, 2H), 7.22-7.19 (m, 3H), 3.54-3.52 (t, J = 6.5 Hz, 2H), 2.80-2.77 (t, J = 7.4 Hz, 
2H), 2.11-2.07 (quint, J = 7.4, 6.7 Hz, 2H) ppm. 13C NMR (125 MHz, CDCl3): δ 140.9, 128.7, 







1-(3-bromopropyl)benzene (23).[7]    General procedure C was employed using 1-(3-
phenylpropyl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and N-bromosuccinimide 
(0.375mmol). A colorless liquid (41 mg, 82%) was isolated. 1H NMR (500 MHz, CDCl3): δ 
7.31-7.28 (m, 2H), 7.22- 7.19 (m, 3H), 3.38 (t, J = 6.6 Hz, 2H), 2.78 (t, J = 7.3 Hz, 2H), 2.20- 




1-(3-iodopropyl)benzene (24).[7]    General procedure C was employed using 1-(3-
phenylpropyl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and iodine (0.375 mmol). A 
colorless liquid (42 mg, 68%) was isolated. 1H NMR (500 MHz, CDCl3): δ 7.31- 7.28 (m, 2H), 
7.22- 7.19(m, 3H), 3.17 (t, J = 6.8 Hz, 2H), 2.73 (t, J = 7.2 Hz, 2H), 2.16- 2.22 (m, 2H) ppm. 13C 







1-(3-Chlorobutyl)benzene (25).[8]  General procedure C was employed using compound 1-(4-
phenylbutan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3] undecane (0.25 mmol) and trichloroisocyanuric 
acid (0.375 mmol). A colorless liquid (26 mg, 62%) was isolated. 1H NMR (500 MHz, CDCl3): δ 
7.31-7.28 (m, 2H), 7.21-7.20 (m, 3H), 4.03-3.96 (m, 1H), 2.88-2.83 (m, 1H), 2.77-2.71 (m, 1H), 
2.06-1.95 (m, 2H), 1.54(d, J = 6.6 Hz, 3H) ppm. 13C NMR(125 MHz, CDCl3): δ 141.3, 128.7, 
128.6, 126.2, 58.1, 42.1, 33.0, 25.6 ppm. 
 
(R)-(3-Chlorobutyl)benzene (34). General procedure E was performed using enantioenriched 1-
(4-phenylbutan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3] undecane (0.1 mmol) and 
trichloroisocyanuric acid (0.15 mmol). After the reaction was done, water was added to quench 
the reaction. The ee value (93% ee) was determined by HPLC analysis of the organic layer. The 







1-(3-Bromobutyl)benzene (26).[9]  General procedure C was employed using compound 
enantioenriched 1-(4-phenylbutan-2-yl) -5-aza-1-stanna-bicyclo[3.3.3] undecane (0.25 mmol) 
and N-bromosuccinimide (0.375 mmol). A colorless liquid (32 mg, 60%) was isolated. 1H NMR 
(500 MHz, CDCl3): δ 7.32-7.28 (m, 2 H), 7.22-7.18 (m, 3 H), 4.11-4.05 (dqd, J = 9.0, 6.5, 4.5 
Hz, 1 H), 2.87 (ddd, J = 14.0, 9.0, 5.5 Hz, 1 H), 2.74 (ddd, J = 14.0, 9.0, 7.0 Hz), 2.17-2.02 (m, 2 
H), 1.73 (d, J = 6.7 Hz, 3 H) ppm. 13C NMR (125 MHz, CDCl3): δ 141.1, 128.7, 128.6, 126.2, 







(R)-(3-Bromobutyl)benzene (35). General procedure E was performed using enantioenriched 1-
(4-phenylbutan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3] undecane (0.1 mmol) and N-
bromosuccinimide (0.15 mmol). After the reaction was done, water was added to quench the 
reaction. The ee value (97% ee) was determined by HPLC analysis of the organic layer.  The 







1-(3-Iodobutyl)benzene (27).[9]  General procedure C was employed using compound 1-(4-
phenylbutan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.25 mmol) and iodine (0.375 mmol). 
A colorless liquid (41 mg, 63%) was isolated. 1H NMR (500 MHz, CDCl3): δ 7.31-7.28 (m, 2 
H), 7.22-7.21 (m, 3 H), 4.15-4.08 (dqd, J = 9.0, 7.0, 4.5 Hz, 1 H), 2.88-2.82 (ddd, J = 14.0, 9.0, 
5.0 Hz, 1 H), 2.73-2.67 (ddd, J = 14.0, 9.0, 7.0 Hz, 1 H), 2.18-2.12 (dtd, J = 14.5, 9.0, 5.0 Hz, 1 
H), 1.95 (d, J = 6.9 Hz, 3 H), 1.92-1.85 (dddd, J = 14.5, 9.0, 7.0, 5.0 Hz, 1 H) ppm. 13C NMR 
(125 MHz, CDCl3): δ 140.7, 128.7, 128.6, 126.2, 44.6, 36.0, 29.8, 29.2 ppm. 
 
(R)-(3-Iodobutyl)benzene (36). General procedure E was performed using enantioenriched 1-(4-
phenylbutan-2-yl)-5-aza-1-stanna-bicyclo[3.3.3]undecane (0.1 mmol) and N-iodosuccinimide 
(0.15 mmol). After the reaction was done, water was added to quench the reaction. The ee value 
(92% ee) was determined by HPLC analysis of the organic layer. The yield (52%) was 
determined by calibrated gas chromatography. 
 





4. Investigation of the Stereochemical Course of the Fluorination Reaction. 
 
 
(S)-1-(3-Fluorobutyl)benzene (S4)[10] At -78 ºC, to the vial with (R)-4-phenylbutan-2-ol (1 
mmol)  in DCM (5 mL) was added diethylaminosulfur trifluoride (DAST, 1.2 mmol, 1.2 equiv.) 
under Ar. The reaction was warmed to room temperature slowly and stirred overnight. The 
reaction was quenched by water and extracted with ether 3 times. The combined organic layers 
were dried over Na2SO4, filtered, concentrated under reduced pressure and purified by purified 


























MHz, CDCl3): 7.33-7.26 (m, 2H), 7.23-7.17 (m, 3H), 4.66 (dm, J = 49.1Hz, 1H), 2.86-2.64 (m, 
2H), 2.08-1.71 (m, 2H), 1.35 (dd, J = 24.0 Hz, 6.18 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3) δ 
141.7, 128.6, 126.1, 90.3 (d, J = 162.8 Hz), 38.9 (d, J = 22.5 Hz), 31.6 (d, J = 4.8 Hz), 21.2 (d, J 










(R)-(3-Fluorobutyl)benzene (S5). General procedure D was employed using (S)-5-(4-
phenylbutan-2-yl)-1-aza-5-stannabicyclo[3.3.3] undecane (0.025 mmol, prepared from (R)-4-
phenylbutan-2-yl methanesulfonate[3]). After the reaction was complete, water was added to 
quench the reaction. The ee value (84% ee) was determined by HPLC analysis of the organic 






















Column IA 250x4.6 
Mobile phase [19:1 v/v Methanol/Acetonitrile]:H2O = 61%: 39%  
Flow rate 0.8 mL/min 
Detector 254 nm 
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and GC decomposition products 










from crude reaction  
1.972 min 











Conditions and results: 
Column IA-3mm 150x4.6 
Mobile Phase Hexane : IPA = 100 : 0.1 
Flow 0.6 mL/min 
Detector 220 nm 
Temp 25°C 



















Conditions and results: 
Column Chiralcel OJ-H 250x4.6 
Mobile Phase Methanol : Water = 95% : 5%   
Flow 1.0 mL/min 
Detector 215 nm 
Temp 25°C 


















Conditions and results 
Column IA 250x4.6 
Mobile phase Hexane : IPA = 90% : 10%  
Flow rate 0.3 mL/min 
Detector 210 nm 
Temperature 25 ºC 































Conditions and results: 
Column IA 250x4.6 
Mobile phase [19:1 v/v Methanol/Acetonitrile] : H2O = 61% : 39%  
Flow rate 0.8 mL/min 
Detector 254 nm 
Temperature 25 ºC 























Conditions and results: 
Column IA 250x4.6 
Mobile phase [19:1 v/v Methanol/Acetonitrile]:Sodium phosphate buffer 
(25mM, pH 7.8) = 60%: 40%  
Flow rate 0.8 mL/min 
Detector 254 nm 
Temperature 25 ºC 

















89% ee, 90% es 
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Scheme 6, compound 32 
 
Column IA 250x4.6 
Mobile phase [19:1 v/v Methanol/Acetonitrile]:Sodium phosphate buffer 
(25mM, pH 7.8) = 60% : 40%  
Flow rate 0.8 mL/min 
Detector 254 nm 
Temperature 25 ºC 
Result 86% ee, 89% es 
 
 





Conditions and results: 
Column IA 250x4.6 
Mobile phase [19:1 v/v Methanol/Acetonitrile]:Sodium phosphate buffer 
(25mM, pH 7.8) = 60% : 40%  
Flow rate 0.8 mL/min 
Detector 254 nm 
Temperature 25 ºC 







 86% ee, 89% es 
 194 





Scheme 6, entry 31 
87% ee (88% es) 
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Conditions and results: 
Column IA 250x4.6 
Mobile phase [19:1 v/v Methanol/Acetonitrile]:H2O = 60% : 40%  
Flow rate 0.9 mL/min 
Detector 210 nm 
Temperature 25 ºC 
























Scheme 6, entry 35 
97% ee (98% es) 
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Conditions and results: 
Column IA 250x4.6 
Mobile phase [19:1 v/v Methanol/Acetonitrile]:H2O = 70% : 30%  
Flow rate 0.8 mL/min 
Detector 254 nm 
Temperature 25 ºC 
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General reagent/analytical information 
General reagent information 
BDH brand ethyl ether was purchased from VWR. EMD brand Omnisolv THF (unstabilized) 
was also purchased from VWR. These solvents were transferred to separate 20 L solvent-
delivery kegs and vigorously purged with argon for 2 h. The solvents were further purified by 
passing them under argon pressure through two packed columns of neutral alumina. Pd(dba)2 and 
JackiePhos were purchased from Strem. Acetonitrile (Sigma-Aldrich) was purged with argon 
prior to use.  5-chloro-1-aza-5-stannabicyclo[3.3.3]undecane was purchased from Sigma-
Aldrich, and purified through silica gel with 100% DCM prior to use. Reagents and solvents 
were used as received unless otherwise noted. Normal phase flash chromatography was 
performed using Silicylcle silica gel (ultra pure grade). Reversed phase flash chromatography 
was performed using C18 silica gel, 17%C, 40-63 µm (Acros). 
 
General analytical information 
All NMR spectra were obtained on a Bruker 300 (300 MHz for 1H and 75 MHz for 13C). All 1H 
NMR experiments are reported in δ units, parts per million (ppm), and were measured relative to 
the signals for residual chloroform (7.26 ppm) unless otherwise noted. The following 
abbreviations are used to express the multiplicities: s = singlet; d = doublet; t = triplet; m = 
multiplet. All 13C NMR spectra are reported in ppm relative to deuterochloroform (77.16 ppm), 
and were obtained with 1H decoupling. All GC analyses were performed on a Shimadzu GC-
2010 gas chromatograph with an FID detector using a 25 m x 0.20 mm capillary column with 
cross-linked methyl siloxane as the stationary phase. Chiral HPLC analyses were performed 
using a Shimadzu Prominence HPLC system with binary mobile phase pumps and UV-vis 
detector (LC-20AB, SPD-20A) using an OJ-RH (dimensions: 4.6 mm x 150 mm; particle size: 5 
µm) chiral column (DAICEL CHEMICAL IND., LTD.), or an IA (dimensions: 4.6 mm x 150 
mm; particle size: 5 µm) chiral column (DAICEL CHEMICAL IND., LTD.).  
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General procedure information 
Preparation of stannatrane-lithium solution: 
To an empty 50mL flame dried one neck RBF was added lithium granules (47.3mg, 2.5eq), 
stannatrane chloride (802mg, 1.0 eq), and naphthalene (35mg, 0.1eq) under a strict argon 
atmosphere.  Without a stirbar, the RBF was sealed with a rubber stopper.  THF (9mL, 0.3M) 
was injected through the rubber stopper, and the RBF was sonnicated at 40-45 °C until lithium 
was almost completely consumed, confirmed by visual inspection, after 4-6 hours of heated 
sonication. The dark green/black opaque solution was then transferred under argon to a sealed 
vessel for storage at -20 °C, at 5-10% decomposition per day. 
 
Preparation of additional stannatrane-anions: 
 
To a 50mL flame dried one neck RBF sealed with a rubber stopper was added 1.0 eq stannatrane 
lithium solution and a glass magnetic stirbar under a strict argon atmosphere. The solution was 
cooled to 0°C, and an appropriate amount of attenuating agent was added as a liquid, or as a 
solid under positive argon pressure.  The mixture was stirred at 0°C for one hour. 
 
Preparation of 2° alkyl mesylate (3-octyl mesylate) 
 
To a 200mL RBF with magnetic stirbar was added the commercially available 2° alkyl alcohol 
(2g, 1.0eq), triethylamine (4.3mL, 2.0eq), and dichloromethane (150mL, 0.1M).   The RBF was 
sealed with a rubber stopper.  At room temperature, methanesulfonyl chloride (1.31mL, 1.1eq) 
was added slowly over 5 minutes.  The solution was allowed to stir at room temperature 
overnight.  TLC with potassium permanganate was used to confirm reaction completion.  The 
organic layer was washed with water, 2x with saturated bicarbonate, dried with sodium sulfate, 
and condensed.  The resulting oil was then purified via flash chromatography using 100% DCM 
as the mobile phase.  
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General procedure A for the preparation of racemic alkylstannatrane via stannatrane anion:  
 
To a 50mL flame dried one neck RBF sealed with a rubber stopper was added 1.0eq alkyl 
mesylate and a glass stirbar.  The flask was evacuated and backfilled 3x with argon.  THF (0.1M) 
was added with stirring, followed by a slow addition of stannatrane anion (1.5 eq).  The reaction 
was allowed to stir overnight.  Water was added, and extracted with hexane 3 times.  The organic 
layers were combined, dried with sodium sulfate, and condensed.  The thick oil was purified with 
reversed phase column chromatography (100% acetonitrile to 15% DCM in acetonitrile), 
fractions were monitored by reversed phase HPLC with a c18 column or reversed phase TLC.  
 
General procedure B for the preparation of enantioenriched alkylstannatrane via stannatrane 
anion: 
 
To a 50mL flame dried one neck RBF sealed with a rubber stopper was added 1.0eq alkyl 
mesylate and a glass stirbar.  The flask was evacuated and backfilled 3x with argon.  n-Hexane 
(0.1M) was added with stirring, followed by a slow addition of stannatrane anion (1.5 eq).  The 
reaction was allowed to stir overnight.  Water was added, and extracted with hexane 3 times.  
The organic layers were combined, dried with sodium sulfate, and condensed.  The thick oil was 
purified with reversed phase column chromatography, fractions monitored by reversed phase 
HPLC with a c18 column.  
 
General procedure C for cross-coupling arylation reactions with aryl-bromides 
Pd(dba)2 (5 mol %, 14.4 mg for 0.5 mmol scale and 28.8 mg for 1.0 mmol scale), JackiePhos (6-
10 mol %), CuCl (2 equiv, 100 mg for 0.5 mmol scale and 200 mg for 1.0 mmol scale) and KF 
(2 equiv, 58 mg for 0.5 mmol scale and 116 mg for 1.0 mmol scale) were weighed out on the 
benchtop, and transferred to an oven-dried screwtop vial with stir bar. With stirring begun, the 
Sealed vial was evacuated (50 mTorr) and backfilled three times with argon using a needle 
attached to a vacuum manifold. The tin reagent (1.1-2.0 equiv) and aryl halide/triflate (1 equiv) 
was then added to the screwtop vial via microsyringe, followed by degassed CH3CN (3 mL for 
0.5-1.0 mmol scale). If the aryl halide/triflate or the tin reagent was a solid, it was weighed out 
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on the benchtop alongside the other solids. The vial was then heated to 60 °C for 6-12h. The 
reaction mixture was cooled to rt, diluted with ether, washed sequentially with saturated aqueous 
KF and brine, and dried over Na2SO4. The reaction solution was filtered and concentrated to 
provide the crude product. The crude product was purified by column chromatography.  
 
Compound characterization data: 
   
5-(6-methyl-5-hepten-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane. General procedure A was 
employed using stannatrane lithium (9mL, 2.73mmol) and racemic 6-methyl-5-hepten-2-yl 
mesylate (375mg, 1.82mmol).  A pale yellow oil was obtained (365mg, 54% yield). 1H NMR 
(300 MHz, CDCl3) δ: 5.12 (m, 1H), 2.35 (m, 6H), 1.92 (m, 2H), 1.80-1.25 (m, 14H), 1.06 (d, J = 
7.5 Hz, 3H), 0.65 (m, 7H) ppm. 13C NMR (75MHz, CDCl3) δ: 130.6, 125.8, 54.9, 36.8, 28.6, 
25.9, 24.1, 23.6, 18.6, 17.8, 5.5 ppm. Racemates were separated by derivatization via cross-
coupling with 4-bromo-2H-1,4-benzoxazin-3(4H)-one. 
   
(S) 5-(6-methyl-5-hepten-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane. General procedure B 
was employed using stannatrane lithium (9.5mL, 2.90mmol) and  (R)-6-methyl-5-hepten-2-yl 
mesylate (400mg, 1.93mmol).  A pale yellow oil was obtained (362mg, 51% yield). 1H NMR 
(300 MHz, CDCl3) δ: 5.12 (m, 1H), 2.35 (m, 6H), 1.92 (m, 2H), 1.80-1.25 (m, 14H), 1.06 (d, J = 
7.5 Hz, 3H), 0.65 (m, 7H) ppm. 13C NMR (75MHz, CDCl3) δ: 130.6, 125.8, 54.9, 36.8, 28.6, 
25.9, 24.1, 23.6, 18.6, 17.8, 5.5 ppm. Enantiopurity of 98.7% ee obtained by derivatization via 








    
5-(3-octyl)-1-aza-5-stannabicyclo[3.3.3]undecane. General procedure A was employed using 
stannatrane lithium (13.5mL, 4.11mmol) and racemic 3-octyl mesylate (521mg, 2.5mmol).  A 
pale yellow oil was obtained (478mg, 51% yield). 1H NMR (300 MHz, CDCl3) δ: 2.35 (m, 6H), 
1.63 (m, 6H), 1.53- 1.15 (m 10H), 0.83 (m, 6H), 0.63 (m, 7H) ppm. 13C NMR (75MHz, CDCl3) 
δ: 55.0, 33.9, 33.2, 29.8, 26.2, 23.7, 23.0, 14.6, 14.4, 6.8 ppm. 
 
   
1-(octan-3-yl)-3,4-(methylenedioxy)benzene. General procedure C was employed using 5-(3-
octyl)-1-aza-5-stannabicyclo[3.3.3]undecane and 1-bromo-3,4-(methylenedioxy)benzene on a 
0.04 mmol scale.  A colorless oil was obtained (9mg, 60% yield) after column chromatography 
0% to 50% DCM in hexane. 1H NMR (300 MHz, CDCl3) δ: 6.72 (d, J = 7.8 Hz, 1H), 6.58 (m, 
2H), 2.30 (m, 1H), 1.51 (m, 4H), 1.71 (m, 6H), 0.84 (t, 3H), 0.75 (t, 3H) ppm.  13C NMR 
(75MHz, CDCl3) δ: 147.6, 145.5, 140.2, 121.0, 108.0, 107.7, 100.8, 47.8, 36.9, 32.1, 30.0, 27.4, 




   
4-(octan-3-yl)-acetophenone. General procedure C was employed using 5-(3-octyl)-1-aza-5-







was obtained (13.4mg, 90% yield) after column chromatography 50% DCM in hexane to 100% 
DCM. 1H NMR (300 MHz, CDCl3) δ: 7.87 (d, J = 8.1Hz, 2H), 7.23 (d, J = 9Hz, 2H), 2.59 (s, 
3H), 2.47 (m, 1H), 1.60 (m, 4H), 1.20 (m, 6H), 0.82 (t, 3H), 0.76 (t, 3H) ppm. 13C NMR 
(75MHz, CDCl3) δ: 198.1, 152.3, 135.3, 128.6, 128.1, 48.1, 36.4, 32.0, 29.7, 27.4, 26.7, 22.7 
ppm.  
 
   
6-(octan-3-yl)-2H-1,4-benzoxazin-3(4H)-one. General procedure C was employed using 5-(3-
octyl)-1-aza-5-stannabicyclo[3.3.3]undecane and 4-bromo-2H-1,4-benzoxazin-3(4H)-one on a 
0.04 mmol scale. A white crystalline solid was obtained (6.3mg, 59% yield) after column 
chromatography 100% DCM to 10% ethylacetate in DCM. 1H NMR (300 MHz, CDCl3) δ: 7.65 
(s, 1H), 6.89 (d, J = 8.4 Hz, 1H), 6.74 (d, J = 9 Hz, 1H), 6.52, (d, J = 2.1Hz, 1H), 4.60 (s, 2H), 
2.32 (m, 1H), 1.61 (m, 4H), 1.21 (m, 6H), 0.84 (t, 3H), 0.76 (t, 3H) ppm. 13C NMR (75MHz, 
CDCl3) δ: 141.8, 141.2, 125.9, 123.5, 116.6, 115.1, 67.5, 47.4, 36.7, 32.1, 29.9, 27.4, 22.7, 31.2, 
14.2, 12.3 ppm.  
 
    
4(4-((tert-Butyldimethylsilyl)oxy)butan-2-yl)-acetophenone. General procedure C was 
employed using 5-(4-((tert-Butyldimethylsilyl)oxy)butan-2-yl)-1-aza-5-
stannabicyclo[3.3.3]undecane and 4-bromoacetophenone on a 0.04 mmol scale. A white 
crystalline solid was obtained (12.1mg, 94% yield) after column chromatography 90% DCM in 
hexane. 1H NMR (300 MHz, CDCl3) δ: 7.89 (d, J = 8.4, 2H), 7.28 (d, J = 8.4, 2H), 3.50 (m, 2H), 
2.97 (m, 1H), 2.59 (s, 3H), 1.80 (q, J = 4.2 Hz, 2H), 1.26 (d, J = 6.9 Hz, 3H), 0.88 (s, 9H), -0.01 
(s, 6H) ppm. 13C NMR (75MHz, CDCl3) δ: 198.0, 153.3, 135.4, 128.7, 127.5, 61.0, 41.0, 36.3, 







reversed phase chiral-HPLC implementing an OJ-RH column, 70% acetonitrile in water, 1.2 
mL/min, 254nm (tR = 35, 39min) 
 
   
1-(4-((tert-Butyldimethylsilyl)oxy)butan-2-yl)-3,4-(methylenedioxy)benzene. General 
procedure C was employed using 5-(4-((tert-Butyldimethylsilyl)oxy)butan-2-yl)-1-aza-5-
stannabicyclo[3.3.3]undecane and 1-bromo-3,4-(methylenedioxy)benzene on a 0.04 mmol scale. 
A white crystalline solid was obtained (9mg, 71% yield) after column chromatography 50% 
DCM in hexane. 1H NMR (300 MHz, CDCl3) δ: 6.68 (m, 3H), 5.92 (s, 2H), 3.50 (m, 2H), 2.81 
(m, 1H), 1.73 (q, J = 6.6Hz, 2H), 1.20 (d, J = 8.4 Hz, 3H), 0.88 (s, 9H), 0.00 (s, 6H) ppm. 13C 
NMR (75MHz, CDCl3) δ: 147.7, 145.7, 141.5, 120.1, 108.2, 107.4, 100.9, 61.3, 41.5, 36.1, 26.1, 
22.7, 18.4, -5.1 ppm. Analytical resolution of the racemate can be achieved by reversed phase 
chiral-HPLC implementing an IA column, 1.0 mL/min, acetonitrile and water at the following 
method, 40%B for 10 minutes, gradient to 60%B at 50 minutes, 254nm (tR = 43, 46min). 
 
 
2-(4-((tert-Butyldimethylsilyl)oxy)butan-2-yl)naphthalene. General procedure C was 
employed using 5-(4-((tert-Butyldimethylsilyl)oxy)butan-2-yl)-1-aza-5-stannabicyclo[3.3.3] 
undecane and 2-bromonaphthalene on a 0.04 mmol scale. A white crystalline solid was obtained 
(9.5mg, 73% yield) after column chromatography 10% to 50% DCM in hexane. 1H NMR (300 
MHz, CDCl3) δ: 7.80 (m, 3H), 7.62 (s, 1H), 7.35 (m, 3H), 3.53 (m, 2H), 3.07 (m, 1H), 1.89 (q, J 
= 6.9Hz, 2H), 1.34 (d, J = 6.9 Hz, 3H), 0.89 (s, 9H), 0.00 (s, 6H) ppm. 13C NMR (75MHz, 
CDCl3) δ: 144.8, 133.8, 132.3, 128.1, 127.7, 127.6, 126.0, 125.9, 125.4, 125.2, 61.4, 41.2, 36.4, 
26.1, 22.5, 18.4, 5.2 ppm. Analytical resolution of the racemate can be achieved by reversed 






254nm (tR = 9.2, 12.2 min). 
 
 
   
6-(6-methyl-5-hepten-2-yl)-2H-1,4-benzoxazin-3(4H)-one. General procedure C was 
employed using 5-(6-methyl-5-hepten-2-yl)-1-aza-5-stannabicyclo[3.3.3]undecane and 4-bromo-
2H-1,4-benzoxazin-3(4H)-one on a 0.04 mmol scale. A white crystalline solid was obtained 
(7mg, 63% yield) after column chromatography 0% to 25% ethylacetate in DCM. 1H NMR (300 
MHz, CDCl3) δ: 8.25 (s, 1H), 6.89 (d, J = 8.4 Hz, 1H), 6.79 (d, J = 6.3, 1H), 6.60 (d, J = 2.0 Hz, 
1H), 5.07 (m, 1H), 4.60 (s, 2H), 2.63 (m, 1H), 1.86 (m, 2H), 1.57 (t, 2H), 1.52 (s, 3H), 1.19 (d, J 
= 6.9 Hz, 3H) ppm. 13C NMR (75MHz, CDCl3) δ:166.1, 142.8, 141.8, 131.8, 126.0, 124.4, 
122.8, 116.7, 114.5, 67.5, 39.0, 38.5, 26.1, 25.9, 22.6, 17.8 ppm. Analytical resolution of the 
racemate can be achieved by normal phase chiral-HPLC implementing an IA column, 5% 
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Retention Time Area Area % Height Height %
34.992 3578646 42.34 54441 43.60
38.808 4034417 47.73 57337 45.92
41.417 486068 5.75 7778 6.23
44.983 45457 0.54 698 0.56
47.000 125127 1.48 2036 1.63
48.417 15840 0.19 171 0.14
53.258 14000 0.17 210 0.17
58.725 90462 1.07 1078 0.86
60.525 62857 0.74 1105 0.89
Totals




Retention Time Area Area % Height Height %
1.275 2453 0.01 249 0.05
1.892 2476 0.01 137 0.03
4.258 9075 0.03 444 0.09
6.108 26246 0.08 693 0.13
35.000 16073110 47.14 246394 47.26
38.817 17279436 50.68 265144 50.86
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Retention Time Area Area % Height Height %
36.658 3323549 18.15 51182 17.69
43.442 7223680 39.45 118075 40.81
46.025 7765933 42.41 120049 41.50
Totals




Retention Time Area Area % Height Height %
0.192 274 0.01 36 0.08
0.333 64 0.00 14 0.03
1.258 2355 0.09 268 0.62
1.367 2267 0.09 237 0.55
1.900 2769 0.10 251 0.58
2.033 1956 0.07 247 0.57
2.475 1194 0.04 83 0.19
2.583 549 0.02 78 0.18
2.758 995 0.04 78 0.18
2.983 166 0.01 25 0.06
3.875 102 0.00 20 0.05
6.317 14428 0.54 393 0.91
7.200 127 0.00 14 0.03
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Area % Report
Data File: C:\EZStart\Data\GR-553-2E-4.dat 
Method: C:\EZStart\Projects\Default\Method\Ma-method-2.met 
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Retention Time Area Area % Height Height %
0.542 48 0.00 15 0.05
0.683 31 0.00 8 0.03
0.983 7444 0.65 692 2.35
1.583 3029 0.26 199 0.67
1.775 1062 0.09 132 0.45
2.208 271 0.02 22 0.07
2.942 767 0.07 64 0.22
3.233 2209 0.19 118 0.40
3.525 957 0.08 51 0.17
5.433 46005 4.00 1081 3.67
6.283 130 0.01 15 0.05
9.233 538040 46.82 14830 50.29
10.333 114 0.01 19 0.06
12.200 546252 47.54 12066 40.91
14.867 2045 0.18 68 0.23
16.217 84 0.01 9 0.03
16.517 74 0.01 22 0.07
20.567 120 0.01 18 0.06
20.858 169 0.01 20 0.07
21.958 76 0.01 17 0.06
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Retention Time Area Area % Height Height %
26.700 10725762 49.72 399508 52.15
27.750 10847408 50.28 366590 47.85
Totals
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Retention Time Area Area % Height Height %
26.708 327149 0.64 12749 0.77
27.875 50496458 99.36 1645319 99.23
Totals




Retention Time Area Area % Height Height %
1.017 8755 0.04 289 0.03
3.425 53647 0.23 1125 0.13
5.492 6843309 28.75 115975 13.42
8.217 4044 0.02 380 0.04
8.408 14911 0.06 365 0.04
10.225 264594 1.11 18598 2.15
10.892 4999472 21.01 326667 37.81
11.892 23434 0.10 1273 0.15
12.492 116523 0.49 7570 0.88
13.025 37355 0.16 1536 0.18
13.433 26398 0.11 1228 0.14
13.758 10155 0.04 690 0.08
14.283 26206 0.11 1587 0.18
14.658 204480 0.86 11636 1.35
15.275 225679 0.95 11011 1.27
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1H and 13C NMR Spectra 
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